FBR's COVID-19 Resources

We're committed to improving health through education

Nearly every medicine, medical device, surgical procedure and therapy we have today has depended on animal testing and research. Animal research is one of the first steps in medical discovery.

“There are diseases in which you vaccinate someone, they get infected with what you are trying to protect them with, and you actually enhance the infection. You can get a good feel for that in animal models,” the director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, said during a White House briefing on March 26.

Contrary to the claims of animal rights groups, animal models have been and will continue to be crucial to medical development and public health. 

The FBR team rounded up articles in the news in recent weeks on potential treatments and potential vaccines for the new coronavirus, as well as other COVID-19 developments, and the animal models used to develop them. In addition, Genetic Engineering & Biotechnology News put together a list (found here) of potential COVID-19 treatments in development.

Animal Research on the Front Lines

2021
December

Dec. 2: ‘Center for Translational Antiviral Research reports novel drug class with activity against SARS-CoV-2,’ Georgia State University

Dec. 2: ‘Hospitals refused to give patients ivermectin. Lockdowns and political pressure followed,’ Kaiser Health News

Dec. 2: ‘Omicron variant may have evolved in rats, one theory says,’ Live Science

Dec. 2: ‘Risk vs. reward: US panel narrowly recommends Merck’s COVID pill,’ Local 4 News

Dec. 2: ‘Some experts suggest Omicron variant may have evolved in an animal host,’ STAT News

Dec. 1: ‘St. Louis Zoo announces big cats recovered from COVID-19,’ KSDK

Dec. 1: ‘Noon Wednesday: What’s known about COVID-19 in deer,’ PBS Wisconsin

Dec. 1: ‘Where did “weird” Omicron come from?’ Science

Dec. 1: ‘Omicron’s best- and worst-case scenarios,’ The Atlantic

Dec. 1: ‘What J&J can still teach us,’ The Atlantic

Dec. 1: ‘COVID-19 cases nearly double in South Africa as Omicron reaches more countries,’ The Wall Street Journal

November

Nov. 30: ‘An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns,’ Business Insider

Nov. 30: ‘Are undiscovered coronaviruses protecting Africa from COVID-19?’ Forbes

Nov. 30: ‘Merck’s COVID-19 pill narrowly wins FDA panel’s support,’ Los Angeles Times

Nov. 30: ‘FDA panel narrowly recommends authorization of first antiviral pill to treat COVID-19,’ STAT News

Nov. 30: ‘New COVID-19 vaccine may protect against existing and future strains of coronavirus,’ Staunton News Leader

Nov. 30: ‘Will omicron – the new coronavirus variant of concern – be more contagious than delta? A virus evolution expert explains what researchers know and what they don’t,’ The Conversation

Nov. 30: ‘COVID-19 antibody drugs are challenged by Omicron, preliminary testing indicates,’ The Wall Street Journal

Nov. 30: ‘City: 5 big cats show signs of COVID-19 at Miller Park Zoo,’ WGLT

Nov. 29: ‘The Omicron variant of SARS-CoV-2 has minimal impact on the T cell epitopes (targets) contained within Gritstone’s self-amplifying mRNA COVID-19 vaccines,’ Globe Newswire

Nov. 29: ‘Extended host range for SARS-CoV-2 variants of concern,’ News Medical

Nov. 29: ‘UGA scientists lead efforts to understand, correct animal-to-human disease spillover,’ The Albany Herald

Nov. 29: ‘Will the new omicron variant cause severe disease or just a runny nose?’ The Telegraph

Nov. 29: ‘APLIF: PRESECO trial unsuccessful in COVID-19..,’ Zacks SCR

Nov. 28: ‘China probably got rid of intermediary COVID-19 host between bats, humans, Fauci says,’ The Hill

Nov. 26: ‘New Hampshire, Vermont asked to test deer for COVID-19,’ The Associated Press

Nov. 26: ‘Singapore Zoo, Night Safari lions infected by COVID-19 Delta strain: AVS,’ Yahoo News Singapore

Nov. 25: ‘No-needle COVID-19 vaccine trials begin with help from ‘special’ participants and dogs,’ WLWT-TV

Nov. 24: ‘The lab-leak theory meets its perfect match,’ The Atlantic

Nov. 24: ‘Robust approach needed to reduce risk of disease transmission between humans and wild animals,’ University of Birmingham

Nov. 23: ‘An increase in the half-life of remdesivir for COVID-19 treatment,’ News Medical

Nov. 23: ‘Which animals are likely to harbour the coronavirus?’ The Economist

Nov. 22: ‘Study shows porcine deltacoronavirus (PDCoV) is capable of zoonotic transfer,’ News Medical

Nov. 22: ‘COVID-19 testing kits also can measure oral microbiome in saliva,’ Rutgers Today

Nov. 21: ‘How will the COVID pills change the pandemic?’ The New Yorker

Nov. 20: ‘SARS-CoV-2 could be lurking in animal hidey-holes,’ The Economist

Nov. 20: ‘Twin State biologists checking deer for COVID-19,’ Valley News

Nov. 19: ‘Research finds rodents could be asymptomatic carriers of SARS-like coronaviruses,’ ANI

Nov. 19: ‘mRNA COVID-19 vaccine improved through mRNA Backbone optimization,’ Genetic Engineering & Biotechnology News

Nov. 19: ‘Column: A new research paper adds to the evidence that COVID-19 came from animals, not a Chinese lab,’ Los Angeles Times

Nov. 19: ‘Here are the facts about fetal cell lines and COVID-19 vaccines,’ National Georgraphic

Nov. 18: ‘CureVac to begin trials for next-generation COVID-19 shots within months,’ Reuters

Nov. 18: ‘Dissecting the early COVID-19 cases in Wuhan,’ Science

Nov. 18: ‘Ivermectin may help COVID-19 patients, but only those with worms,’ The Economist

Nov. 18: ‘First known Covid case was vendor at Wuhan market, scientist says,’ The New York Times

Nov. 18: ‘New design may boost potency of monoclonal antibodies against COVID,’ The Rockefeller University

Nov. 18: ‘Prominent scientist who said lab-leak theory of covid-19 origin should be probed now says evidence points to Wuhan market,’ The Washington Post

Nov. 17: ‘Philly Zoo almost halfway through first batch of vaccines for animals,’ Axios Philadelphia

Nov. 17: ‘Coronavirus spreads in deer and other animals. Scientists worry about what that means for people,’ CNN

Nov. 17: ‘The definition of “fully vaccinated” is changing to 3 COVID-19 doses,’ CNN

Nov. 17: ‘Zoos vaccinate animals against SARS-CoV-2,’ Journal of the American Veterinary Medical Association

Nov. 17: ‘AI predicts which mammals are most likely to spread COVID-19,’ New Scientist

Nov. 17: ‘A video that originated on InfoWars is filled with falsehoods about COVID-19 vaccines,’ PolitiFact

Nov. 17: ‘Prophet in purgatory,’ Science

Nov. 17: ‘COVID can cause strange eye and ear symptoms,’ Scientific American

Nov. 17: ‘With 128 Covid vaccines in clinical development, we don’t know if the approved/authorized ones are the best ones,’ STAT News

Nov. 17: ‘The double-whammy COVID-flu,’ The Atlantic

Nov. 16: ‘The animal kingdom is full of coronaviruses. Here’s what that means for COVID’s future,’ Popular Science

Nov. 15: ‘8 lingering questions about the new Covid pills from Merck and Pfizer,’ STAT News

Nov. 15: ‘Why don’t we have a Covid vaccine for pets?’ The New York Times

Nov. 15: ‘Lions, tigers, leopards all have tested positive for COVID: What we know about the virus in animals,’ USA Today

Nov. 14: ‘How monkeys were tracked for Covaxin trial!’ Press Trust of India

Nov. 14: ‘A zoo’s three “beloved” snow leopards die of COVID-19,’ The Washington Post

Nov. 13: ‘Snow leopards die of COVID-19 complications at Nebraska zoo,’ CNN

Nov. 13: ‘Three “beloved” snow leopards died of Covid complications at Nebraska zoo,’ The New York Times

Nov. 12: ‘China’s wildlife is a pandemic “waiting to happen,” study finds,’ Bloomberg

Nov. 12: ‘COVID-19 weekly newsletter: Cases rise for first time in two months, global vaccine tracker unveiled,’ Faegre Drinker

Nov. 12: ‘Investigating antidepressants’ surprising effect on COVID deaths,’ Scientific American

Nov. 12: ‘Eight big cats at St. Louis Zoo test positive for coronavirus,’ St. Louis Post-Dispatch

Nov. 12: ‘Nova Scotia to pay for COVID-19 vaccines for mink as B.C. shutters industry,’ The Canadian Press

Nov. 12: ‘Omaha zoo reports two tigers with COVID-19,’ WOWT

Nov. 11: ‘Viral evolution in animals could reveal future of COVID-19,’ Colorado State University

Nov. 11: ‘8 big cats at the Saint Louis Zoo test positive for SARS-CoV-2,’ KMOV.com

Nov. 11: ‘How do people resist COVID infections? Hospital workers offer a hint,’ Nature

Nov. 10: ‘COVID-19 update: Pfizer requests broad booster authorization, long COVID questioned,’ BioSpace

Nov. 10: ‘Gritstone announces positive preclinical data in non-human primate challenge study with second-generation COVID-19 vaccine against SARS-CoV-2,’ Globe Newswire

Nov. 10: ‘Gritstone Bio sees positive data from trial for potential COVID-19 vaccine,’ MarketWatch

Nov. 10: ‘Cause of neurological COVID-19 symptoms explored,’ Medical News Today

Nov. 10: ‘How SARS-CoV-2 in American deer could alter the course of the global pandemic,’ NPR

Nov. 10: ‘Lots of wild deer are getting SARS-CoV-2. Scientists say this could be a huge problem,’ NPR

Nov. 10: ‘How COVID might sow chaos in the brain,’ Scientific American

Nov. 10: ‘COVID vaccinations for pets, still not recommended according to Virginia Tech veterinarian,’ Virginia Tech

Nov. 9: ‘A measles-vectored COVID-19 vaccine induces strong immunity in animal model,’ News Medical

Nov. 9: ‘SARS-CoV-2 leaves long-term impact on olfactory neurocircuit,’ News Medical

Nov. 8: ‘Columbus Zoo vaccinates animals against COVID-19,’ Axios Columbus

Nov. 8: ‘Study offers insights on why the elderly are more susceptible to COVID-19,’ Brown University

Nov. 8: ‘Pfizer oral antiviral safe and effective against SARS-CoV-2,’ Medical News Today

Nov. 8: ‘How protein-based COVID vaccines could change the pandemic,’ Nature

Nov. 7: ‘COVID-19 infecting whitetail deer, studies find,’ Billings Gazette

Nov. 7: ‘COVID-19 vaccines and myocarditis link probed by researchers,’ The Wall Street Journal

Nov. 5: ‘Covid linked to heart inflammation in cats and dogs,’ NBC News

Nov. 5: ‘COVID variant tied to heart inflammation in cats, dogs,’ HealthDay News

Nov. 5: ‘Experimental Pfizer pill prevents Covid hospitalizations and deaths,’ STAT News

Nov. 5: ‘Is the debate over the origin of COVID-19 still worth having?’ STAT News

Nov. 5: ‘Denver Zoo reports world’s first coronavirus cases in hyenas,’ The Associated Press

Nov. 5: ‘COVID-19 found to infect neurons through nose, passing blood barrier and causing brain fogs,’ The Science Times

Nov. 5: ‘SARS-CoV-2 variant detected in dogs and cats with suspected myocarditis,’ Wiley

Nov. 4: ‘Iowa study: 82.5% of deer tested positive for COVID-19,’ FOX 9

Nov. 4: ‘Glowing viruses allow San Antonio researchers to track how COVID-19 spreads in real time,’ KSAT

Nov. 4: ‘How Covid attacks the brain may explain long-lasting symptoms,’ NBC News

Nov. 4: ‘Novel model-based framework evaluates immune mechanism of COVID-19 vaccine response,’ News Medical

Nov. 4: ‘Pandemic coronavirus is widespread in Iowa deer,’ Science

Nov. 4: ‘UK authorizes Merck antiviral pill, 1st shown to treat COVID,’ The Associated Press

Nov. 3: ‘COVID-19 can infect inner ear cells, researchers say,’ Fox News

Nov. 3: ‘Pre-clinical follow-up study boosting with original formulation and next generation INO-4802 SARS-CoV-2 vaccine candidate,’ News Medical

Nov. 3: ‘LSU vet school lab testing pet cats and dogs for COVID-19,’ The Associated Press

Nov. 3: ‘Preventing future pandemics starts with recognizing links between human and animal health,’ The Conversation

Nov. 2: ‘New study suggests SARS-CoV-2 spreading widely within wild deer population,’ Ars Technica

Nov. 2: ‘Sniffing out COVID-19,’ curiousSCIENCEwriters

Nov. 2: ‘Monoclonal antibodies prevent COVID-19 inflammation in macaques,’ Drug Target Review

Nov. 2: ‘Widespread coronavirus infection found in Iowa deer, new study says,’ The New York Times

Nov. 2: ‘Does biological sex influence COVID-19 outcomes?’ The Scientist

Nov. 1: ‘TGen study indicates humans spread COVID-19 to pets, not the other way around,’ 3TV/CBS 5

Nov. 1: ‘A COVID-19 vaccine patch could produce a better immune response than an injection, an early study shows,’ Business Insider

Nov. 1: ‘Infertility is not a risk with COVID-19 vaccines for kids,’ CNN

Nov. 1: ‘The vaccine shots that rang around the world,’ Nature

Nov. 1: ‘Virus detective: searching for Zika, dengue and SARS-CoV-2,’ Nature

Nov. 1: ‘Pregnant people were shut out of Covid vaccine trials — with disastrous results,’ Politico

Nov. 1: ‘Joe Rogan has COVID-19, is taking unproven deworming medicine,’ The Washington Post

Nov. 1: ‘Antibody treatment prevents inflammation in lungs, nervous system in macaques with SARS-CoV-2,’ UC Davis

October

Oct. 31: Zydus Cadila testing a multi-variant COVID-19 vaccine on animals,’ Business Standard

Oct. 30: ‘University professors successfully diagnose COVID-19 in two new animal species,’ The Daily Illini

Oct. 29: ‘Common antidepressant slashes risk of COVID death,’ Nature

Oct. 29: ‘The search for people who never get COVID,’ Nature

Oct. 29: ‘New COVID-19 treatment being tested in Riverside County,’ Patch

Oct. 29: ‘US intel doesn’t expect to determine origins of COVID-19,’ The Associated Press

Oct. 29: ‘Intelligence community releases spy agency’s “case” for Wuhan lab leak COVID-19 hypothesis,’ Washington Examiner

Oct. 28: ‘Clinical trials of oral therapeutics for COVID-19 patients will take place at Riverside University Health System Medical Center,’ Palm Springs Desert Sun

Oct. 28: ‘U.S. bets on COVID-19 boosters’ efficacy against a changing virus, as doses roll out,’ The Wall Street Journal

Oct. 28: ‘Opinion: Why I still believe COVID-19 could not have originated in a lab,’ Undark Magazine

Oct. 28: ‘Study shows vaccine protects dogs against Valley fever,’ Vet Candy

Oct. 27: ‘San Diego Zoo tigers believed to have breakthrough COVID cases,’ FOX 5 San Diego

Oct. 27: ‘The shifting sands of “gain-of-function” research,’ Nature

Oct. 27: ‘Study of SARS-CoV-2 antibody seroprevalence among domestic cats,’ News Medical

Oct. 27: ‘3 takeaways from the emergence of the “Delta Plus” coronavirus variant,’ STAT News

Oct. 26: ‘Can my pet get COVID and do they need a vaccine?’ ABC Radio Melbourne

Oct. 26: ‘Could AstraZeneca’s COVID-19 vaccine be just as effective via intranasal delivery?’ BioPharma-Reporter

Oct. 26: ‘Gain of function,’ Science

Oct. 25: ‘Babies are not all equal in the face of COVID-19,’ Archyde

Oct. 25: ‘mRNA vaccines for Covid and beyond,’ Chemistry World

Oct. 25: ‘Are non-human primates at risk of SARS-CoV-2 exposure through wastewater contact?’ News Medical

Oct. 25: ’11 African lions at the Denver Zoo test positive for COVID-19,’ Scripps Media

Oct. 24: ‘Study reveals how COVID-19 can directly damage brain cells,’ New Atlas

Oct. 23: ‘Can intranasal vaccines stop breakthrough COVID?’ MedPage Today

Oct. 21: ‘COVID vaccine booster increases antibody responses, is protective in rhesus macaques,’ National Institutes of Health

Oct. 21: ‘Japanese scientists create new covid drugs,’ Receive News

Oct. 21: ‘NIH says grantee failed to report experiment in Wuhan that created a bat virus that made mice sicker,’ Science

Oct. 21: ‘NIH demands unpublished data on coronavirus experiment, but says research is not linked to the pandemic,’ The Washington Post

Oct. 21: ‘Screening new antiviral drugs against COVID-19 just got easier,’ University at Buffalo

Oct. 20: ‘CARE to protect animals with Zoetis COVID-19 vaccine,’ Center for Animal Research and Education

Oct. 20: ‘Scientific reports revealing early promise for universal coronavirus vaccine,’ Financial News Media

Oct. 20: ‘Statement on misinformation about SARS-CoV-2 origins,’ National Institutes of Health

Oct. 20: ‘Safety and oral immunogenicity of a VSV-derived mucosal vaccine against SARS-CoV-2,’ News Medical

Oct. 20: ‘COVID: Cincinnati zoo vaccinates animals,’ TeeRoy’s 2 Cents

Oct. 19: ‘KSAT Explains: The COVID-19 research done in San Antonio,’ KSAT

Oct. 19: ‘Zoo animals are getting COVID vaccines made specially for them,’ Popular Science

Oct. 18: ‘Controversial drug ivermectin to be clinically tested in El Paso,’ KTSM

Oct. 18: ‘From COVID to SARS to MERS, scientists believe they can create a “universal” coronavirus vaccine,’ Salon

Oct. 18: ‘The coronavirus is still mutating. But will that matter? “We need to keep the respect for this virus,”’ The Washington Post

Oct. 18: ’80 animals receive COVID-19 vaccination at the Cincinnati Zoo,’ WLWT

Oct. 16: ‘National Zoo vaccinates primates against COVID-19,’ Fox News

Oct. 16: ‘Our animal kin get the Covid jab at the National Zoo, zoo says,’ The Washington Post

Oct. 15: ‘Cathie Wood just bought shares of this vaccine underdog. Should you?’ The Motley Fool

Oct. 14: ‘Which animals can catch the coronavirus?’ Illinois News Bureau

Oct. 14: ‘WHO names researchers to reboot outbreak origin investigations,’ Nature

Oct. 14: ‘Two tigers at Denver Zoo test positive for COVID-19,’ The Denver Post

Oct. 14: ‘Newly discovered bat viruses give hints to Covid’s origins,’ The New York Times

Oct. 14: ‘Merck’s COVID-19 pill and the “https://www.1011now.com/2021/10/13/animals-lincoln-childrens-zoo-test-positive-covid-19/unknown risk” of DNA mutation,’ The Philadelphia Inquirer

Oct. 14: ‘How the hunt for this deadly virus shaped the search for coronavirus’s origins,’ The Washington Post

Oct. 13: ‘Studies ongoing into effects of SARS-CoV-2 variants on animals,’ Journal of the American Veterinary Medical Association

Oct. 13: ‘Animals at Lincoln Children’s Zoo test positive for COVID-19,’ KOLN

Oct. 13: ‘Merck’s COVID pill has been called a “game changer” — is it?’ MedPage Today

Oct. 13: ‘COVID scientists in the public eye need protection from threats,’ Nature

Oct. 13: ‘Preparing for “Disease X,”’ Science

Oct. 13: ‘WHO unveils new 26-member panel to restart study of the pandemic’s origins,’ Science

Oct. 13: ‘WHO announces new expert group to investigate origins of COVID-19 and other outbreaks,’ The Washington Post

Oct. 12: ‘CureVac drops COVID-19 vaccine candidate; shifts focus to second-generation mRNA program,’ BioPharma-Reporter

Oct. 12: ‘Pets and COVID: What research shows about infection, spread,’ Local 4 News

Oct. 12: ‘mRNA flu shots move into trials,’ Nature

Oct. 12: ‘Inovio announces preprint publication of NHP study on immunity after INO-4800,’ The Fly

Oct. 12: ‘CureVac has withdrawn its Covid vaccine application to European regulators,’ The New York Times

Oct. 11: ‘Oral COVID-19 vaccine reduces transmission in animal model,’ Drug Target Review

Oct. 11: ‘The mysterious case of the COVID-19 lab-leak theory,’ The New Yorker

Oct. 11: ‘In search for covid origins, Hubei caves and wildlife farms draw new scrutiny,’ The Washington Post

Oct. 10: ‘Russian spy STOLE the blueprint for the Oxford/AstraZeneca jab so Putin could use it to develop his own Sputnik vaccine, security sources tell ministers,’ Daily Mail

Oct. 10: ‘Vaxart may be a COVID vaccine game changer — but is it too late?’ The Motley Fool

Oct. 9: ‘First, impressive vaccines for Covid. Next up: The flu,’ The New York Times

Oct. 8: ‘Immuron : IMM-124E drug shows antiviral benefits in animal, human trials,’ MarketScreener

Oct. 8: ‘Heart-inflammation risk from Pfizer COVID vaccine is very low,’ Nature

Oct. 8: ‘How antiviral pill molnupiravir shot ahead in the COVID drug hunt,’ Nature

Oct. 8: ‘Great Plains Zoo snow leopard dies after “respiratory function” decline, unknown if COVID-19 related,’ Sioux Falls Argus Leader

Oct. 8: ‘Delta variant nearly killed a lion during National Zoo’s covid outbreak,’ The Washington Post

Oct. 7: ‘Who will take Merck’s new COVID-19 pills?’ Bloomberg

Oct. 7: ‘Preventing the next pandemic: WSU will lead $125M global project to find, analyze animal viruses,’ GeekWire

Oct. 7: ‘Tiger at Great Plains Zoo tests positive for COVID-19,’ KELO

Oct. 7: ‘Nanotechnology offers alternative ways to fight COVID-19 pandemic with antivirals,’ Nature Biotechnology

Oct. 6: ‘New antiviral drug combo may fight off coronavirus infection,’ Medical News Today

Oct. 6: ‘“Spillover” diseases are emerging faster than ever before—thanks to humans,’ National Geographic

Oct. 6: ‘Why Jimiyu — and orangutans and big cats too — are getting COVID shots at the St. Louis Zoo,’ St. Louis Public Radio

Oct. 5: ‘UVA scientist developing new COVID-19 vaccine,’ CBS19 NEWS

Oct. 5: ‘Global researchers to investigate coronaviruses in humans and animals,’ Global Ag Media

Oct. 5: ‘NanoViricides provides update on its pan-coronavirus COVID-19 drug development program at Benzinga Healthcare Small Cap Conference,’ PR Newswire

Oct. 5: ‘Kansas City Zoo gorilla tests positive for COVID-19,’ Scripps Media

Oct. 5: ‘Chinese official urges virus screening for wildlife,’ Taiwan News

Oct. 4: ‘COVID-19: launch of vaccination for mink in Finland,’ Le Figaro

Oct. 4: ‘What we know — and don’t know — about Merck’s new COVID-19 pill,’ STAT News

Oct. 4: ‘Chimpanzees get COVID-19 vaccinations at Project Chimps in N. Ga,’ The Atlanta Journal-Constitution

Oct. 4: ‘To prevent the next pandemic, scientists seek one vaccine for many coronaviruses,’ The Wall Street Journal

Oct. 3: ‘Bailey: We have animals to thank for mRNA vaccines,’ Boston Herald

Oct. 1: ‘What it takes to get a vaccine FDA approved,’ Discover

Oct. 1: ‘Merck to ask FDA for emergency approval of its new antiviral pill for COVID-19,’ HealthDay News

Oct. 1: ‘Third COVID vaccine dose boosts protection in solid tumor patients,’ MedPage Today

Oct. 1: ‘Two-mAb cocktail prevents SARS-CoV-2 infection, study suggests,’ News Medical

Oct. 1: ‘WaPo recognizes animal research in reporting new drug treatment for COVID,’ Speaking of Research

Oct. 1: ‘Emory University research helps develop potential COVID-19 treatment drug,’ The Atlanta Journal-Constitution

Oct. 1: ‘Is the coronavirus getting better at airborne transmission?’ The New York Times

Oct. 1: ‘Antiviral pill lowers risks of COVID-19 hospitalization, death,’ The Scientist

Oct. 1: ‘Merck’s experimental pill to treat COVID-19 cuts risk of hospitalization and death in half, the pharmaceutical company reports,’ The Washington Post

Oct. 1: ‘Birmingham Zoo’s African lions test positive for COVID after showing symptoms,’ WVTM 13

September

Sept. 30: ‘African lions at Akron Zoo test positive for COVID-19,’ Cleveland.com

Sept. 30: ‘“Lab-leak” and natural origin proponents face off—civilly—in forum on pandemic origins,’ Science

Sept. 30: ‘Should we be concerned about animals testing positive for COVID-19?’ WKBN

Sept. 29: ‘Close cousins of SARS-CoV-2 found in a cave in Laos yield new clues about pandemic’s origins,’ Science

Sept. 29: ‘China kills 3 housecats that tested positive for COVID-19,’ The Associated Press

Sept. 29: ‘Ivermectin disinformation leads to new kinds of chaos,’ The Hill

Sept. 29: ‘The llama, the hamster, and a new path for Covid treatment,’ WIRED

Sept. 28: ‘New study shows how Covid could someday be eradicated,’ Forbes

Sept. 28: ‘AIM ImmunoTech submits pre-IND application to the FDA for Phase 2 clinical studies of Ampligen as a potential early-onset therapeutic for COVID-19,’ GlobeNewswire

Sept. 28: ‘How Covid misinformation created a run on animal medicine,’ The New York Times

Sept. 27: ‘CyanVac starts Phase 1 clinical trial for intranasal COVID-19 vaccine,’ BioPharma-Reporter

Sept. 27: ‘USDA confirms COVID in deer, Missouri to also test deer,’ KOAM News Now

Sept. 27: ‘Trial of Sanofi/GSK SARS-CoV-2 vaccine boosters against variants in non-human primates,’ News Medical

Sept. 26: ‘Letter to the editor | Animal experiments are useful,’ The News-Gazette

Sept. 26: ‘WHO seeks to revive stalled inquiry into origins of COVID-19 with new team,’ The Wall Street Journal

Sept. 25: ‘National Zoo continues to treat great cats positive for COVID-19, lions of most concern,’ NBC Washington

Sept. 24: ‘A daily pill to treat Covid could be just months away, scientists say,’ Kaiser Health News

Sept. 24: ‘Closest known relatives of virus behind COVID-19 found in Laos,’ Nature

Sept. 24: ‘Watching SARS-CoV-2 spread in animal models in real time,’ Texas Biomedical Research Institute

Sept. 24: ‘USDA: Ferret tests positive for COVID-19 in Florida,’ The Associated Press

Sept. 24: ‘Virus research has exploded since COVID-19 hit. Is it safe?’ The Wall Street Journal

Sept. 24: ‘National Zoo’s covid-infected lions and tigers won’t eat their meat, so zookeepers are trying goat cheese and chicken broth,’ The Washington Post

Sept. 24: ‘Confirmation of COVID-19 in ferret in Florida,’ USDA Animal and Plant Health Inspection Service

Sept. 24: ‘Ferret tests positive for coronavirus in Florida, officials say,’ WPLG Local10.com

Sept. 24: ‘Don’t like needles? Researchers working on vaccine patches, treatment pills,’ WRAL

Sept. 23: ‘Llama antibodies show “significant potential” as coronavirus treatment,’ German Press Agency dpa

Sept. 23: ‘The innovation system behind Moderna’s COVID-19 vaccine,’ HBR IdeaCast

Sept. 23: ‘Can llama antibodies fight COVID in humans? New research says they might,’ HealthDay News

Sept. 23: ‘Tiny particles could make a powerful COVID vaccine,’ Nature

Sept. 23: ‘Americans await booster details after FDA okays Pfizer-BioNTech for some groups,’ The Washington Post

Sept. 22: ‘Covid: Immune therapy from llamas shows promise,’ BBC News

Sept. 22: ‘Pfizer study of COVID-19 vaccine in pregnant women delayed by slow enrollment,’ The Wall Street Journal

Sept. 21: ‘A look at COVID-19 treatments: Which ones work best?’ CBS News

Sept. 21: ‘Overview of nonhuman primate models of SARS-CoV-2,’ Comparative Medicine

Sept. 21: ‘FDA-approved gout drug could show promise in fighting COVID-19,’ Fox News

Sept. 20: ‘Cambodia bat researchers on mission to track origin of COVID-19,’ Reuters

Sept. 20: ‘Nasal medicines to treat COVID-19 being developed,’ The Japan News

Sept. 20: ‘The struggle to define long COVID,’ The New Yorker

Sept. 19: ‘Lions and endangered tigers sick with coughs test positive for COVID at National Zoo,’ McClatchy DC

Sept. 19: ‘A new synthetic multiantigen MVA vaccine COH04S1 effective against SARS-CoV-2,’ News Medical

Sept. 19: ‘How ivermectin became the new focus of the anti-vaccine movement,’ NPR

Sept. 19: ‘Gottlieb: COVID-19 origins may never be known,’ The Hill

Sept. 19: ‘Horse owners can’t find ivermectin as Americans flock to unproven coronavirus cure,’ The Washington Post

Sept. 18: ‘Lions and tigers at DC’s National Zoo test presumptive positive for COVID-19,’ CNN

Sept. 18: ‘Big cats likely sick with COVID-19 at National Zoo in Washington,’ New York Post

Sept. 18: ‘Lions and tigers at the Smithsonian’s National Zoo test positive for the virus,’ The New York Times

Sept. 18: ‘Nine big cats in the Smithsonian Institution’s National Zoo test positive for COVID,’ USA Today

Sept. 17: ‘Multiple Smithsonian National Zoo big cats test presumptively positive for COVID-19,’ CBS News

Sept. 17: ‘New insights into bats’ immunity could point to therapeutic approaches for fighting COVID-19,’ Fierce Biotech

Sept. 17: ‘All the lions and tigers at D.C.’s National Zoo have tested positive for COVID-19,’ HuffPost

Sept. 17: ‘Is a variant worse than Delta on the way? Viral evolution offers clues,’ National Geographic

Sept. 17: ‘Covid outbreak hits lions, tigers at National Zoo,’ NBC News

Sept. 17: ‘9 Lions and tigers at the National Zoo are being treated for COVID,’ NPR

Sept. 17: ‘6 lions and 3 tigers at the Smithsonian’s National Zoo test positive for COVID,’ People

Sept. 17: ‘Lions and tigers at the Smithsonian’s National Zoo test positive for COVID-19,’ Smithsonian Magazine

Sept. 17: ‘Great cats tested presumptive positive for COVID-19 at the Smithsonian’s National Zoo,’ Smithsonian’s National Zoo & Conservation Biology Institute

Sept. 17: ‘Tracking the FDA advisory panel meeting on COVID-19 booster shots,’ STAT News

Sept. 17: ‘Lions, tigers at National Zoo return positive COVID-19 tests,’ The Hill

Sept. 17: ‘Lions, tigers at National Zoo in D.C. test positive for the coronavirus,’ The Washington Post

Sept. 17: ‘Big cats at National Zoo test presumptive positive for COVID-19,’ UPI

Sept. 17: ‘The National Zoo’s big cats have tested positive for Covid,’ Washingtonian

Sept. 16: ‘How Fauci and the NIH got ahead of the FDA and CDC in backing boosters,’ Kaiser Health News

Sept. 16: ‘Did the coronavirus jump from animals to people twice?’ Nature

Sept. 16: ‘Live oral SARS-CoV-2 vaccine provides partial protection in rhesus macaques,’ News Medical

Sept. 16: ‘There’s no evidence COVID-19 vaccines hurt fertility. Here’s what’s fueling the myth,’ PBS NewsHour

Sept. 15: ‘Where might the next COVID come from? Scientists look to those infected by animals carrying coronaviruses,’ Fortune

Sept. 15: ‘Where are the cures for COVID-19?’ NBC Bay Area

Sept. 15: ‘A sweet pill to swallow: oral nucleoside analog of Remdesivir improved SARS-CoV-2 pathogenesis in mice,’ News Medical

Sept. 15: ‘SARS-like viruses may jump from animals to people hundreds of thousands of times a year,’ Science

Sept. 15: ‘An mRNA pioneer discusses how her work led to the COVID vaccines,’ Scientific American

Sept. 15: ‘No-fridge coronavirus vaccine looks promising: study,’ The Hill

Sept. 15: ‘Maryland Zoo in Baltimore is one of 70 U.S. facilities vaccinating wild animals against the coronavirus,’ The Washington Post

Sept. 14: ‘Thousands of Covid-like cases raise risk of future pandemics,’ Bloomberg News

Sept. 14: ‘The Covid virus is sneaky. Booster shots can protect us from it,’ CNN

Sept. 14: ‘The tangled history of mRNA vaccines,’ Nature

Sept. 14: ’18 of 20 gorillas at Atlanta’s zoo have contracted COVID,’ The Associated Press

Sept. 14: ‘The Maryland Zoo in Baltimore is preparing to vaccinate otters, chimps, lions and more against COVID-19,’ The Baltimore Sun

Sept. 14: ‘Zoo Atlanta gorillas test positive for COVID,’ WebMD

Sept. 13: ‘Vaccine Q&A: Are mRNA vaccines going to replace other vaccines?’ North Carolina State University

Sept. 13: ‘Our views: Despite variant’s contagion, research shows us the way to fight coronavirus,’ The Advocate

Sept. 13: ’18 gorillas in Atlanta zoo show COVID symptoms after delta exposure, may receive vaccines,’ USA Today

Sept. 13: ‘Researchers are investigating whether viper venom molecule can be developed to treat COVID-19,’ WTSP

Sept. 12: ‘Thirteen gorillas at Atlanta zoo test positive for COVID-19,’ Axios

Sept. 12: ‘Fake News Buster: Vaccines have undergone animal testing,’ Bangalore Mirror

Sept. 12: ‘COVID-19 could become like the flu if more people get vaccinated,’ The Wall Street Journal

Sept. 12: ‘A group of gorillas is being treated for covid. The great apes will soon get their shots, too, zoo says,’ The Washington Post

Sept. 11: ‘Gorillas at Zoo Atlanta test positive for COVID-19,’ CBS News

Sept. 11: ‘Gorillas at Zoo Atlanta being treated after initial testing reveals COVID-19 virus,’ CNN

Sept. 11: ‘Maryland Zoo prepares to vaccinate animals against COVID-19,’ WUSA-9

Sept. 10: ‘Why it’s so tricky to trace the origin of COVID-19,’ National Geographic

Sept. 10: ‘What is ivermectin, and how did people get the idea it can treat covid?’ The Washington Post

Sept. 10: ‘Fact check: Pfizer, Moderna and Johnson & Johnson COVID-19 vaccines all passed animal testing,’ USA Today

Sept. 9: ‘Co-inventor of mRNA shots sets sights on pan-coronavirus vaccine,’ Agence France-Presse

Sept. 9: ‘Miami International Airport boasting world’s first COVID-detecting dogs,’ CBS News

Sept. 9: ‘Study finds lasting immunity and protection from COVID-19 by single-shot, room-temperature, stable vaccine,’ Ophthalmology Times

Sept. 8: ‘Biotech Exscientia, Gates Foundation put up $35M each to prepare antivirals for next global pandemic threat,’ Fierce Biotech

Sept. 8: ‘Animal research is saving our skins, but only if we do our part,’ InsideSources

Sept. 8: ‘Lessons from the ivermectin debacle,’ RealClearScience

Sept. 8: ‘False meme: Nobel laureate did not say ivermectin “cures” COVID-19,’ The Washington Post

Sept. 7: ‘You know who’s getting the COVID vaccine? Animals at Brookfield Zoo,’ Chicago Tribune

Sept. 7: ‘SARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications,’ Emerging Microbes & Infections

Sept. 7: ‘Study: Plant-, bacteria-based vaccines unaffected by COVID-19 mutations,’ Laboratory Equipment

Sept. 7: ‘Brookfield Zoo gives COVID vaccine to “high-risk animals,”’ NBC Chicago

Sept. 7: ‘Inside the Wuhan lab: French engineering, deadly viruses and a big mystery,’ Washington Post

Sept. 6: ‘Scientists discover antibodies that may neutralize a range of SARS-CoV-2 variants,’ Medical News Today

Sept. 4: ‘Sanofi GSK vaccine trials being conducted at SRM Medical College and Research Centre,’ DT Next

Sept. 4: ‘Airborne transmission of viruses “more prevalent than previously recognized,”’ Medical News Today

Sept. 4: ‘The coronavirus is here to stay, researchers say,’ Sciencenorway.no

Sept. 3: ‘Revolutionary cancer vaccine trials inspired by COVID jab begin,’ BBC Science Focus

Sept. 2: ‘Covid vaccine: Thai researchers invent a nasal spray vaccine Believe to help solve the epidemic crisis – fresh news,’ Archyde

Sept. 2: ‘The shaky science behind ivermectin as a COVID-19 cure,’ National Geographic

Sept. 2: ‘India’s DNA COVID vaccine is a world first – more are coming,’ Nature

Sept. 2: ‘Call of the wild,’ Science

Sept. 2: ‘The important role of animal research in mRNA COVID-19 vaccine development,’ Speaking of Research

Sept. 2: ‘Ivermectin, a deworming medicine, is the latest quack cure for COVID-19,’ The Economist

Sept. 2: ‘American Medical Association calls for “immediate end” to use of ivermectin for COVID-19,’ The Hill

Sept. 1: ‘GSK, CureVac’s 2nd-generation Covid-19 vaccine shows promising study results,’ Korea Biomedical Review

Sept. 1: ‘B.C. vet refuses to sell ivermectin as some seek drug to treat, prevent COVID-19,’ NEWS 1130

Sept. 1: ‘Use of antiparasitic drug ivermectin against COVID-19 prompts warnings,’ The Wall Street Journal

Sept. 1: ‘Although COVID-19 rare in cats & dogs, pharmaceutical company says, they’re ready with a vaccine if needed,’ CBS Detroit

August

Aug. 31: ‘Animals at San Antonio Zoo to get COVID-19 vaccinations,’ KSAT

Aug. 31: ‘Brazilian viper venom may become tool in fight against coronavirus, study shows,’ Reuters

Aug. 31: ‘Why the COVID-19 origin report came up inconclusive,’ The Hill

Aug. 31: ‘Brazilian snake venom holds promise in fight against Covid,’ The National

Aug. 30: ‘In the pipeline: What the next wave of COVID-19 vaccines could look like,’ BioPharma-Reporter

Aug. 30: ‘Self-injecting pill could offer oral administration for monoclonal antibodies, insulin and other drugs,’ BioPharma-Reporter

Aug. 30: ‘Detroit Zoo’s most susceptible animals are getting COVID-19 vaccinations,’ Detroit Free Press

Aug. 30: ‘Inside Pfizer’s labs, “variant hunters” race to stay ahead of the pandemic’s next twist,’ STAT News

Aug. 30: ‘Demand surges for deworming drug for Covid, despite no evidence it works,’ The New York Times

Aug. 30: ‘Help stop misuse of animal ivermectin in humans,’ Vet Candy

Aug. 29: ‘Ohio white-tailed deer become first to test positive for COVID-19,’ Staten Island Advance

Aug. 29: ‘One year later: Five ways our profession has changed since the onset of the COVID pandemic,’ Vet Candy

Aug. 28: ‘An oral history of Oxford/AstraZeneca: “Making a vaccine in a year is like landing a human on the moon,”’ The Guardian

Aug. 27: ‘A group founded by a Capitol riot defendant is prescribing an unproven COVID-19 treatment, ivermectin, through a telemedicine site for $90 a pop,’ BusinessInsider.com

Aug. 27: ‘White-tailed deer in Ohio first in the world to test positive for COVID,’ Cleveland.com

Aug. 27: ‘Clamoring for ivermectin, some turn to a pro-Trump telemedicine website,’ CNBC.com

Aug. 27: ‘US COVID origins report: researchers pleased with scientific approach,’ Nature

Aug. 27: ‘U.S. reports world’s first deer with COVID-19,’ Reuters

Aug. 27: ‘Airborne transmission of respiratory viruses,’ Science

Aug. 27: ‘COVID-19’s origins still uncertain, U.S. intelligence agencies conclude,’ Science

Aug. 27: ‘The animal origin of SARS-CoV-2,’ Science

Aug. 27: ‘New drug may be a cure for both COVID-19 and herpes,’ Study Finds

Aug. 27: ‘US intel review inconclusive on COVID-19 origin,’ The Hill

Aug. 27: ‘Biden’s COVID-19 origins report leaves the lab leak on the table,’ Vanity Fair

Aug. 26: ‘A Science in the Shadows,’ Washington Post

Aug. 26: ‘What would proof of a COVID lab leak look like?,” Wired

Aug. 26: ‘Airborne transmission of respiratory viruses,’ Forbes.com

Aug. 26: ‘Reliance gets nod to start Covid-19 vaccine trials,’ Times of India

Aug. 26: ‘Anti-parasite drug’s use at Arkansas jail sparks probe,’ Associated Press

Aug. 25: ‘Ivermectin for Covid-19: abundance of hype, dearth of evidence,’ STAT

Aug. 25: ‘State health officials discuss uses, dangers of anti-parasitic animal drug Ivermectin,’ KATV ABC 7 (Little Rock, Ark.)

Aug. 25: ‘Alaska mayor promotes debunked treatment for COVID-19,’ ABC News

Aug. 25: ‘An animal dewormer to treat COVID? Poison control centers see uptick in calls, stores sell out,’ USA Today

Aug. 25: ‘Origins of SARS-CoV-2: Window is Closing for Key Scientific Studies,’ Nature

Aug. 25: ‘New WHO group aims to improve efforts to find pathogen origins,’ Science

Aug. 25: ‘Covid-19 vaccines flirted with perfection at first. Reality is more complicated.’ STAT 

Aug. 25: ‘Good news! Ilama and Camel Antibodies Can Kill Covid 19,’ World News Today

Aug. 25: ‘Building a Better Vaccines for SARS-CoV-2,’ Eurasia Review

Aug. 25: ‘U.S. intelligence agencies delivered a report to Biden on the virus’s origins,’ Washington Post

Aug. 25: ‘China accuses US of politicizing COVID-19 origins research,’ Associated Press

Aug. 25: ‘The WHO is looking for experts to help investigate the origins of pathogens — including the coronavirus,’ STAT

Aug. 24: ‘New U.S. Intelligence Report Doesn’t Provide Definitive Conclusion on Covid-19 Origins

Aug. 24: ‘U.S. intelligence agencies delivered a report to Biden on the virus’s origins, New York Times

Aug. 24: ‘Caught in the Crossfire Over Covid’s Origins,’ New York Times

BREAKING NEWS: Aug. 24: ‘COVID vaccines and blood clots: what researchers know so far,’ Nature

Aug. 24: ‘Why do short-lived lung infections lead to long-lasting lung damage?,’ Medical Express

Aug. 24: ‘Llama antibodies blunt COVID variants in lab trial, says Belgian start-up,’ Reuters

Aug. 24: ‘Building a better vaccine for SARS-CoV-2,’ ScienceDaily

Aug. 24: ‘Arkansans calling poison control after taking livestock deworming drug,’ 40/21 TV News (Rogers, Ark.)

Aug. 24: ‘COVID hysteria over Ivermectin begins to impact animal health,’ WTVA/WLOV TV News (Saltillo, Miss.)

Aug. 24: ‘Vaxart Inc. (NASDAQ: VXRT) Receives FDA Approval For its IND for S-Only SARS-CoV-2 Vaccine Candidate,’ BioPharma Journal

Aug. 24: ‘The link between COVID-19, rattlesnake venom and a killer enzyme inspires treatment target,’ FierceBiotech

Aug. 23: ‘Starpharma’s Nasal Spray Reduces SARS-CoV-2 by Over 99.9% in Animal Studies,’ BioSpace.com

Aug. 23: ‘Researchers working toward one vaccine for many variants,’ In-cyprus.com

Aug. 23: ‘White House says report on COVID origins could be released next week,’ New York Post

Aug. 23: ‘A lucky few seem ‘resistant’ to Covid-19. Scientists want to know why,’ STAT News

Aug. 23: ‘Gorillas, gibbons, orangutans: Memphis Zoo taking precautions to protect primates from COVID-19,’ The Commercial Appeal (Memphis, Tenn.)

Aug. 23: ‘COVID-19 updates: F.D.A.’s vaccine approval leads Pentagon and others to add requirements,’ The New York Times

Aug. 22: ‘A microscopic video shows the coronavirus on the rampage,’ New York Times

Aug. 21: ‘FDA urges people to stop taking ivermectin to treat COVID-19,’ Axios

Aug. 21: ‘Antibodies elicited by COVID-19 vaccination effective against delta variant,’ Technology.org

Aug. 21: ‘The world needs a proper investigation into how covid-19 started,’ The Economist

BREAKING NEWS: Aug. 21: ‘FDA warns against using animal parasite medicine as at-home COVID-19 treatment,’ The Hill

BREAKING NEWS: Aug. 20: ‘Bears, baboons and tigers are getting COVID vaccines at zoos across the U.S.,’ National Geographic

Aug. 19: ‘How Chinese pressure on coronavirus origins probe shocked the WHO — and led its director to push back,’ Washington Post

Aug. 19: ‘New SARS-CoV-2 variants have changed the pandemic. What will the virus do next?,’ Science

Aug. 19: ‘Even Delta Variant Can’t Evade Vaccine-Linked Antibodies: Study,’ Healthday

Aug. 19: ‘Findings Help Explain Why Vaccinated People At Low Risk During Delta Surge,’ The West Side Gazette (Fort Lauderdale, Fl.)

Aug. 19: ‘NIH hamster study evaluates airborne and fomite transmission of SARS-CoV-2,’ www.PharmaBiz.com

Aug. 19: ‘COVID-19 vaccine mandate by Texas Biomed will protect not just humans,’ KSAT TV (San Antonio, Texas)

Aug. 18: ‘COVID-19 Vaccination Antibodies Are Effective Against Delta Variant,’ Futurity.org

Aug. 18: ‘Decades-old SARS virus infection triggers potent response to COVID vaccines,’ Nature

Aug. 18: ‘The important role of animal research in mRNA COVID-19 vaccine development,’ National Institute of Allergy and Infectious Diseases

BREAKING NEWS: Aug. 18: ‘COVID-19 vaccines may trigger super-immunity in people who had SARS long ago,’ Science

Aug. 18: ‘Interview with Texas Biomedical Research Institute’s Dr. Isis Kanevsky and Dr. Deepak Kaushal,’ TBRI YouTube channel

Aug. 18: ‘Bangavax animal trials begin,’ The Financial Express

Aug. 18: ‘How Pfizer covid vax cuts risk of Delta infection,’ www.andhravilas.net

Aug. 17: ‘Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possible,’ Forbes.com

Aug. 17: ‘Antibodies elicited by COVID-19 vaccination effective against delta variant,’ wustl.edu

Aug. 17: ‘NIH Hamster Study Evaluates Airborne and Fomite Transmission of SARS-CoV-2,’ Science Daily

Aug. 17: ‘Delayed Wuhan Report Adds Crucial Detail to Covid Origin Puzzle,’ Bloomberg News

Aug. 16: ‘FALSE: Conspiracy theory that COVID-19 vaccines’ spike proteins are ‘cytotoxic’ debunked by experts,’ CW 39 TV (Houston, Texas)

Aug. 16: ‘GSK and CureVac’s second Covid vaccine yields stronger response,’ Financial Times

Aug. 16: ‘Scientist at Berkeley Lab Played a Hand in “Inescapable” COVID-19 Antibody Discovery,’ Lawrence Berkeley National Laboratory

Aug. 16: ‘GSK, CureVac’s next-gen COVID-19 vaccine shows promise in monkey trial,’ Reuters

BREAKING NEWS: Aug. 16: ‘Positive data for CureVac and GSK’s second generation COVID-19 shot,’ www.biopharma-reporter.com

Aug. 15: ‘COVID is Probably Here to Stay,’ Cape Charles Mirror (Cape Charles, Va.)

Aug. 15: ‘Coronavirus: US scientists suggest another animal link in tests on deer samples,’ South China Morning Post

Aug. 14: ‘Oh, dear! Wild deer found to have COVID-19 antibodies in four-state study,’ FOX 8 TV (Cleveland, Oh.)

Aug. 13: ‘Has COVID taught us anything about pandemic preparedness?,’ Nature

Aug. 13: ‘U.S. chimp sanctuary is poised to give its primates a COVID-19 vaccine — will others follow its lead?’ Science

Aug. 13: ‘Why the coronavirus lab leak theory won’t go away,’ Politico

Aug. 13: ‘COVID-19: China Pressured WHO Team to Dismiss Lab Leak Theory, Claims Chief Investigator,’ British Journal of Medicine

Aug. 12: ‘The Vaccine Scientist Spreading Vaccine Misinformation,’ The Atlantic

Aug. 12: ‘USDA study finds COVID-19 antibodies in Pa. deer, first sign of wild animals’ virus exposure,’ The Philadelphia Inquirer

Aug. 12: ‘Sunshine Biopharma’s coronavirus treatment anticipated to be effective against Delta and the other variants of concern,’ Globe Newswire

Aug. 12: ‘Syrian hamsters show scientists how COVID-19 affects lungs,’ Genetic Engineering and Biotechnology Now

Aug. 11: ‘How doe the FDA Approve Vaccines?,’ Voice of America radio

Aug. 11: ‘Intranasal vaccine blocks Covid, stops transmission in animal trials,’ Press Trust of India

Aug. 11: ‘Human studies begin on artificial Intelligence discovered COVID-19 treatment with up to 97 percent effectiveness,’ PR Newswire

Aug. 11: ‘Thailand to start human trials on COVID-19 shots via nasal spray,’ Reuters

Aug. 11: ‘Zydus completes “pragmatic trials” for second vax,’ The Hindu Business Line

Aug. 10: ‘Future vaccines will conquer both cancer and AIDS – Science Times,’ Archyde

Aug. 10: ‘UIC studying IV drug as potential COVID-19 treatment,’ Outsourcing-Pharma

Aug. 10: ‘Farm supply stores are running short on a horse dewormer/pseudoscience COVID cure,’ Slate

Aug. 10: ‘A snort or a jab? Scientists debate potential benefits of intranasal COVID-19 vaccines,’ STAT News

Aug. 9: ‘Arcturus Therapeutics announces second quarter 2021 financial results and mRNA vaccine and therapeutics pipeline progress,’ Business Wire

Aug. 9: ‘Michigan’s white-tailed deer exposed to COVID-19: What it means,’ Detroit Free Press

Aug. 9: ‘Learning from llamas, U of M scientists develop a candidate COVID-19 drug,’ University of Minnesota

Aug. 7: ‘Cats and dogs top list of COVID-19 infected animals in U.S.,’ NBC Bay Area

Aug. 6: ‘How will the pandemic end? The science of past outbreaks offers clues,’ National Geographic

Aug. 6: ‘Inhalable COVID-19 treatment shows potentially lower viral transmission in animal studies,’ Ophthalmology Times

Aug. 6: ‘COVID: What happens if a far more lethal coronavirus emerges in pets?’ The Conversation

Aug. 5: ‘Tulane researchers design nanotechnology blood test to find hidden COVID-19 infections,’ Tulane University

Aug. 5: ‘Vets urged not to lose sight of zoonotic threats following coronavirus pandemic,’ Vet Times

Aug. 4: ‘Researchers find nature, origin of immune cells damaging COVID-19 patients’ lungs,’ Korea Biomedical Review

Aug. 4: ‘Two monoclonal antibodies broadly neutralize SARS-CoV-2 variants of concern,’ News Medical

Aug. 4: ‘Up to 40% of wild deer population in US exposed to coronavirus, study finds,’ The Independent

Aug. 4: ‘Remdesivir currently being modified from intravenous to oral administration; study describes potential of the antiviral drug in treating COVID-19,’ The Science Times

Aug. 4: ‘Pitt develops new COVID-19 nanobody treatment,’ WPXI-TV

Aug. 3: ‘Coronavirus: University of Pittsburgh scientists develop new COVID-19 nanobody treatment,’ Cox Media Group

Aug. 3: ‘Nasal version of AstraZeneca SARS-CoV-2 vaccine prevents infection in animal models,’ News Medical

Aug. 3: ‘Suspected COVID-19 cases in tigers leads to closure of Safari Park exhibit,’ Nexstar Media Wire

Aug. 3: ‘Wild deer have coronavirus antibodies,’ Science

Aug. 3: ‘Animals expected to get COVID-19 vaccine shots at N.C. Zoo,’ WSPA

Aug. 2: ‘Vaxart scores IND for S-only oral tablet COVID-19 vaccine candidate,’ BioSpace

Aug. 2: ‘Vaxart shares jump after FDA clearance of investigational new drug application,’ MarketWatch

Aug. 2: ‘Wild U.S. deer found with coronavirus antibodies,’ National Geographic

Aug. 2: ‘Arcturus Therapeutics lines up Phase 1/2/3 trial for next-generation mRNA COVID-19 vaccine,’ Outsourcing-Pharma

Aug. 2: ‘FDA OKs Vaxart’s IND application for S-only oral tablet SARS-CoV-2 vaccine candidate – quick facts,’ RTTNews

Aug. 2: ‘GOP report on COVID-19 origins homes in on lab leak theory,’ The Hill

Aug. 2: ‘Opinion: New congressional report says COVID-19 likely emerged in Wuhan months earlier than originally thought,’ The Washington Post

Aug. 1: ‘Zoetis’ COVID-19 vaccines for animals bolster Southwest Michigan’s life sciences profile,’ MiBiz

July

July 30: ‘What Delta has changed in the Covid pandemic — and what it hasn’t,’ STAT News

July 30: ‘Gorillas, chimpanzees set to receive their first doses of COVID-19 vaccine at North Carolina Zoo,’ WGHP

BREAKING NEWS: July 29: ‘Over half the deer tested in Michigan have been exposed to SARS-CoV-2,’ Ars Technica

July 29: ‘New COVID-19 vaccine formulation produces effective vaccine candidate,’ Baylor College of Medicine

July 29: ‘Taking the needles and syringes out of COVID-19 vaccination,’ Malay Mail

July 29: ‘How did the COVID-19 pandemic begin?’ The Hill

July 29: ‘There are 2 snow leopards at the San Diego Zoo. Both endangered cats now have COVID-19,’ The San Diego Union-Tribune

July 28: ‘How a zoo decides which “high-risk” animals should get a COVID vaccine,’ Slate

July 27: ‘T cells are not critical for recovery of primates from acute COVID-19 infections, study reveals,’ News Medical

July 27: ‘Why it’s still so hard to find treatments for early COVID-19,’ Science News

July 26: ‘Two mink test positive for SARS-CoV-2 on Abbotsford mink farm,’ Daily Hive Vancouver

July 26: ‘A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge,’ Emerging Microbes & Infections

July 26: ‘A “mix and match” approach to SARS-CoV-2 vaccination,’ Nature Medicine

July 26: ‘China vs the WHO: Where to look next in the hunt for COVID-19’s origins,’ South China Morning Post

July 26: ‘Inhaled nanobodies: A potential treatment for COVID-19,’ Technology Networks

July 26: ‘Covid treatment options remain elusive, despite months of effort and rising Delta cases,’ The Wall Street Journal

July 26: ‘COVID from animals, not likely, but wash your hands,’ WIBC

July 25: ‘A rare snow leopard at the San Diego Zoo has tested positive for coronavirus,’ CNN

BREAKING NEWS: July 24: ‘Unvaccinated snow leopard at San Diego Zoo catches COVID-19,’ The Associated Press

July 23: ‘UAE scientists launch animal study in quest to help treat Covid in humans,’ The National

July 22: ‘Potential COVID-19 treatment, masitinib inhibits SARS-CoV-2 replication in mice,’ Genetic Engineering & Biotechnology News

July 22: ‘China rejects WHO push for more investigation into covid origins in Wuhan,’ The Washington Post

July 21: ‘Which animals can SARS-CoV-2 infect? Complex cell cultures clarify,’ Genetic Engineering & Biotechnology News

July 21: ‘Coexisting with the coronavirus,’ The New Yorker

July 20: ‘New studies highlight promising candidates for second-generation COVID-19 vaccines,’ Forbes

July 20: ‘Potent nasal vaccine protects non-human primates from SARS-CoV-2,’ News Medical

July 20: ‘Scientists explore susceptibility of different animals to SARS-CoV-2 infection,’ News Medical

July 20: ‘Yeast expressed, RBD-based vaccine provides robust immune responses against SARS-CoV-2,’ News Medical

July 20: ‘Oakland Zoo vaccinates its animals against COVID-19,’ PBS

July 20: ‘Inhaled COVID-19 vaccine shows promising results in animal models,’ The Daily Iowan

July 20: ‘J.&J. vaccine may be less effective against Delta, study suggests,’ The New York Times

July 20: ‘Second WHO COVID-19 origins investigation will examine lab leak hypothesis,’ Washington Examiner

July 19: ‘Celltrion: COVID-19 antibody treatment effective against Delta variant,’ BioPharma-Reporter

July 19: ‘Meissa’s intranasal COVID-19 vaccine shows promise in non-human primates,’ BioSpace

July 19: ‘Selva to present preclinical data at ASV 2021 demonstrating prophylactic and therapeutic oral dosing of SLV213 for COVID-19 protected lungs from SARS-CoV-2-induced damage,’ Business Wire

July 19: ‘US boosts funding to breed more test monkeys in wake of Covid,’ Indo-Asian News Service

July 19: ‘Best life: Researchers studying the spread of COVID-19 in animals,’ Ivanhoe Newswire

July 19: ‘New data leads to rethinking (once more) where the pandemic actually began,’ National Public Radio

July 19: ‘Messenger RNA vaccine pioneer Katalin Karikó shares her long journey to COVID-19 vaccines,’ STAT News

July 19: ‘Cats are better than dogs (at catching the coronavirus),’ The New York Times

July 18: ‘US invests millions to breed more test monkeys in wake of COVID-19: Report,’ Fox News

July 18: ‘Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model,’ News Medical

July 17: ‘Fauci says he still thinks nature, not Wuhan lab, “most likely” origin for COVID-19,’ Washington Examiner

July 16: ‘Senior Biden officials finding that Covid lab leak theory as credible as natural origins explanation,’ CNN

July 16: ‘Celltrion confirms Regkirona’s efficacy in treating Delta variant in animal test,’ Korea Biomedical Review

July 16: ‘Bristol County Sheriff’s Office debuts first K9s trained to detect COVID-19,’ WPRI

July 15: ‘New COVID-19 vaccine candidate, option for low- to mid-income countries,’ Baylor College of Medicine

July 15: ‘The US is boosting funding for research monkeys in the wake of COVID,’ Nature

July 15: ‘COVID-19 vaccine candidate that can be produced in yeast proves effective in macaques,’ News Medical

July 15: ‘New vaccine candidate could be a cost-effective option against emerging SARS-CoV-2 variants,’ News Medical

July 15: ‘New COVID-19 vaccine candidate provides effective option for low- to mid-income countries,’ Newswise

July 15: ‘There are few good COVID antivirals, but that could be changing,’ Scientific American

July 15: ‘WHO chief: “Premature” to rule out COVID-19 lab leak theory,’ The Hill

July 15: ‘New COVID-19 vaccine candidate provides effective option for low- to mid-income countries,’ Yerkes National Primate Research Center

July 14: ‘Scientists studying possible transmission of COVID-19 from animals to humans,’ KABC-TV

July 14: ‘This “super antibody” for COVID fights off multiple coronaviruses,’ Nature

July 14: ‘EXPLAINED: Why India-made Gennova vax could give protection at a fraction of cost of other mRNA shots,’ News18

July 14: ‘University of Iowa researchers pursuing nose-spray vaccine against COVID-19,’ The Gazette

July 13: ‘Australian research: Gene editing technology prevents the spread of new coronavirus in human cells,’ Archyde

July 13: ‘Cancer treatment developed by Victorian scientists stops coronavirus replicating in cells,’ Australian Broadcasting Corporation

July 13: ‘New research: Inhaled COVID-19 vaccine shows promise in animal study,’ Express News Service

July 13: ‘Inhaled COVID vaccine shows promise in animal trials,’ HealthDay News

July 13: ‘COVID 19 coronavirus: Gut bacteria under the microscope in New Zealand vaccine study,’ New Zealand Herald

July 13: ‘The long view on COVID-19 vaccine safety and efficacy,’ Penn Today

July 12: ‘Columbus Zoo, The Wilds to vaccinate high-risk animals against COVID-19,’ 10TV

July 12: ‘Afraid of injections? Single-dose, inhalable COVID19 vaccine shows promising results in animal testing phase,’ Gaon Connection

July 12: ‘Are animals spreading COVID to humans?’ News4JAX

July 12: ‘MRNA-based COVID-19 vaccine CV07050101 demonstrates limited immunogenicity in non-human primates,’ News Medical

July 11: ‘Bat scientists warn that the world may never know COVID-19 origins,’ The Wall Street Journal

July 10: ‘Covid origins: Scientists weigh up evidence over virus’s origins,’ BBC News

July 9: ‘Bipartisan lawmakers press NIH for info on deleted coronavirus data,’ The Hill

July 9: ‘A group of scientists presses a case against the lab leak theory of Covid,’ The New York Times

July 8: ‘Korean researchers discover “200-fold effect of remdesivir” for COVID-19 treatment,’ Archyde

July 8: ‘Zoetis donates over 11,000 COVID-19 vaccines to high-risk zoo animals,’ DVM 360

July 8: ‘An economist’s perspective on “gain-of-function” virus research,’ The Hill

July 8: ‘Origin of Covid mirrors SARS genesis in animals, study finds,’ ThePrint

July 8: ‘Wisconsin farms working to vaccinate mink against coronavirus,’ Wisconsin Public Radio

July 7: ‘Coronavirus almost certainly came from an animal, not a lab leak, top scientists argue,’ CNN

July 7: ‘Vaccinate big cats? New report shows SARS-CoV-2 Delta variant infecting endangered lions,’ News Medical

July 6: ‘Magic Valley mink farmer decries bill banning his industry for COVID-19 protection,’ Intermountain Farm & Ranch

July 6: ‘Inhaled COVID-19 vaccine prevents disease and transmission in animals,’ University of Iowa Health Care

July 5: ‘Oregon makes ranchers vaccinate their mink against COVID-19,’ OPB

July 5: ‘Denver Zoo will start vaccinating animals for COVID-19 as early as next week,’ Scripps Media

July 5: ‘Not just vaccine, even monkeys used in Covaxin trial were “made in India,”’ ThePrint

July 5: ‘First social distancing, now vaccines: How zoos are preventing coronavirus outbreaks among animals,’ The Washington Post

July 2: ‘K-State virologists publish new findings on SARS-CoV-2 treatment option,’ Kansas State University

July 2: ‘Kalamazoo researchers help develop COVID-19 vaccine donated for zoo animals across the country,’ MLive.com

July 2: ‘Gordon: Got a COVID vaccination? You can thank research and science,’ Portland Tribune

BREAKING NEWS: July 2: ‘Zoetis donates animal COVID-19 vaccine candidate to about 70 U.S. zoos,’ Reuters

July 2: ‘Oakland Zoo delivers COVID-19 shots to lions, tigers, bears – and ferrets,’ San Francisco Chronicle

July 2: ‘Zoo animals are getting experimental coronavirus vaccines,’ The New York Times

July 2: ‘K-State research may lead to COVID treatment breakthrough,’ WIBW

July 1: ‘Study into whether animal drug can treat Covid,’ Bangkok Post

July 1: ‘Pets can catch Covid from owners, study suggests,’ BBC News

July 1: ‘Could editing the genomes of bats prevent future coronavirus pandemics? Two scientists think it’s worth a try,’ STAT News

July 1: ‘Biologists mask up to protect bats (yes, bats) from COVID-19,’ WIRED

July 1: ‘You’ve had or might have an mRNA vaccine. Here’s what you need to know,’ World Economic Forum

June

June 30: ‘COVID-19 vaccines show safety, immunity in infant model,’ Cornell Chronicle

June 30: ‘No, vaping doesn’t make you more susceptible to coronavirus,’ Forbes

June 30: ‘Your pets can catch Covid from you, and cats appear more susceptible than dogs,’ NBC News

June 30: ‘With a “liquid assembly line,” Penn researchers produce mRNA-delivering-nanoparticles a hundred times faster than standard microfluidic technologies,’ Penn Engineering Today

June 30: ’12 lessons COVID-19 taught us about developing vaccines during a pandemic,’ STAT News

June 30: ‘Cutting out the proteins that give SARS-CoV-2 its power,’ Texas Biomedical Research Institute

June 30: ‘Search for Covid’s origins leads to China’s wild animal farms—and a big problem,’ The Wall Street Journal

June 30: ‘Coronavirus vaccines are widely available in the U.S. So why are scientists working on new ones?’ The Washington Post

June 30: ‘Nearly all COVID-19-induced loss-of-smell recovers within a year,’ U.S. Pharmacist

June 29: ‘The antivirals that weren’t: drug repurposing for COVID-19 produced misleading results,’ Chemical & Engineering News

June 29: ‘How do COVID-19 vaccines work? Hear from a researcher who helped develop the Johnson & Johnson vaccine,’ Harvard University

June 29: ‘Inside the risky bat-virus engineering that links America to Wuhan,’ MIT Technology Review

June 29: ‘The quest for a universal coronavirus vaccine’ The Scientist

June 28: ‘Pfizer, Moderna COVID vaccines might protect long-term: Researchers,’ Newsmax

June 28: ‘COVID-19 survivors may not get back sense of smell and taste for a year: Study,’ Republic World

June 28: ‘Why no one is sure if Delta is deadlier,’ The Atlantic

June 28: ‘The neuroscience behind why your brain may need time to adjust to “un-social distancing,”’ The Conversation

June 28: ‘Pfizer and Moderna vaccines likely to produce lasting immunity, study finds,’ The New York Times

June 27: ‘Covid survivors may take a year to get back taste, smell: Study,’ Indo-Asian News Service

June 27: ‘COVID-19 survivors might take a year to recover loss of smell and taste,’ The Science Times

June 26: ‘What we know about the origins of COVID-19,’ The Wall Street Journal

June 25: ‘Most COVID-19 patients recover smell at one year,’ HealthDay News

June 25: ‘COVID-19 virus being copied and trapped, “nanodecoy” cells produced by human lungs,’ The Science Times

June 24: ‘Universal vaccine against coronavirus could prevent pandemic,’ Archyde

June 24: ‘After COVID, when will sense of smell return?’ MedPage Today

June 24: ‘Deleted coronavirus genome sequences trigger scientific intrigue,’ Nature

June 24: ‘The mRNA vaccines are extraordinary, but Novavax is even better,’ The Atlantic

June 23: ‘Engineered nanobodies can help Combat SARS-CoV-2 virus and its variants,’ AZoNano

June 23: ‘Universal vaccine protects mice against five coronaviruses, neutralizes variants,’ Genetic Engineering & Biotechnology News

June 23: ‘Claim that Chinese team hid early SARS-CoV-2 sequences to stymie origin hunt sparks furor,’ Science

June 23: ‘The only way we’ll know when we need COVID-19 boosters,’ The Atlantic

June 23: ‘Chinese COVID-19 gene data that could have aided pandemic research removed from NIH database,’ The Wall Street Journal

June 23: ‘Seattle scientist digs up deleted coronavirus genetic data, adding fuel to the covid origin debate,’ The Washington Post

June 22: ‘Dual antibodies effective against SARS-CoV-2 variants in animal study,’ Drug Target Review

June 22: ‘“Super-antibodies” could curb COVID-19 and help avert future pandemics,’ Nature Biotechnology

June 22: ‘Safety of COVID-19 antibody treatment tested #InMice #InMonkeys,’ Speaking of Research

June 21: ‘A tapeworm drug against SARS-CoV-2?’ Charité, the University of Bonn and the DZIF

June 21: ‘Antibody disease enhancement of COVID-19 does not appear to occur in animal models,’ Duke Health

June 21: ‘Nanodecoys bind SARS-CoV-2 for destruction by immune system,’ Medgadget

June 21: ‘Dual-antibody drugs effective against COVID-19 variants in animal study,’ Reuters

June 21: ‘COVID-19 study could greatly enhance opportunities to treat viral infections,’ Stockhouse

BREAKING NEWS: June 21: ‘COVID-19 dual-antibody therapies effective against variants in animal study,’ Washington University School of Medicine in St. Louis

June 21: ‘COVID-19 treatment in pill form tested in Triangle could shorten infection time,’ WNCN

June 20: ‘Uganda COVID-19 vaccine at animal testing stage, says govt scientist,’ Daily Monitor

June 20: ‘Fight over Covid’s origins renews debate on risks of lab work,’ The New York Times

June 20: ‘Scientists battle over the ultimate origin story: Where did the coronavirus come from?’ The Washington Post

June 18: ‘What went wrong with CureVac’s highly anticipated new mRNA vaccine for COVID-19?’ Science

June 18: ‘Did COVID-19 leak from a Chinese lab?’ The Economist

June 17: ‘These two COVID-19 vaccines show safety and produce immunity in a child model,’ Archyde

June 17: ‘Arizona scientists study dogs and cats infected with COVID-19,’ KNAU

June 17: ‘“Nanodecoy” therapy binds and neutralizes SARS-CoV-2 virus,’ NC State News

BREAKING NEWS: June 17: ‘Study details the treatment of COVID-19 vaccine-associated myocarditis-like illness in 7 patients,’ News Medical

June 17: ‘Texas Biomed gets $37 million to care for San Antonio monkeys that helped develop COVID-19 vaccine,’ San Antonio Express-News

June 17: ‘CureVac’s mRNA Covid vax just 47% effective,’ SocialNews.XYZ

June 17: ‘Second lion dies of Covid at Indian zoo,’ The Independent

June 17: ‘Vaccination, previous infection, protect against COVID-19 gamma/P.1 variant in animal model,’ UW–Madison News

June 16: ‘Two COVID-19 vaccines show safety and strong immunity in infant model,’ Drug Target Review

June 16: ‘COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials,’ News Medical

June 16: ‘Increased viral replication and shedding in nonhuman primates carrying SARS-CoV-2 B.1.1.7 variant,’ News Medical

June 16: ‘CureVac’s COVID-19 vaccine disappoints in clinical trial,’ The New York Times

June 16: ‘G-7 and Biden pin hopes on WHO to lead follow-up COVID-19 origins investigation,’ Washington Examiner

June 15: ‘Could a nasal spray of designer antibodies help to beat COVID-19?’ NIH Director’s Blog

June 15: ‘SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques,’ Science Immunology

June 15: ‘Southwest National Primate Research Center at Texas Biomed receives $37 million NIH grant,’ Texas Biomedical Research Institute

June 15: ‘Federal watchdog to examine NIH grants, likely including Wuhan funding,’ The Hill

June 15: ‘Two COVID-19 vaccines show safety, strong immunity in infant model,’ UNC Health

June 14: ‘Diabetes mainstay metformin tamps down lung inflammation in COVID models,’ FierceBiotech

June 14: ‘A white-knuckle ride of open COVID drug discovery,’ Nature

June 14: ‘Powerful new COVID-19 vaccine shows 90% efficacy, could boost world’s supply,’ Science

June 14: ‘Why scientists tweak lab viruses to make them more contagious,’ Scientific American

June 13: ‘Pfizer, AstraZeneca … or both? A mixed approach may hold promise,’ The New York Times

June 12: ‘How to make the COVID vaccine fast-track the new standard,’ The Hill

June 12: ‘Covid-sniffing dogs are accurate but face hurdles for widespread use,’ The New York Times

June 12: ‘Similarities between human-animal SARS-Cov-2: Study,’ The Pioneer

June 11: ‘Ask Ethan: How Can You Be So Sure That COVID-19 Didn’t Happen From A Lab Leak?’ Forbes.com

June 11: ‘Is SARS-CoV-2 infection in pets more common than we thought?’ Medical News Today

June 11: ‘Fighting COVID-19 on all fronts,’ MSUToday

June 11: ‘A better understanding of “wet markets” is key to safeguarding human health and biodiversity,’ Princeton University

June 11: ‘Novavax announces positive data from three complementary studies of COVID-19 Beta (B.1.351) variant strain vaccine,’ PR Newswire

June 10: ‘Chinese researchers find batch of new coronaviruses in bats,’ CNN

June 10: ‘How primates are helping the fight against COVID-19 in Louisiana,’ Reuters

June 9: ‘Nasal spray antibody treatment shows promise against COVID-19, variants in mouse study,’ www.msn.com

June 9: ‘Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned,’ Globe Newswire

June 9: ‘Selva Announces SLV213, a Potential Oral COVID-19 Treatment, Has Broad Activity Against SARS-CoV-2 Variants of Concern,’ www.rfdtv.com

June 9: ‘A “Universal” Coronavirus Vaccine to Prevent the Next Pandemic,’ Scientific American

June 9: ‘Common diabetes drug shows promise as treatment for COVID-19 lung inflammation,’ ScienceDaily

BREAKING NEWS: June 9: ‘Johnson & Johnson COVID-19 vaccine protects against virus variants, study shows,’ USA Today

June 9: ‘How does COVID-19 affect wildlife and pets?,’ ExBulletin

June 9: ‘Explainer: How does COVID-19 affect wild animals and pets?,’ FirstPost.com

June 9: ‘Why We Don’t Know the Animal Origins of the Coronavirus,’ Scientific American

June 9: ‘Research documents extent of wildlife trade in Wuhan’s markets,’ Seattle Times

June 9: ‘Fauci Says He Didn’t Play Down China Lab-Leak Theory of COVID-19 Origins,’ The Wall Street Journal

June 9: ‘Fauci: Attacks on me are really also “attacks on science,”’ The Hill

June 9: ‘Nasal spray antibody treatment shows promise against COVID-19, variants in mouse study,’ The Week

June 8: ‘“Faucigate” emails prove nothing about a Covid lab leak,’ Bloomberg

BREAKING NEWS: June 8: ‘Oregon requires coronavirus vaccines for farmed mink,’ Capital Press

June 8: ‘The forever virus,’ Foreign Affairs

June 8: ‘FIGHTING ON ALL FRONTS: MSU ALUMNUS HELPS DEVELOP COVID VACCINE, CONNECTS COMMUNITIES WITH VACCINE INFORMATION,’ Michigan State University College of Veterinary Medicine

June 8: ‘The COVID lab-leak hypothesis: What scientists do and don’t know,’ Nature

June 8: ‘Over 47,000 wild animals sold in Wuhan markets before Covid outbreak, study shows,’ The Wall Street Journal

June 8: ‘U.S. report found it plausible COVID-19 leaked from Wuhan lab,’ The Wall Street Journal

June 7: ‘Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants,’ Nature

June 7: ‘China markets sold mink, civets, stoking natural origins theory,’ Bloomberg

June 7: ‘New antibody drug shows promise in mouse study; vaping may increase lung vulnerability to virus,’ Reuters

June 7: ‘Could a breast cancer candidate treat COVID-19? Polyphor’s drug shows dual action in early study,’ Fierce Biotech

June 7: ‘Odisha institute develops animal models for research on COVID-19,’ Press Trust of India

June 6: ‘Intranasal vaccines aim to stop COVID-19 where it starts,’ Chemical & Engineering News

June 5: ‘Lioness dies of COVID-19 in Indian zoo,’ AAP

June 5: ‘Address questions on COVID-19 vaccine policy,’ Hindustan Times

June 5: ‘Lioness dies of Covid, tiger too suspected victim,’ Hindustan Times

June 5: ‘Lioness dies of COVID-19 at Chennai zoo, eight other lions test positive,’ The Indian Express

June 4: ‘How animal vaccines will prevent the next human pandemic,’ BBC Science Focus

June 4: ‘NIH has identified promising oral drug to treat COVID-19,’ KCPQ-TV

June 4: ‘What you need to know about the COVID-19 lab-leak hypothesis,’ National Geographic

June 4: ‘Antibody-laden nasal spray could provide COVID protection — and treatment,’ Nature

June 4: ‘Coronapod: Uncertainty and the COVID “lab-leak” theory,’ Nature Podcast

June 4: ‘Chinese military “engineered mice with human lungs” to test virus, report says,’ The Daily Wire

June 4: ‘Fauci calls on China to release medical records of Wuhan researchers,’ The Hill

June 4: ‘Lion dies of Covid at Vandalur Zoo, 9 test positive,’ The Hindu Business Line

June 4: ‘Lioness dies of suspected coronavirus infection in Chennai’s Vandalur zoo; nine lions test positive,’ The Times of India


BREAKING NEWS: June 4: ‘Regeneron’s COVID-19 drug is authorized for injection,’ The Wall Street Journal

June 4: ‘We may never know where the virus came from. But evidence still suggests nature,’ The Washington Post

June 3: ‘Skin-patch COVID-19 vaccine could offer enhanced antibody responses, according to preclinical data,’ BioPharma-Reporter

June 3: ‘Chinese military “engineered mice with humanized lungs” in 2019 to test viruses on them – just months before the pandemic erupted,’ Daily Mail

June 3: ‘Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets,’ Science

June 3: ‘A scientist adventurer and China’s “Bat Woman” are under scrutiny as coronavirus lab-leak theory gets another look,’ The Washington Post

June 3: ‘The lab-leak theory: Inside the fight to uncover COVID-19’s origins,’ Vanity Fair

June 2: ‘Study offers insights for communicating about wildlife, zoonotic disease amid COVID-19,’ NC State News

June 2: ‘New study on swine influenza virus may be relevant to influenza, coronavirus infection in humans,’ News Medical

June 2: ‘NIH director: We need an investigation into the Wuhan lab-leak theory,’ The Atlantic

June 2: ‘Fauci sought answers about Wuhan lab at start of pandemic,’ Washington Examiner

June 1: ‘Now proven against coronavirus, mRNA can do so much more,’ CNN

June 1: ‘Antibody cocktail effectively inhibits SARS-CoV-2 in the rhesus macaque model,’ News Medical

June 1: ‘Compelling evidence of SARS-CoV-2 exposure and neutralizing antibodies in domestic cats in Peru,’ News Medical

June 1: ‘Scientists hope they’re closing in on a cure for COVID-19,’ PBS NewsHour

June 1: ‘Fact check-COVID-19 vaccines did not skip animal trials because of animal deaths,’ Reuters

June 1: ‘Deadly fungi are the newest emerging microbe threat all over the world,’ Scientific American

June 1: ‘How did COVID-19 originate? The question may be larger than it looks,’ The Hill

May

May 31: ‘Not only COVID-19, Pompeo exploded, Wuhan laboratory is still studying deadly virus,’ Archyde

May 31: ‘Where could the next coronavirus jump to humans? New research offers clues,’ Vox

May 30: ‘Animal experiments are helpful,’ The News-Gazette

May 30: ‘Leading scientist says that without a full investigation of lab leak theory, the world will face “covid-26 and covid-32,”’ The Washington Post

May 29: ‘COVID-19 DNA vaccine candidates show promise in hamsters, mice,’ Medical News Today

May 29: ‘Another Voice: Animal research made Covid vaccines possible,’ The Buffalo News

May 29: ‘Assessing the theory that COVID-19 leaked from a Chinese lab,’ The Economist

May 29: ‘Coronavirus “lab leak” theory jumps from mocked to maybe as Biden orders intelligence review,’ The Washington Post

May 28: ‘Oregon will require all captive mink to get COVID-19 vaccines,’ Salem Statesman Journal

May 27: ‘Perspective: COVID-19 and the false blame on animal ag,’ AGDAILY

May 27: ‘Divisive COVID “lab leak” debate prompts dire warnings from researchers,’ Nature

May 27: ‘DNA vaccines for COVID-19 effective in mice, hamsters,’ PLOS

May 27: ‘Biden says he will release findings of probe into coronavirus origins,’ The Hill

May 27: ‘Intel community: Competing COVID-19 origin theories not “more likely than the other,”’ The Hill

May 27: ‘“It was clear from the biosecurity experts that a lab leak was quite feasible”—SARS-CoV-2’s origins,’ The Intelligence

May 27: ‘The sudden rise of the coronavirus lab-leak theory,’ The New Yorker

May 27: ‘Scientists don’t want to ignore the “lab leak” theory, despite no new evidence,’ The New York Times

May 27: ‘Biden calls for intelligence report on origins of COVID-19,’ The Wall Street Journal

May 27: ‘Russia rolls out COVID-19 vaccine for animals,’ The Wall Street Journal

May 27: ‘Time is running out in COVID-19 origins inquiry, say WHO-led team members,’ The Wall Street Journal

May 27: ‘What a proven coronavirus lab leak theory would mean,’ The Washington Post

May 27: ‘Yes, we’ll probably need coronavirus booster shots. But which one?’ The Washington Post

May 26: ‘Covid: Russia starts vaccinating animals,’ BBC News

May 26: ‘Pitt’s inhalable “nanobody” fights off COVID-19 in hamsters at ultralow doses,’ FierceBiotech

May 26: ‘Animal disease labs stepped up during COVID-19 and could help prevent the next pandemic,’ KOSU

May 26: ‘The lab-leak hypothesis for COVID-19 is becoming a conspiracy theory,’ Massive Science

May 26: ‘How Covaxin became a victim of vaccine triumphalism,’ Mint

May 26: ‘The COVID vaccine pioneer behind southeast Asia’s first mRNA shot,’ Nature

BREAKING NEWS: May 26: ‘Moderna’s COVID vaccine proves effective against South African variant in primates,’ News Medical

May 26: ‘Dems back growing calls for Congress to probe Covid lab leak theory,’ Politico

May 26: ‘Russian regions begin vaccinating animals against COVID-19 – RIA,’ Reuters

May 26: ‘Biden adds voice to calls for further investigation into origins of pandemic virus,’ Science

May 26: ‘If the lab-leak theory is right, what’s next?’ The Atlantic

May 26: ‘Biden asks intel community to “redouble” efforts probing COVID-19 origins,’ The Hill

May 26: ‘Stopping the next pandemic: We need a “space race” against viruses,’ The Hill

May 26: ‘Biden asks intelligence community to redouble efforts to determine definitive origin of the coronavirus,’ The Washington Post

May 26: ‘Top U.S. health official calls for follow-up investigation into pandemic’s origins,’ The Washington Post

May 26: ‘Statement by President Joe Biden on the investigation into the origins of COVID-19,’ The White House

May 26: ‘Biden asks intelligence agencies to step up investigation of COVID-19 origins,’ UPI

May 25: ‘Pompeo-led effort to hunt down Covid lab theory shut down by Biden administration over concerns about quality of evidence,’ CNN

May 25: ‘No, veterinarians are not giving pets the COVID-19 vaccine,’ FOX61

May 25: ‘Tissues, not blood, are where immune cells function,’ Nature

May 25: ‘QIMR Berghofer researchers create drugs for COVID-19,’ Pharmaceutical Technology

May 25: ‘FALSE: Animal testing skipped for COVID-19 vaccines,’ Rappler.com

May 25: ‘Will the four-legged friends we share our homes with need vaccines?’ The Oklahoman

May 25: ‘Inquiry into COVID-19’s origins splits U.S. and China,’ The Wall Street Journal

May 25: ‘Timeline: How the Wuhan lab-leak theory suddenly became credible,’ The Washington Post

May 25: ‘Cancer drug could protect against future SARS-CoV-2 illness, study finds,’ WNCN

May 24: ‘COVID-19 vaccines were subject to animal trials,’ AFP Fact Check

May 24: ‘Flying insects not likely to transmit SARS-CoV-2, ARS studies show,’ Agricultural Research Service

May 24: ‘Gottlieb says there’s growing circumstantial evidence that Covid may have originated in a lab,’ CNBC

May 24: ‘Unraveling the corona virus origin mystery with Dr. Lawrence Sellin,’ GoaChronicle

May 24: ‘Universal coronavirus vaccine is highly effective in monkeys,’ Live Science

May 24: ‘I’m subject NL002-0060 and I’m dropping out of my COVID-19 vaccine trial,’ Science

May 24: ‘COVID-19 Wuhan lab theory gets more serious look,’ The Hill

May 24: ‘Former FDA chief: Growing circumstantial evidence that COVID “could have come out of a lab,”’ The Hill

May 24: ‘White House pushes for independent investigation on COVID-19 origins,’ The Hill

May 23: ‘COVID vaccines could convey avalanche of neurological illness,’ Editorials 360

May 23: ‘Intelligence on sick staff at Wuhan lab fuels debate on COVID-19 origin,’ The Wall Street Journal

May 22: ‘Severe COVID-19: We have the culprit,’ Archyde

May 21: ‘Newly described antibodies with ‘special shape’ could unlock vaccine strategies for HIV, COVID,’ Genetic Engineering & Biotechnology News 

May 21: ‘New type of coronavirus originating in dogs found – study,’ Reuters

May 21: ‘COVID-19 vaccine makers are looking beyond the spike protein,’ The Atlantic

May 20: ‘UN bodies set up “One Health” panel to advise on animal disease risks,’ Reuters

May 20: ‘Fact check: COVID-19 vaccine makers did not halt animal tests, and there were no widespread animal deaths,’ USA Today

May 19: ‘Timeline of a vaccine under debate,’ Archyde

May 19: ‘Instagram posts spread Texas lawmaker’s false claims on vaccine testing,’ FactCheck.org

May 19: ‘Dogs nearly as effective as nasal swab tests in detecting Covid, study finds,’ Forbes

May 19: ‘These sniffer dogs are learning to smell the coronavirus,’ National Geographic

May 19: ‘How the Covid pandemic ends: Scientists look to the past to see the future,’ STAT News

May 19: ‘Your next COVID-19 test could be a dog’s sniff,’ The Wall Street Journal

May 18: ‘COVID-19 vaccines were tested in animals and clinical trials before receiving authorization; vaccinated people aren’t dying at a higher rate than unvaccinated people,’ Health Feedback

May 18: ‘SARS-CoV-2 mRNA vaccine PTX-COVID19-B safe and highly immunogenic in preclinical study,’ News Medical

May 18: ‘Instagram post falsely claims COVID-19 vaccines “skipped all animal trials,”’ PolitiFact

May 18: ‘Prepping the next generation of COVID-19 vaccines and treatments,’ POZ

May 18: ‘China’s Clover says its COVID-19 vaccine candidate shows immune response in mice,’ Reuters

May 18: ‘Luck is not a strategy: The world needs to start preparing now for the next pandemic,’ STAT News

May 18: ‘Have Australian researchers developed an effective COVID-19 treatment? Potentially, but we need to wait for human trials,’ The Conversation

May 18: ‘Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19,’ The Journal of Clinical Investigation

May 18: ‘Scientists have found a way to remove COVID-19 from mice’s lungs,’ VICE News

May 17: ‘Researchers discuss new vaccine that could prevent future pandemics,’ Duke Today

May 17: ‘Prepping the next generation of COVID-19 vaccines and treatments,’ FierceBiotech

May 17: ‘Duke researchers present new vaccine to prevent all future COVID-like pandemics,’ HealthExec

May 17: ‘Military medicine heroes recognized for COVID-19 pandemic response,’ Military Health System

May 17: ‘CureVac-GSK coronavirus variant vaccine generates good immune response in rats,’ Reuters

May 17: ‘Animals are our overlooked allies in the fight against Covid,’ The Guardian

May 17: ‘The curious case of the COVID-19 origin,’ The Hill

May 17: ‘Texas GOP state senator urged use of unproven hydroxychloroquine treatment for COVID-19. Now he’s spreading doubt about vaccines,’ The Texas Tribune

May 17: ‘On the horizon: Duke Human Vaccine Institute working on universal coronavirus shot,’ WNCN

May 16: ‘Pfizer and Moderna jabs “may help stop future pandemics” by blocking animal viruses,’ Daily Mirror

May 16: ‘Coronavirus: The animal shortage in China’s life science labs,’ South China Morning Post

May 15: ‘Debunked: No, COVID-19 vaccines didn’t “skip” or “fail” animal trials,’ TheJournal.ie

May 15: ‘China recorded a shortage of monkeys for laboratory research,’ US News Latest

May 14: ‘A universal vaccine for coronavirus and some common colds? Seattle scientists are working on it,’ KING 5

May 14: ‘Mammalian enteral ventilation ameliorates respiratory failure,’ Med

May 14: ‘GSK, CureVac’s next-gen COVID-19 jab generates positive preclinical data,’ PharmaTimes

May 14: ‘Investigate the origins of COVID-19,’ Science

May 14: ‘The pandemic surge at home is threatening an Indian vaccinemaker’s bid to protect the world,’ Science

May 14: ‘Breathing through the rectum saves oxygen-starved mice and pigs,’ The New York Times

May 14: ‘Fauci touts Duke-developed COVID-19 vaccine in national briefing,’ WNCN

May 13: ‘Top researchers are calling for a real investigation into the origin of COVID-19,’ MIT Technology Review

May 13: ‘A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity,’ News Medical

May 13: ‘Scientists call for deeper investigation into COVID-19 origin,’ The Wall Street Journal

May 13: ‘Opinion: Herd immunity is not a helpful concept for COVID-19. It’s time to retire it,’ The Washington Post

May 13: ‘The 60-year-old scientific screwup that helped Covid kill,’ WIRED

May 12: ‘Inovio’s pan-COVID-19 vaccine candidate can provide immune responses against variants, animal study shows,’ Benzinga

May 12: ‘Oregon mulls ban on mink farms as COVID threat,’ Journal of the American Veterinary Medical Association

May 12: ‘Defeat the next pandemic — in advance,’ The Hill

May 12: ‘Novavax reports positive data from animal trial of its COVID-19/flu combo shot,’ The Motley Fool

May 11: ‘Combined vaccination against corona and flu is coming – coronavirus,’ Archyde

May 11: ‘Altimmune’s intranasal COVID-19 vaccine shows sterilising immunity,’ Clinical Trials Arena

May 11: ‘Coronavirus variants are spreading in India — what scientists know so far,’ Nature

May 11: ‘Mice with severe COVID symptoms could speed vaccine effort,’ Nature

May 11: ‘Widely used in India, WHO recommends Ivermectin only for clinical trials, not treatment of Covid,’ News18

May 11: ‘New vaccine blocks novel coronavirus, variants in the animal study,’ Press Trust of India

May 11: ‘Study: Horses could be susceptible to COVID-19 infection,’ The Horse

May 11: ‘Just like humans, zoo animals will be vaccinated against COVID-19. Here’s how,’ WJZ

May 10: ‘Novavax’s flu / COVID combo vaccine shows “robust responses”: Preclinical data,’ BioPharma-Reporter

May 10: ‘Flagship launches Laronde to develop circular RNA therapies,’ Chemical & Engineering News

May 10: ‘New vaccine blocks COVID-19 and variants, plus other coronaviruses,’ Duke Health

May 10: ‘The firm that birthed Moderna unveils new startup for next play in RNA,’ MedCity News

May 10: ‘Novavax combined influenza/COVID-19 vaccine shows promise in animal study,’ Reuters

May 10: ‘COVID-19 vaccine in development at Duke, could be used alone or as booster shot,’ WNCN

May 10: ‘New vaccine created by Duke doctors shows promising results in blocking COVID variants in animals,’ WTVD

May 7: ‘Bees in the Netherlands trained to detect COVID-19 infections,’ Reuters

May 7: ‘Scientists may have found a new coronavirus rapid-testing method: Bees,’ The Washington Post

May 7: ‘How has COVID‐19 changed our views of the One Health agenda?’ Vet Record

May 6: ‘Scientists have taught bees to smell the coronavirus. They can identify a case within seconds,’ Business Insider

BREAKING NEWS: May 6: ‘Indian SARS-CoV-2 variant shows enhanced host cell entry and immune evasion,’ News Medical

BREAKING NEWS: May 6: ‘Moderna COVID-19 booster: Effective protection against new variants, early clinical trial shows,’ The Science Times

May 5: ‘FDA approves 100th monoclonal antibody product,’ Nature

May 5: ‘Eight lions in Indian zoo test positive for COVID-19,’ Reuters

May 5: ‘This new Covid vaccine could bring hope to the unvaccinated world,’ The New York Times

May 5: ‘Penn Vet seeking volunteers for COVID-19 detection dog T-shirt study,’ WPVI

May 4: ‘Your COVID vaccine booster might be a patch or a pill. Or it might come with your flu shot,’ CBS News

May 4: ‘Researchers identify nanobodies that may block SARS-CoV-2,’ Medical News Today

May 4: ‘What happens in the first few days of SARS-CoV-2 infection?’ News Medical

May 4: ‘Latest FDA COVID-19-related advice and actions,’ Outsourcing-Pharma

May 4: ‘EU regulator begins real-time review of first Chinese COVID-19 vaccine,’ Reuters

May 4: ‘Does animal research produce cures?’ Speaking of Research

May 3: ‘Pompeo ties coronavirus to China lab, despite spy agencies’ uncertainty,’ The New York Times

May 3: ‘Next generation of COVID-19 vaccines could be pill or spray,’ The Wall Street Journal

May 2: ‘How have COVID-19 pandemic lockdowns affected our immune systems?’ Medical News Today

May 2: ‘Live “attenuated” influenza virus vaccine protects animals against respiratory infections, including SARS-CoV-2,’ News Medical

May 2: ‘Opinion: We need research monkeys to advance medical therapies,’ The Detroit News

April

April 30: ‘Future COVID-19 vaccines might not have to be kept so cold,’ National Geographic

April 30: ‘Russia produces first batch of COVID-19 vaccine for animals -regulator,’ Reuters

April 29: ‘Might your physique render future COVID vaccines ineffective?’ Editorials 360

April 29: ‘You might have given the coronavirus to your cat,’ FiveThirtyEight

April 29: ‘Scientists scour the Amazon for pathogens that could spark the next pandemic,’ Science

April 29: ‘COVID-19-sniffing dog on staff at Florida hospital,’ Tampa Bay Times

April 28: ‘Scientists set out to connect the dots on long COVID,’ Nature Methods

April 27: ‘Study reveals a cause of heart damage in COVID-19 patients,’ Cornell Chronicle

April 27: ‘Nanobody cocktail shown to block SARS-CoV-2 infection in mouse models,’ Drug Target Review

April 27: ‘Texas Biomed shares critical work in development of Pfizer COVID-19 vaccine,’ Texas Biomed

April 27: ‘U.S. aims to shape new phase of WHO-led probe into origin of COVID-19,’ The Wall Street Journal

April 26: ‘Scientists find evidence of human-to-cat COVID-19 transmission,’ CTV News

April 26: ‘Could heart medications increase COVID-19 risk?’ Experimental Biology

April 26: ‘These savvy humans are saving bats from human COVID,’ Forbes

April 26: ‘Nanobody cocktails keep SARS-CoV-2 from infecting mice,’ Genetic Engineering & Biotechnology News

April 26: ‘Is a cheap “universal” coronavirus vaccine on the way?’ HealthDay News

April 26: ‘COVID-19 gave scientists an opening to better understand how brain disorders arise,’ STAT News

April 26: ‘One vaccine to rule them all,’ The Atlantic

April 26: ‘Eight key measures against the coronavirus (which is in the air and not so much on surfaces),’ The Conversation

April 26: ‘Exclusive: Virginia Zoo tigers’ COVID diagnosis and recovery,’ WAVY

April 26: ‘UVA, Virginia Tech develop new vaccine that could protect against COVID-19, other coronaviruses,’ WTKR

April 25: ‘University of Queensland COVID-19 vaccine still in redevelopment, but won’t be available soon,’ Australian Broadcasting Corporation

April 25: ‘New vaccine from IIT Kanpur,’ The Hindu Business Line

April 24: ‘Revealed: How a single pill home cure for Covid could be available this year,’ The Telegraph

April 23: ‘A scientist stopped by and made Covid vaccine in my kitchen,’ Bloomberg

April 23: ‘Kitten dies after human-to-cat COVID-19 transmission,’ Evening Standard

April 23: ‘Rare side effects from the AstraZeneca and Johnson & Johnson vaccines may have been seen in 15 year old animal studies,’ ScienceNorway

April 23: ‘Cats and Covid: UK scientists identify two cases of human-to-pet transmission,’ The i

April 23: ‘Henry Vilas Zoo plans to vaccinate animals against COVID-19,’ WMTV

April 22: ‘AVMA honors COVID-19 veterinary responders on World Veterinary Day,’ American Veterinary Medical Association

April 22: ‘COVID-19: Will we ever work out where it came from?’ BBC Science Focus Magazine

April 22: ‘Disinfecting technologies under study at Texas Biomed,’ KSAT-TV

April 22: ‘Do preservative and stray proteins cause rare COVID-19 vaccine side effect?’ Science

April 22: ‘Confirmation of COVID-19 in otters at an aquarium in Georgia,’ USDA Animal and Plant Health Inspection Service

April 21: ‘COVID-19 vaccinations: What’s the progress?’ DW

April 21: ‘Georgia Aquarium otters join list of animals testing positive for SARS-CoV-2,’ eScienceCommons

April 21: ‘Expert: Otters, others closely related to minks are more susceptible to virus that causes COVID-19,’ FOX 5 Atlanta

April 21: ’23 dogs in Washington test positive for COVID-19 antibodies,’ KING 5

April 21: ‘You and your dog: Variants of coronavirus may affect pets,’ South Coast Herald

April 21: ‘Study determines how to best enhance protection of new COVID-19 vaccine,’ Tulane University

April 20: ‘In evolving to infect mink, SARS-CoV-2’s risk for humans changes,’ Ars Technica

April 20: ‘How do we stop the next pandemic? Here’s a new strategy,’ National Public Radio

April 20: ‘Long COVID’s long R&D agenda,’ Nature

April 20: ‘We know a lot about COVID-19. Experts have many more questions,’ STAT News

April 20: ‘Penn Vet study finds dogs can detect positive COVID-19 samples by scent,’ The Daily Pennsylvanian

April 20: ‘Are the COVID vaccines experimental? Did they skip animal trials?’ The Dispatch

April 20: ‘No, we don’t know if vaccines change your period,’ The New York Times

April 19: ‘MK-4482 antiviral effective against SARS-CoV-2 in hamster study,’ Drug Target Review

April 19: ‘Will vaccinated folks be extra weak to variants?’ Editorials 360

April 19: ‘Coronavirus antiviral drug shows promise in hamsters, enters human testing,’ Fox News

April 19: ‘Translate Bio announces publication of preclinical results of COVID-19 mRNA vaccine candidate MRT5500 in npj Vaccines,’ Globe Newswire

April 19: ‘Stanford tests new COVID-19 vaccine that can be more easily distributed around the world,’ KGO

April 19: ‘J&J COVID-19 vaccine reviewed for links to additional reports of severe side effects -CDC,’ Reuters

April 19: ‘Otters at Georgia Aquarium test positive for COVID-19,’ The Hill

April 19: ‘The race to untangle the secrets of rare, severe blood clots after Johnson & Johnson vaccination,’ The Washington Post

April 19: ‘New COVID-19 vaccine may offer broad protection from coronaviruses,’ UVA Health

BREAKING NEWS: April 18: ‘Otters at Georgia Aquarium test positive for virus that causes COVID-19,’ 11Alive

April 18: ‘Georgia Aquarium otters test positive for COVID-19,’ Meredith/CNN

April 18: ‘Otters at Georgia Aquarium test positive for COVID-19,’ NBC News

April 18: ‘Otters at Georgia Aquarium test positive for COVID, are “expected to make a full recovery,”’ People

April 17: ‘COVID-19 cats: Three Virginia Zoo tigers test positive for virus,’ WYDaily

April 16: ‘Trained dogs can smell coronavirus in your pee,’ Live Science

April 16: ‘Are dogs really that good at sniffing out COVID? Another study leaves no doubt,’ McClatchy

April 16: ‘Experimental antiviral for COVID-19 effective in hamster study,’ National Institutes of Health

April 16: ‘The blood-clot problem is multiplying,’ The Atlantic

BREAKING NEWS: April 15: ‘Pittsburgh Zoo: 2 lions positive for COVID-19, others tested for virus,’ KDKA

April 15: ‘Chronic COVID syndrome: A new study shows the positive effects of using Apportal, a targeted nutritional supplement,’ PharmaNutra Spa

April 15: ‘Vaccines that can protect against many coronaviruses could prevent another pandemic,’ Science

April 15: ‘COVID-19 vaccines are entering uncharted immune territory,’ The Atlantic

April 14: ‘Expert panel explains science behind COVID-19 vaccines,’ Cornell Chronicle

April 14: ‘COVID-19 vaccine did not kill every animal it was tested on,’ Full Fact

April 14: ‘UK variant of COVID-19 confirmed in 2 Brazos County pets,’ KTRK

April 14: ‘The race for antiviral drugs to beat COVID — and the next pandemic,’ Nature

April 14: ‘Updated Moderna vaccines neutralize South African SARS-CoV-2 variant in mice,’ News Medical

April 14: ‘Fact check- COVID-19 vaccines are not experimental and they have not skipped trial stages,’ Reuters

April 14: ‘Moderna vaccines promising vs variants in mouse study; no higher risk for poor outcomes found with UK variant,’ Reuters

April 14: ‘Origin story—where did SARS-CoV-2 come from?’ The Economist

April 14: ‘U.S. intel chief: Coronavirus originated either from Chinese lab breach or infected animal,’ The Washington Times

April 14: ‘How to develop vaccines faster before the next pandemic,’ Vox

April 14: ‘Mixing covid vaccines could boost immune response, animal research suggests,’ WalesOnline

April 14: ‘Virginia Zoo tigers test positive for coronavirus,’ WAVY

April 14: ‘Two Virginia Zoo tigers test positive for COVID-19,’ WVEC

April 13: ‘Moderna Covid vaccine efficacy falls slightly to 90% in US trial,’ Agence France-Presse

April 13: ‘Akston Biosciences takes second-generation COVID-19 vaccine into Phase 1/2 clinical trial,’ BioPharma-Reporter

April 13: ‘Volunteer cats from COVID households wanted for new study,’ CBC News

April 13: ‘Connecticut puppy that died unexpectedly tested positive for coronavirus, UConn researchers say,’ Hartford Courant

April 13: ‘Microbes in your gut may be new recruits in the fight against viruses,’ National Geographic

April 13: ‘Could zebrafish larvae be a novel animal model for SARS-CoV-2?’ News Medical

April 13: ‘HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trials,’ Press Trust of India

April 13: ‘UPDATE 2-Mexican-made COVID-19 vaccine could be ready this year,’ Reuters

April 12: ‘Virus spillover and emerging pathogens pick up speed,’ Contagion

April 12: ‘Vaccine development for emerging infectious diseases,’ Nature

April 12: ‘Tweaked COVID vaccines in testing aim to fend off variants,’ The Associated Press

May-June: ‘The CEO of Pfizer on developing a vaccine in record time,’ Harvard Business Review

April 11: ‘Military programs aiming to end pandemics forever,’ 60 Minutes

April 11: ‘Scientists have a new tool to predict the next pandemic virus,’ Deseret News

April 9: ‘How could a COVID vaccine cause blood clots? Scientists race to investigate,’ Nature

April 9: ‘Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants,’ News Medical

April 9: ‘Scientists work toward an elusive dream: A simple pill to treat COVID-19,’ STAT News

April 8: ‘Army scientists hope their COVID-19 vaccine will be a universal booster shot,’ McClatchy DC

April 8: ‘Kati Kariko helped shield the world from the coronavirus,’ The New York Times

April 8: ‘Supporters tout anti-parasite drug as covid-19 treatment, but skeptics call it the “new hydroxychloroquine,”’ The Washington Post

April 7: ‘PharmAust delivers COVID-19 antiviral breakthrough,’ Business News

April 7: ‘A new low-cost vaccine made from eggs could change the course of this pandemic,’ EN24 News

April 7: ‘Clinical trials mix vaccine types to boost COVID protection,’ Medscape

April 7: ‘Intravacc announces positive preclinical data for its SARS-CoV-2 nose spray vaccine,’ PR Newswire

April 7: ‘PharmAust’s MPL and MPLS drug candidates again indicate antiviral activity in SARS-CoV2,’ Small Caps

April 6: ‘Study suggests T-cells don’t determine survival in severe COVID-19,’ News Medical

April 6: ‘Anixa and OntoChem to enter next stage of COVID-19 therapy development,’ Pharmaceutical Technology 

April 6: ‘Russia’s COVID-19 defense may depend on mystery vaccine from former bioweapons lab—but does it work?’ Science

April 6: ‘COVID-19 vaccine developed by U.S. Army begins human testing,’ The Wall Street Journal

April 6: ‘A new low-cost COVID-19 vaccine candidate enters clinical trials,’ The Wire Science

April 5: ‘Pfizer’s Vizimpro is among 3 FDA-approved drugs that combat COVID-19 in lung cells: Report,’ FierceBiotech

April 5: ‘The story of one dose inside the sprawling operational puzzle of bringing the Johnson & Johnson COVID vaccine to the public,’ Intelligencer – New York Magazine

April 5: ‘New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks,’ News Medical

April 5: ‘As WHO highlights COVID animal origins, China wildlife crackdown needs more teeth – experts,’ Reuters

April 5: ‘An HIV lab’s pivot to develop a single-dose COVID-19 vaccine wins STAT Madness “Editors’ Pick,”’ STAT News

April 5: ‘Coronavirus | Government releases names of vaccine expert panel,’ The Hindu

April 5: ‘Researchers are hatching a low-cost coronavirus vaccine,’ The New York Times

April 4: ‘How long will coronavirus vaccines protect people?’ CNN

April 3: ‘German professional panel says under-60s who acquired first AstraZeneca shot ought to obtain different vaccine for second jab,’ Editorials 360

April 2: ‘We still don’t know the origins of the coronavirus. Here are 4 scenarios,’ National Geographic

April 2: ‘The powerful technology behind the Pfizer and Moderna vaccines,’ PBS NewsHour

April 1: ‘After the WHO report: What’s next in the search for COVID’s origins,’ Nature

April 1: ‘Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate,’ News Medical

March

March 31: ‘COVID-19 antibodies found in a stray cat and dog in Brazil: Study,’ Forbes

March 31: ‘Russia is testing COVID-19 vaccine for pets,’ New York Post

March 31: ‘Why scientists are developing inhaled COVID-19 vaccines,’ Quartz

March 31: ‘Russia registers world’s first COVID-19 vaccine for animals,’ Reuters

March 31: ‘Russia claims to be the first country to develop coronavirus shots for animals,’ The New York Times

March 31: ‘Virus variants can infect mice, scientists report,’ The New York Times

March 31: ‘Beijing pushes back at criticism of WHO coronavirus origin report, insists China shared data,’ The Washington Post

March 31: ‘China’s rapid urbanization will make another pandemic more likely,’ The Washington Post

March 31: ‘Russia unveils world’s first coronavirus vaccine for dogs, cats and other animals,’ The Washington Post

March 30: ‘Oakland Zoo’s great apes to receive modified COVID vaccine,’ KRON

March 30: ‘Globally accessible therapy is found to protect against lethal inflammation from COVID-19 in animal models,’ Mount Sinai

March 30: ‘WHO report into COVID pandemic origins zeroes in on animal markets, not labs,’ Nature

March 30: ‘Researchers develop broadly neutralizing SARS-CoV-2 ferritin nanoparticle vaccine,’ News Medical

March 30: ‘“Compromise” WHO report resolves little on pandemic’s origins, but details probe’s next steps,’ Science

March 30: ‘US joins 13 countries in raising “concerns” with data in WHO team’s virus report,’ The Hill

March 30: ‘COVID-19 origin study points to bats and animal hosts as pathway,’ The Japan Times 

March 30: ‘U.S. calls for independent study of COVID-19 origin,’ The Wall Street Journal

March 30: ‘Opinion: Where did the pandemic begin? China holds the key,’ The Washington Post

March 30: ‘WHO report leaves unsettled “lab-leak” theory on origins of covid pandemic,’ The Washington Post

March 30: ‘WHO-China report on coronavirus’s origin conflicts with declassified US intelligence,’ Washington Examiner

March 29: ‘TGen is testing cats and dogs in Arizona for COVID-19,’ Cronkite News

March 29: ‘Where did COVID-19 come from? WHO study points to bats, animals,’ Eyewitness News

March 29: ‘The next wave of COVID-19 vaccines: In through the nose,’ Healthy Debate

March 29: ‘Developing orally administrable drugs to combat SARS-CoV-2,’ News Medical

March 29: ‘Fooling coronavirus with new decoy protein renders it impotent,’ Northwestern University

March 29: ‘AP exclusive: WHO report says animals likely source of COVID,’ The Associated Press

March 29: ‘WHO report into COVID-19 origins leaves key questions unanswered,’ The Wall Street Journal

March 29: ‘WHO Wuhan report leaves question of coronavirus origins unresolved,’ The Washington Post

March 28: ‘What happened in Wuhan? Why questions still linger on the origin of the coronavirus,’ 60 Minutes

March 27: ‘“A lab leak isn’t 100% certain but it seems to be the only logical source of Covid”: Washington expert who led inquiry into the cause of the virus reveals three Wuhan lab scientists fell ill in November 2019,’ Daily Mail

March 27: ‘High-tech face masks aim to step up the fight against COVID-19,’ The Wall Street Journal

March 27: ‘Biden adminstration in wait-and-see mode on coronavirus origins ahead of WHO-China report,’ Washington Examiner

March 26: ‘What we know about QUIVAX, the Mexican vaccine against COVID-19,’ Explica

March 26: ‘Antibody used for COVID-19 therapy does not inhibit SARS-Cov-2 variants,’ News Medical

March 26: ‘Redfield tells CNN he believes origin of the coronavirus pandemic is a lab in China,’ The Hill

March 26: ‘Herd immunity won’t save us—but we can still beat COVID-19,’ The Wall Street Journal

March 25: ‘Oxford University to trial giving AstraZeneca Covid vaccine as a nasal spray with the hope it will trigger a better and faster immune response in the lungs,’ Daily Mail

March 25: ‘China’s exotic farms may be a missing link behind the pandemic’s leap to people,’ National Geographic

March 25: ‘HOW THE PANDEMIC WILL END,’ The Atlantic

March 25: ‘The search for animals that could carry the next deadly virus,’ The Wall Street Journal

March 25: ‘COVID variants detected in animals, may find hosts in mice,’ WebMD

March 24: ‘Voltron Therapeutics, Inc. announces positive data from animal testing of self-assembling vaccine in the fight against COVID-19,’ Globe Newswire

March 24: ‘Scientists at UVA, Virginia Tech develop possible COVID-19 vaccine,’ Richmond Times-Dispatch

March 24: ‘The coronavirus variants don’t seem to be highly variable so far,’ Scientific American

March 24: ‘COVID-19 and the investigator pipeline,’ The New England Journal of Medicine

March 23: ‘Good news! Manu said the future could have oral drugs that could prevent COVID-19,’ Archyde

March 23: ‘CureVac’s COVID-19 vaccine shows protection against South Africa variant in preclinical study,’ BioPharma-Reporter

March 23: ‘B.1.1.7 variant found in animals—are people at risk of catching a COVID-19 variant from their pets?’ Forbes

March 23: ‘Covid vaccine used on apes at San Diego Zoo trialled on mink,’ The Guardian

March 23: ‘Transcript: The path forward: Combating COVID-19 with Eli Lilly CEO David Ricks,’ Washington Post Live

March 23: ‘Cleveland Clinic experts discuss controversy surrounding AstraZeneca vaccine doses,’ WOIO

March 22: ‘Are mRNA Covid vaccines risky? Here’s what the experts say,’ Bloomberg

March 22: ‘Cougar, 3 tigers test positive for COVID-19 at Texas wildlife rescue,’ CBSDFW.com

March 22: ‘What the science says about 7 common COVID-19 vaccine myths,’ Fast Company 

March 22: ‘Wider image: By catching bats, these “virus hunters” hope to stop the next pandemic,’ Reuters

March 22: ‘San Antonio infectious disease expert and Texas Biomed CEO nabs honor for global impact,’ San Antonio Express-News

March 22: ‘Could an accident have caused COVID-19? Why the Wuhan lab-leak theory shouldn’t be dismissed,’ USA Today

March 21: ‘Vets warn of new Covid variant’s possible link to heart problems in pets,’ The Guardian

March 20: ‘Leprosy drug fights COVID-19 in hamsters,’ Chemical & Engineering News

March 19: ‘No virus variants can evade all antibody types, so far; new variants can infect mice,’ Reuters

March 19: ‘Major coronavirus variant found in pets for first time,’ Science

March 19: ‘“I still have a lot of confidence in the Astrazeneca vaccine:” Doctor,’ Yahoo Finance

March 18: ‘Finding new ways to fight coronavirus … from studying bats,’ NIH Director’s Blog

March 18: ‘Timing the SARS-CoV-2 index case in Hubei province,’ Science

March 18: ‘Animal science vs. coronavirus,’ University of Delaware

March 18: ‘CDC, WHO create threat levels for COVID variants,’ WebMD

March 17: ‘Autolus seeks partner for clinical trials of pan-COVID-19 product,’ BioPharma-Reporter

March 17: ‘CDC, WHO establish new threat levels for COVID-19 variants,’ Medscape 

March 17: ‘Innovators target vaccines for variants and shortages in global South,’ Nature

March 17: ‘The fate of bats is hanging in the balance. That could have very real consequences for us,’ PBS NewsHour

March 17: ‘From primate models to SARS-CoV-2 sequencing and testing,’ Promega Connections

March 17: ‘How the WHO’s hunt for Covid’s origins stumbled in China,’ The Wall Street Journal

March 17: ‘Spray created in Estonia may help prevent corona infection,’ University of Tartu

March 16: ‘Zoo vaccinates apes to protect both animals and humans from COVID-19,’ National Public Radio

March 16: ‘Riems: The most dangerous pathogens are being researched on the isolated German laboratory island – including SARS-CoV-2,’ PressFrom

March 16: ‘UK virus variant found in Brazos County pets,’ The Eagle

March 15: ‘ImmunityBio announces positive interim Phase I safety data of hAd5 T-cell COVID-19 vaccine candidate in oral and sublingual formulations,’ Business Wire

March 15: ‘Texas A&M research uncovers first known COVID-19 UK variant in animals,’ KBTX

March 15: ‘New research suggests vaccines reduce risk of COVID-19 spread through nose and mouth,’ McClatchy DC

March 15: ‘WHO points to wildlife farms in southern China as likely source of pandemic,’ National Public Radio

March 15: ‘The first 12 months of COVID-19: A timeline of immunological insights,’ Nature

March 15: ‘COVID-19: Unprecedented but expected,’ Nature Medicine

March 15: ‘Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases,’ Nature Medicine

March 15: ‘Nowcasting epidemics of novel pathogens: Lessons from COVID-19,’ Nature Medicine

March 15: ‘Tomorrow’s biggest microbial threats,’ Nature Medicine

BREAKING NEWS: March 15: ‘White-tailed deer susceptible to SARS-CoV-2, finds study,’ News Medical

March 15: ‘FOCUS-Money, talent flowing into mRNA sector after COVID-19 success,’ Reuters

March 15: ‘Texas A&M research uncovers first known COVID-19 UK variant in animals,’ Texas A&M College of Veterinary Medicine & Biomedical Sciences

March 14: ‘Corona vaccination soon as a nasal spray? Spray instead of syringe as a new hope in the vaccination sky,’ Archyde

March 14: ‘What science has learned works and what doesn’t in COVID-19 treatments,’ USA Today

March 12: ‘Ridgeback’s molnupiravir (EIDD-2801) “appears to stop SARS-CoV-2 in its tracks.” Or does it?’ American Council on Science and Health

March 12: ‘Did CDC’s misguided mask advice drive up Covid death toll for health workers?’ Kaiser Health News

March 12: ‘Lonza to commission Houston suite to supply Altimmune’s COVID-19 vaccine candidate,’ Reuters

March 11: ‘Monoclonal antibodies: GSK and Vir to seek US approval for their COVID-19 candidate, EMA starts rolling review of Lilly’s medicines,’ BioPharma-Reporter 

March 11: ‘Even more evidence shows vaccinated people are unlikely to transmit the coronavirus or get asymptomatic infections,’ Business Insider

March 11: ‘Combatting COVID-19 with help from genetically engineered mice,’ curiousSCIENCEwriters 

March 11: ‘COVID-19 vaccine development: What’s the progress?’ DW

March 11: ‘New hope for a COVID-19 vaccine that protects against all variants,’ Forbes

March 11: ‘FDA authorizes first single-shot COVID-19 vaccine,’ Nature

March 11: ‘Researchers race to develop antiviral weapons to fight the pandemic coronavirus,’ Science

March 11: ‘Sinopharm chairman claims he received COVID-19 vaccine one year ago, has antibodies,’ The Epoch Times

March 11: ‘Merck oral COVID-19 drug shows promise in early trials,’ Verywell Health

March 11: ‘Experts: Reducing wildlife trade could prevent more animal-to-human virus spread,’ WRAL

March 10: ‘Arizona pets to be subject of coronavirus study at TGen lab,’ ABC15 Arizona

March 10: ‘Pfizer vaccine may be effective against all coronavirus variants,’ BBC Science Focus

March 10: ‘Running out of lab monkeys,’ Moncrieff Highlights

March 10: ‘Call in the veterinarians to aid in mitigating spread of coronavirus,’ Nation Africa

March 10: ‘Bamlanivimab COVID-19 antibody treatment description,’ Precision Vaccinations

March 10: ‘What’s in the huge pandemic relief bill for science?’ Science

March 10: ‘“Then the world caved in”: 8 experts describe the day they realized COVID-19 was here to stay,’ STAT News

March 10: ‘Q&A: Unique circumstances for minority scientists during COVID-19,’ The Scientist

March 10: ‘WHO team expert expects COVID-19’s origins will be found “within a few years,”’ The Wall Street Journal

March 10: ‘VERIFY: COVID-19 vaccines for zoo animals have no impact on human shot distribution,’ WUSA9

BREAKING NEWS: March 9: ‘Detection of a SARS-CoV-2 variant of concern in South Africa,’ Nature

March 9: ‘Researchers report zoonotic spillover of adapted SARS-CoV-2 from minks to humans,’ News Medical

March 9: ‘SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection,’ News Medical

March 9: ‘Capitalizing on measles vaccine’s successful history to protect against SARS-CoV-2,’ Ohio State News

March 8: ‘Meet the scientists using TikTok to fight COVID misinformation,’ Bustle

March 8: ‘Approval and initiation of the COVID-19 clinical phase I/II study for the ABNCoV2 vaccine,’ ExpreS2ion Biotechnologies

March 8: ‘Nearly 100 pet dogs and cats have contracted COVID-19. Here’s how to protect your pets,’ KTVX

March 8: ‘San Diego Zoo primates vaccinated against COVID-19,’ MRT

March 8: ‘Study suggests sewer rats immune to SARS-CoV-2,’ News Medical

March 8: ‘In 2018, diplomats warned of risky coronavirus experiments in a Wuhan lab. No one listened,’ POLITICO Magazine

March 8: ‘San Diego Zoo primates vaccinated against COVID-19,’ PressFrom

March 8: ‘Finnish researchers introduce a nasal COVID vaccine,’ PR Newswire

March 7: ‘Biologists change handling procedures in the field to prevent the possible spread of COVID into Wyoming’s wildlife populations,’ Casper Star-Tribune

March 7: ‘Great apes at San Diego Zoo receive COVID-19 vaccine,’ FOX 11 Los Angeles

March 7: ‘The research monkey shortage is real,’ InsideSources

March 6: ‘We have vaccines for COVID-19. Why don’t we have good treatments?’ BuzzFeed News

BREAKING NEWS: March 6: ‘Without these lipid shells, there would be no mRNA vaccines for COVID-19,’ Chemical & Engineering News

March 6: ‘At the San Diego Zoo, the first gorillas vaccinated against the COVID-19,’ PressFrom

March 5: ‘Great apes at San Diego Zoo receive first Covid vaccines,’ Agence France-Presse 

March 5: ‘Inhaled CRISPR treatment targets influenza and SARS-CoV-2 infections,’ Genetic Engineering & Biotechnology News

March 5: ‘Coronapod: COVID’s origins and the “lab leak” theory,’ Nature Podcast

March 5: ‘Great apes at the San Diego Zoo got coronavirus vaccines: “These animals are incredibly precious,”’ The Washington Post

March 4: ‘Soligenix shares rally on positive preclinical data for COVID-19 vaccine candidate,’ Benzinga

March 4: ‘Great apes at San Diego Zoo become first non-humans to receive COVID-19 vaccine,’ CBS News

March 4: ‘Nine great apes at San Diego Zoo become first non-humans to receive COVID-19 vaccine after outbreak saw eight gorillas infected,’ Daily Mail

March 4: ‘Soligenix announces positive progress in the pre-clinical development of its COVID-19 vaccine,’ PR Newswire

March 4: ‘Nine great apes in San Diego become first non-human primates vaccinated for COVID-19,’ Reuters

March 4: ‘For early testing of convalescent plasma, we were “building the plane while we were flying it,”’ STAT News

March 4: ‘9 great apes get COVID-19 vaccinations at San Diego Zoo,’ The Associated Press

March 4: ‘A group of great apes received a COVID-19 vaccine at the San Diego Zoo,’ The Hill

March 4: ‘Popular drug does not alleviate mild COVID-19 symptoms, study finds,’ The New York Times

March 4: ‘San Diego Zoo vaccinates apes against COVID-19,’ The San Diego Union-Tribune

March 4: ‘WHO investigators to scrap plans for interim report on probe of COVID-19 origins,’ The Wall Street Journal

March 3: ‘Racing to save humans through animal research,’ Journal of the American Veterinary Medical Association

March 3: ‘Veterinary medicine and COVID-19: “A lot of lessons here,”’ Journal of the American Veterinary Medical Association

BREAKING NEWS: March 3: ‘First great apes at U.S. zoo receive COVID-19 vaccine made for animals,’ National Geographic

March 3: ‘Vaccine research must include pregnant women during COVID and beyond,’ The Hill

March 3: ‘Results of Covaxin study on monkeys out,’ The Times of India

March 2: ‘Vaccination with SARS-CoV-2 spike protein and AS03 adjuvant induces rapid anamnestic antibodies in the lung and protects against virus challenge in nonhuman primates,’ bioRxiv

March 2: ‘These four policy changes could help us get vaccines for the next pandemic even faster,’ Forbes

March 2: ‘The search for animals harbouring coronavirus — and why it matters,’ Nature

March 2: ‘Orally-administered antiviral drug tested at UNC shows promise in treating COVID-19,’ The Daily Tar Heel

March 1: ‘Team of Texas A&M researchers identify potential new drug to treat COVID-19,’ KBTX

March 1: ‘To beat COVID, we may need a good shot in the nose,’ Scientific American

March 1: ‘Sex differences in immune responses to viral infection,’ The Scientist

March 1: ‘COVID-19 virus studies yield new clues on pandemic’s origin,’ The Wall Street Journal

February

BREAKING NEWS: Feb. 28: ‘FDA authorizes a third COVID-19 Vaccine,’ Tufts Now

Feb. 27: ‘Scientists get serious about mixing and matching COVID-19 vaccines,’ Los Angeles Times

Feb. 27: ‘Getting the vaccine will protect you from the coronavirus — and it may keep people around you healthier, too,’ The Washington Post

Feb. 26: ‘Can COVID spread from frozen wildlife? Scientists probe pandemic origins,’ Nature

Feb. 26: ‘Where did COVID come from? Five mysteries that remain,’ Nature

Feb. 26: ‘Hunt for COVID-19 origins: Questions surface over China’s testing of suspect animals,’ South China Morning Post

Feb. 26: ‘Tracking an FDA advisory panel’s meeting on J&J’s COVID-19 vaccine,’ STAT News

Feb. 26: ‘The secret life of a coronavirus,’ The New York Times

Feb. 25: ‘Data on pregnancy and the Covid vaccine is sparse. These women are changing that,’ NBC News

Feb. 25: ‘Neuroinvasiveness of SARS-CoV-2 shown by viral RNA and inflammation in the brain,’ News Medical

Feb. 25: ‘1B COVID vaccine expansion includes pregnant women. Should they take the shot?’ WCBU Peoria Public Radio

Feb. 24: ‘Preclinical testing for vaccines,’ News Medical

Feb. 24: ‘J&J one-shot vaccine appears to fare better against worrisome COVID-19 variants than first reported,’ The Boston Globe

Feb. 24: ‘FDA review confirms safety, efficacy of single-shot Johnson & Johnson coronavirus vaccine, especially against severe cases,’ The Washington Post

Feb. 23: ‘China’s Clover generates US$230m in funding as its COVID-19 vaccine candidate edges towards late stage clinical trial,’ BioPharma-Reporter

Feb. 23: ‘Episode 43: Pandemic Primates — A look at the critical role the Tulane National Primate Research Center is playing in the fight against COVID-19,’ Biz New Orleans

Feb. 23: ‘After billions of dollars and dozens of wartime declarations, why are vaccines still in short supply?’ Kaiser Health News

Feb. 23: ‘UL Lafayette helps in the development and research of the nation’s first available COVID-19 vaccine,’ KLFY

Feb. 23: ‘Future COVID-19 vaccines jeopardized by monkey shortage,’ Newsmax

Feb. 23: ‘Research predicts which mammal species can spread SARS-CoV-2,’ News Medical

Feb. 23: ‘Future vaccines depend on test subjects in short supply: Monkeys,’ The New York Times

Feb. 23: ‘Novavax nears COVID-19 vaccine game changer—after years of failure,’ The Wall Street Journal

Feb. 23: ‘Can a vaccinated person still spread the coronavirus?’ The Washington Post

Feb. 23: ‘Facebook’s false fact check protected a viable source of COVID-19: Wuhan Institute of Virology,’ The Washington Times

Feb. 23: ‘NC Zoo veterinarians take steps to prevent COVID-19 transmission between animals and zoo staff, visitors,’ WRAL

BREAKING NEWS: Feb. 22: ‘Pfizer/BioNTech to trial COVID-19 vaccine in pregnant women and children,’ BioPharma-Reporter

Feb. 22: ‘Vitamin D supplementation reduces COVID-19 deaths by 64%,’ Mercola.com

Feb. 22: ‘The “human error” theory on COVID origin still very much alive,’ National Review

Feb. 22: ‘COVID-19 vaccine candidate shows potential against SARS-CoV-2 and potential future zoonotic coronaviruses,’ News Medical

Feb. 22: ‘Opinion: The U.S. should reveal its intelligence about the Wuhan laboratory,’ The Washington Post

Feb. 21: ‘COVID-19 is circulating in some animals. What does that mean for us?’ ABC News

Feb. 21: ‘Vaccines still effective against different COVID-19 strains,’ The Daily Iowan

Feb. 21: ‘WHO said what about Wuhan?’ The Wall Street Journal

Feb. 19: ‘ImmunoPrecise announces data from preclinical study of TATX-03 PolyTope™ monoclonal antibody cocktail candidate against COVID-19,’ Business Wire

Feb. 19: ‘Selfie-taking tourists risk giving wild gorillas COVID-19, other diseases,’ National Geographic

Feb. 19: ‘Different species of animal models in preclinical testing,’ News Medical

Feb. 19: ‘To get ahead of variants, COVID-19 drug makers use evolutionary biology as a guide,’ STAT News

Feb. 19: ‘And then the gorillas started coughing,’ The New York Times

Feb. 19: ‘COVID-19 was spreading in China before first confirmed cases, fresh evidence suggests,’ The Wall Street Journal

Feb. 19: ‘Mink farmers are skipping to the front of the vaccine line — for an important reason,’ The Washington Post

Feb. 18: ‘On pins and needles: Tracking COVID-19 vaccines and therapeutics,’ McKinsey & Company

Feb. 18: ‘Pfizer plans to test COVID-19 vaccine booster targeting the South African variant,’ Reuters

Feb. 18: ‘SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model,’ Science

Feb. 18: ‘EPA approves chemical “air treatment” against COVID, despite known health hazards,’ The Defender

Feb. 18: ‘In hunt for COVID-19 origin, WHO team focuses on two animal types in China,’ The Wall Street Journal

Feb. 18: ‘Opinion: Six takeaways from COVID-19 that could shape our future,’ The Washington Post

Feb. 17: ‘Nasal spray blocks COVID-19 infection in ferrets,’ Cornell Chronicle

Feb. 17: ‘Tourist selfies could be spreading COVID to endangered mountain gorillas,’ Euronews Living

Feb. 17: ‘Anixa initiates animal testing of COVID-19 therapeutic candidates,’ Pharmaceutical Technology 

Feb. 17: ‘Machine learning used to predict where new coronaviruses might develop next,’ VOA Learning English

Feb. 16: ‘Preventing cellular hijacking: Study pinpoints potential pathway to new therapeutic approaches for COVID-19,’ BioPharma-Reporter

Feb. 16: ‘San Diego Zoo gorillas make full recovery from COVID-19,’ CNN

Feb. 16: ‘Selfie-taking tourists could be spreading COVID-19 to gorillas,’ CNN

Feb. 16: ‘Animal research during a pandemic: new podcast episode goes live,’ Imperial College London

Feb. 16: ‘The coronavirus is here to stay — here’s what that means,’ Nature

Feb. 16: ‘U.S. still hasn’t ruled out lab accident origin for Covid because China hasn’t been transparent,’ NBC News

Feb. 16: ‘Researchers used AI to determine which overlooked animals could host a new coronavirus,’ Neural

Feb. 16: ‘Anixa Biosciences begins animal testing of COVID-19 therapeutic candidates,’ PR Newswire

Feb. 16: ‘Ocular MRI findings in patients with severe COVID-19: A retrospective multicenter observational study,’ Radiology

Feb. 16: ‘How soon will COVID-19 vaccines return life to normal?’ Science

Feb. 16: ‘Midwestern mink farms navigate COVID fears,’ Star Tribune

Feb. 16: ‘Potential for new coronaviruses may be greater than known,’ The New York Times

Feb. 16: ‘What pseudoviruses bring to the study of SARS-CoV-2,’ The Scientist

Feb. 15: ‘Nanoparticle COVID-19 vaccine stimulates robust and long lasting immunity in primates,’ News Medical

Feb. 15: ‘Absolutist views crumble as COVID-19 vaccine becomes available,’ Speaking of Research

Feb. 15: ‘Anatomy of a conspiracy: With COVID, China took leading role,’ The Associated Press

Feb. 15: ‘The superspreaders behind top COVID-19 conspiracy theories,’ The Associated Press

Feb. 15: ‘Seoul offered free coronavirus tests for pets and soon found its first case in a lethargic, vomiting cat,’ The Washington Post

Feb. 14: ‘CNN exclusive: WHO Wuhan mission finds possible signs of wider original outbreak in 2019,’ CNN

Feb. 14: ‘“Politics was always in the room.” WHO mission chief reflects on China trip seeking COVID-19’s origin,’ Science

Feb. 14: ‘The Hindu Explains | What has the WHO team’s field visit to China thrown up regarding the spread of SARS-CoV-2?’ The Hindu

Feb. 13: ‘Two tiger cubs probably died of COVID-19, reports Pakistani zoo,’ The Washington Post

Feb. 12: ‘The 3 factors that make someone a COVID-19 “superspreader,”’ Laboratory Equipment

Feb. 12: ‘Developing a “super vaccine” that protects against mutated corona strains and colds,’ Saudi 24 News

Feb. 12: ‘Will we be ready for the next pandemic?’ The Wall Street Journal

Feb. 11: ‘Coronavirus: Bat scientists find new evidence,’ BB

Feb. 11: ‘Study: Exhaled COVID-19 aerosol droplets dictated by age, infection and body mass index,’ BioSpa

Feb. 11: ‘ImmunityBio and NantKwest announce FDA authorization to dtudy hAd5 T-cell COVID-19 vaccine for combination of subcutaneous, oral and sublingual boost to induce T-cell, mucosal, and antibody immunity,’ Business Wire

Feb. 11: ‘Obese and aged having COVID-19? You can be a super spreader,’ Mint

Feb. 11: ‘This COVID-vaccine designer is tackling vaccine hesitancy — in churches and on Twitter,’ Nature

Feb. 11: ‘From animals to people and back again,’ Penn Today

Feb. 11: ‘Scientists unravel what makes some people COVID-19 super-spreaders,’ Press Trust of India

Feb. 11: ‘Researchers uncover more key factors that make people COVID-19 “superspreaders,”’ RT

Feb. 11: ‘EXPLAINER: What the WHO coronavirus experts learned in Wuhan,’ The Associated Press

Feb. 11: ‘How do some people become Covid super-spreaders? Obesity, age, and the state of the infection play a huge role,’ The Economic Times

Feb. 10: ‘Cougar, tiger test positive for COVID-19 in Texas,’ 21 News

Feb. 10: ‘Sunshine Biopharma initiates COVID-19 treatment mice study,’ Accesswire

Feb. 10: ‘COVID-19, Hendra and SARS: How scientists trace viruses through animals to their source,’ Australian Broadcasting Corporation

Feb. 10: ‘Exhaled respiratory droplets increase with the onset of COVID-19 infection and with aging and obesity,’ Harvard John A. Paulson School of Engineering and Applied Sciences

Feb. 10: ‘Monkeys at UL’s New Iberia Research Center play a role in COVID-19 vaccine development,’ Lafayette Daily Advertiser

Feb. 10: ‘“Major stones unturned”: COVID origin search must continue after WHO report, say scientists,’ Nature

Feb. 10: ‘UL reveals role of primate center in vaccine development,’ Scripps Media

Feb. 10: ‘WHO team: Coronavirus unlikely to have leaked from China lab,’ The Associated Press

Feb. 10: ‘Possible early COVID-19 cases in China emerge during WHO mission,’ The Wall Street Journal

BREAKING NEWS: Feb. 10: ‘Confirmation of COVID-19 in a cougar at a wild animal exhibitor in Texas,’ USDA Animal and Plant Health Inspection Service

BREAKING NEWS: Feb. 10: ‘New study reinforces the importance of wearing masks to stop the spread of COVID,’ WWL Eyewitness News

Feb. 9: ‘Additional preclinical data for Atea pharma’s COVID-19 antiviral drug candidate, highlighted in online manuscript,’ Benzinga

Feb. 9: ‘Intermediary host species likely introduced SARS-CoV-2 virus, says WHO,’ BioWorld

Feb. 9: ‘Researchers hope to “predict and prevent” future pandemics,’ Farm Journal

Feb. 9: ‘U.S. rushes to fill void in viral sequencing as worrisome coronavirus variants spread,’ Science

Feb. 9: ‘Ohio State veterinary researchers hope to prevent the next pandemic,’ The Columbus Dispatch

Feb. 9: ‘WHO: “Extremely unlikely” that coronavirus escaped from Wuhan lab,’ The Hill

Feb. 9: ‘Could a single vaccine work against all coronaviruses?’ The New York Times

Feb. 9: ‘WHO team rules out China “lab leak” theory in Covid origins investigation,’ The Telegraph

Feb. 9: ‘Coronavirus likely came from animal, not leaked from laboratory, WHO says,’ The Wall Street Journal

Feb. 9: ‘Researchers unravel what makes someone a COVID-19 super-spreader,’ Tulane University

Feb. 9: ‘Novavax vaccine demonstrates strong immune response,’ University of Maryland, Baltimore

Feb. 9: ‘Groundbreaking study suggests COVID-19 virus might enter human brain,’ UTSA Today

Feb. 9: ‘Do pets need to get the COVID-19 vaccine?’ WCNC

Feb. 9: ‘Doctors: COVID-19 reinfections rare as virus variants spread,’ WJW

Feb. 9: ‘UNC COVID-19 treatment sees positive results in mice; human study underway,’ WNCN

Feb. 8: ‘NanoViricides’s broad-spectrum antiviral drug candidate for the treatment of COVID-19 infections was well tolerated in GLP and non-GLP animal safety studies,’ Accesswire

Feb. 8: ‘Atea Pharmaceuticals announces publication of preclinical data highlighting potent activity of AT-527 against SARS-CoV-2,’ Globe Newswire

Feb. 8: ‘Tonix Pharmaceuticals to develop COVID-19 skin test (TNX-2100) to measure SARS-CoV-2 exposure and T cell immunity,’ Globe Newswire

Feb. 8: ‘Variant-proof vaccines — invest now for the next pandemic,’ Nature

Feb. 8: ‘4th preclinical study for Novavax in non-human primates, tests SARS-CoV-2 variants,’ News Medical

Feb. 8: ‘South Africa suspends use of AstraZeneca’s COVID-19 vaccine after it fails to clearly stop virus variant,’ Science

Feb. 8: ‘Seoul to give free COVID-19 tests to pets,’ The Associated Press

Feb. 8: ‘UC Berkeley researchers find new drug therapies to treat COVID-19,’ The Daily Californian

Feb. 8: ‘How Russian biotech trampled protocols — and challenged the West — in race for Sputnik V vaccine,’ The Washington Post

Feb. 8: ‘China’s plan for medical domination,’ UnHerd

Feb. 7: ‘Iran to start human trials on second local COVID vaccine,’ Al Jazeera

Feb. 7: ‘India developing seven more COVID vaccines, says health minister,’ The Week

Feb. 6: ‘Where did Covid come from? Investigator foreshadows fresh clues,’ Bloomberg

Feb. 6: ‘Emory MVA COVID-19 vaccine safe in animal models,’ Medindia

Feb. 6: ‘How vaccines are made, and why it is hard,’ The Economist

Feb. 6: ‘Two tigers at Fort Wayne Children’s zoo test positive for COVID-19,’ WPTA21

Feb. 5: ‘New COVID-19 vaccine elicits strong protective immunity in mice and monkeys,’ Drug Target Review

Feb. 5: ‘Scientists are optimistic that the vaccine will partially prevent infection,’ Elemental

Feb. 5: ‘Common questions about COVID-19 vaccinations answered,’ Mayo Clinic

Feb. 5: ‘The coronavirus is mutating—but what determines how quickly?’ National Geographic

Feb. 5: ‘New COVID-19 vaccine platforms emerge, are effective in preclinical models,’ The Science Advisory Board

Feb. 4: ‘Could mixing COVID vaccines boost immune response?’ Nature

Feb. 4: ‘Are COVID-sniffing dogs the new tool in helping detect the virus?’ NC State University

Feb. 4: ‘Animal research crucial in COVID-19 vaccine development,’ Orlando Sentinel

Feb. 4: ‘Research on pets contracting COVID-19 moves forward at Texas A&M’s veterinary school,’ Scripps Media

Feb. 4: ‘Covid: Oxford trial to test efficacy of mix of vaccines for individuals,’ The Guardian

Feb. 4: ‘Scientists test a new COVID-19 vaccine question: Mixing different doses,’ The Wall Street Journal

Feb. 4: ‘Scientists establish multiple primate models of SARS-CoV-2 airborne infection,’ U.S. Army Medical Research Institute of Infectious Diseases

Feb. 4: ‘Emory MVA COVID-19 vaccine safe and effective in animal models,’ Yerkes National Primate Research Center

Feb. 3: ‘OSU researchers are testing animals for SARS-CoV-2 to help prevent future outbreaks,’ 10TV – WBNS

Feb. 3: ‘On the frontline: NCSU professor shares science behind COVID-19 sniffing dogs,’ ABC11 Eyewitness News

Feb. 3: ‘UK government to test mixing COVID vaccines in new trial,’ ABC News

Feb. 3: ‘Scientists probe way to lessen COVID’s effect on elderly,’ Anadolu Agency

Feb. 3: ‘Can you still transmit COVID-19 after vaccination?’ BBC

Feb. 3: ‘Vaxart shares shaken despite apparently positive early data for oral COVID-19 vaccine,’ BioWorld

Feb. 3: ‘WHO team heads to China bat lab at the center of coronavirus conspiracies,’ CNN

Feb. 3: ‘Coronavirus: Trained dogs detect COVID 94% of the time, German study finds,’ DW

Feb. 3: ‘Is intranasal drug delivery the best way to administer COVID-19 therapeutics?’ European Pharmaceutical Review

Feb. 3: ‘Can pets get COVID-19? NM veterinarian gives tips on how to keep animals safe,’ KRQE

Feb. 3: ‘India budget pledges billions for virus research amid COVID pandemic,’ Nature

Feb. 3: ‘J&J SARS-CoV-2 vaccine shows immunity in non-human primates 6 months after vaccination,’ News Medical

Feb. 3: ‘German sniffer dogs detect COVID-19 with 94% accuracy,’ Reuters

Feb. 3: ‘How the Oxford-AstraZeneca vaccine works,’ The New York Times

Feb. 3: ‘These are the top coronavirus vaccines to watch,’ The Washington Post

Feb. 3: ‘WHO visits suspect China lab,’ The Washington Times

Feb. 3: ‘Tulane University to lead national research partnership to speed up COVID-19 vaccines and drug discoveries,’ Tulane University

Feb. 3: ‘University of Nottingham scientists uncover potential antiviral treatment for COVID-19,’ University of Nottingham

Feb. 2: ‘Ohio researchers studying potential for animals to harbor coronavirus mutations,’ Becker’s Hospital Review

Feb. 2: ‘Selva Therapeutics announces successful completion of Phase 1 clinical study of SLV213, a potential oral treatment for COVID-19,’ Business Wire

Feb. 2: ‘China’s COVID Secrets,’ Frontline

Feb. 2: ‘COVID research updates: Russia’s Sputnik V vaccine shows high effectiveness,’ Nature

Feb. 2: ‘Ampio’s inhaled COVID-19 drug shows clinical improvement in Phase I trial,’ Pharmaceutical Technology

Feb. 2: ‘Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure,’ PLOS One

Feb. 2: ‘Why COVID vaccines are likely safe for pregnant people,’ Scientific American

Feb. 2: ‘Comparing the COVID-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson,’ STAT News

Feb. 2: ‘WHO team visits Wuhan virus lab at center of speculation,’ The Associated Press

Feb. 1: ‘Pfizer and BioNTech publish preclinical data from investigational COVID-19 vaccine program in Nature,’ Globe Newswire

Feb. 1: ‘Inhaled single dose vaccine creates antibodies and prevents infection in rhesus macaques,’ News Medical

Feb. 1: ‘Beyond the green vaccination summit table: How more corona vaccine can be produced and adapted to mutants – knowledge,’ NewsyList

Feb. 1: ‘EMA starts rolling review of Regeneron’s COVID-19 antibody,’ Reuters

Feb. 1: ‘Poland finds first case of COVID-19 in mink,’ Reuters

Feb. 1: ‘WHO-led COVID-19 probe team in China visits animal health facility,’ Reuters

Feb. 1: ‘The Sputnik V vaccine and Russia’s race to immunity,’ The New Yorker

Feb. 1: ‘COVID-19 vaccines leave pregnant women in a quandary,’ The Wall Street Journal

Feb. 1: ‘New diabetes cases linked to COVID-19,’ The Washington Post

Feb. 1: ‘Top 10 COVID-19 vaccine myths,’ Understanding Animal Resarch

Feb. 1: ‘Researchers at Ohio State University are studying COVID-19 in animals and the environment to identify future pandemic threats,’ WKYC

January

Jan. 31: ‘How COVID-19 “vaccines” might destroy the lives of thousands and thousands,’ Editorials 360

Jan. 31: ‘What COVID-19 in gorillas teaches us about viral evolution,’ Forbes

Jan. 31: ‘WHO teams visits Wuhan food market in search of virus clues,’ The Associated Press

Jan. 30: ‘WHO team visits 2nd Wuhan hospital in virus investigation,’ The Associated Press

Jan. 30: ‘In the search for Covid protection, Cormac the “extremely charismatic” llama may hold a key,’ The Guardian

Jan. 29: ‘Open letter: Support data sharing for COVID-19,’ COVID-19 Data Portal

Jan. 29: ‘Vilsack weighs in on parallel between COVID-19 and animal disease outbreaks,’ Farm Journal’s PORK

Jan. 29: ‘One-dose COVID-19 vaccine candidate that can be stored at room temperature prompts immunity in animals,’ FierceBiotech

Jan. 29: ‘Politics drives India’s fight against the COVID-19 pandemic even as questions over DCGI’s approvals for vaccines persist,’ Frontline

Jan. 29: ‘Mouse research aids COVID-19 response,’ Mount Desert Islander

Jan. 29: ‘How to redesign COVID vaccines so they protect against variants,’ Nature

Jan. 29: ‘EXPLAINER: How experts will hunt for COVID origins in China,’ The Associated Press

Jan. 29: ‘Zoos share information about COVID-19 treatment for different species,’ WHAS11

Jan. 28: ‘Researchers found far higher levels of coronavirus in the brains of mice than the lungs — a possible explanation for neurological symptoms,’ Business Insider

Jan. 28: ‘Sweden suspends mink farming in 2021 and plans assessment of zoonotic disease risk,’ Business Insider Polska

Jan. 28: ‘K-State compound chosen as potential treatment against COVID-19,’ KSNW

Jan. 28: ‘COVID-19 is an unprecedented tragedy; it also made medical history,’ InsideSources

Jan. 28: ‘Moderna vaccine shows robust suppression of SARS-CoV-2 infection in animal model,’ News Medical

Jan. 28: ‘This wildlife vet tracks deadly microbes in the African jungle. Now, he’s on the trail of COVID-19,’ Science

Jan. 28: ‘What can COVID-19 teach us about the mysteries of smell?’ The New York Times Magazine

Jan. 28: ‘May I borrow your Covid immunity?’ WIRED

Jan. 27: ‘Preliminary data from animal study shows immune response for ZyCoV-D,’ Business Standard

Jan. 27: ‘Could dogs detect COVID-19? Amarillo expert weighs in,’ KVII

Jan. 27: ‘Codagenix granted U.S. patent for codon-deoptimized RSV vaccine,’ NW Diamond Notes

Jan. 27: ‘COVID-19: Spanish medicine reduces viral load to almost 100%,’ Pplware

Jan. 27: ‘Positive antiviral activity of plitidepsin found against SARS-CoV-2,’ Precision Vaccinations

Jan. 27: ‘WHO recommends against Moderna, Pfizer vaccines for most pregnant women,’ The Wall Street Journal

Jan. 26: ‘Plitidepsin shows promise against SARS-CoV-2 in preclinical models,’ Genetic Engineering & Biotechnology News

Jan. 26: ‘Minnesota tiger tests positive for coronavirus,’ KSTP-TV

Jan. 26: ‘Arkansas Department of Health confirms COVID-19 case in house cat,’ Local 24

Jan. 26: ‘Patent covers human codon-deoptimized RSV vaccine candidates in G and other RSV genes,’ PR Newswire

Jan. 26: ‘Vaccine 2.0: Moderna and other companies plan tweaks that would protect against new coronavirus mutations,’ Science

BREAKING NEWS: Jan. 26: ‘Minnesota sanctuary tiger tests positive for COVID-19,’ Star Tribune

Jan. 26: ‘Animal research playing vital role,’ The Altoona Mirror

Jan. 26: ‘Chemicals in some North Carolina drinking water may worsen COVID-19 effects,’ The Daily Tar Heel

Jan. 26: ‘Spanish drug reduces viral load in animal testing,’ The Media Line

Jan. 26: ‘The false rumors about vaccines that are scaring women,’ The New York Times

Jan. 26: ‘Declassified U.S. intelligence bolsters Wuhan lab theory in coronavirus outbreak,’ The Washington Times

Jan. 26: ‘Luck, foresight and science: How an unheralded team developed a COVID-19 vaccine in record time,’ USA Today

Jan. 25: ‘Why camels are worrying coronavirus hunters,’ BBC

Jan. 25: ‘Moderna developing COVID-19 vaccine booster shot against South Africa variant,’ BioPharma-Reporter

Jan. 25: ‘Moderna COVID-19 vaccine retains neutralizing activity against emerging variants first identified in the U.K. and the Republic of South Africa,’ Business Wire

Jan. 25: ‘San Diego Zoo Safari Park gorilla troop recovering from COVID-19 scare,’ City News Service

Jan. 25: ‘Rhesus macaques with SARS-CoV-2 develop promising immune response,’ Drug Target Review

Jan. 25: ‘Pet cats and dogs may need their own Covid vaccine, scientists suggest,’ Evening Standard

Jan. 25: ‘New research: Rhesus macaque shows promise as model for Covid-19 vaccine studies,’ Express News Service

Jan. 25: ‘Gut bacteria point to novel strategies for combating asthma, COVID-19,’ FierceBiotech

Jan. 25: ‘Gorilla gets monoclonal antibody therapy for COVID-19,’ National Public Radio

Jan. 25: ‘Utah officials allegedly failed to disclose mink farm worker died of COVID after outbreak,’ Newsweek

Jan. 25: ‘Miami Heat is using COVID-sniffing dogs to screen fans. But how effective is that?’ Prevention

Jan. 25: ‘The UCSF-led team racing to find a COVID cure may have found a promising candidate,’ San Francisco Chronicle

Jan. 25: ‘Vaccine roundup: Merck wipes out (and more),’ Science

BREAKING NEWS: Jan. 25: ‘Moderna vaccine protects against British and South African variants, company says,’ The Washington Post

Jan. 25: ‘“It makes sense” Pets should be given Covid vaccine in future to curb spread of the virus, say research scientists,’ WalesOnline

Jan. 24: ‘The Hindu explains | Is a nasal vaccine suitable for COVID-19?’ The Hindu

Jan. 22: ‘NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests,’ American Society for Microbiology

Jan. 22: ‘Researchers at UC Davis use rhesus monkeys to understand long-term efficacy of COVID-19 vaccines,’ KTXL

Jan. 22: ‘Woodland Park Zoo’s new tiger was one of world’s first animals to test positive for coronavirus. She made a full recovery,’ The Seattle Times

Jan. 21: ‘VBI Vaccines to begin Phase 1/2 study of coronavirus vaccine candidate,’ BioPharma-Reporter

Jan. 21: ‘MRNA Vaccines: What happens,’ Science

Jan. 21: ‘How cancer research played a role in the understanding of COVID-19 treatment,’ WTVD

Jan. 20: ‘ImmunityBio to begin COVID-19 vaccine candidate trial in South Africa,’ Clinical Trials Arena

Jan. 20: ‘A closer look at COVID-19 vaccines by infectious disease specialist Dr. Alao,’ Crystal Run Healthcare

Jan. 20: ‘“Encouraging data”: Corona vaccination could also protect against transmission,’ Salzburger Nachrichten

Jan. 19: ‘State to allow dentists, veterinarians and chiropractors to administer COVID-19 vaccines,’ 9NEWS

Jan. 19: ‘Gritstone sending a mixed-modality COVID vaccine to Phase I,’ BioCentury

Jan. 19: ‘Tulane researchers identify potential animal model for COVID-19,’ Biz New Orleans

Jan. 19: ‘Can chemistry thaw the vaccine cold chain?’ Chemistry World

Jan. 19: ‘Nasal spray COVID vaccine shows promise in animal trials,’ HealthDay News

Jan. 19: ‘Understanding antibodies to avoid pandemics,’ MIT News

Jan. 19: ‘Looking beyond COVID-19 vaccine phase 3 trials,’ Nature Medicine

Jan. 19: ‘New immunization technology explored at Caltech could protect against many strains of coronaviruses,’ Pasadena Now

Jan. 19: ‘K18-hACE2 mice develop respiratory disease resembling severe COVID-19,’ PLOS Pathogens

Jan. 19: ‘Is COVID-19 infecting wild animals? We’re testing species from bats to seals to find out,’ The Conversation

Jan. 19: ‘Tulane researchers identify potential animal model for severe COVID-19 infections,’ Tulane University

Jan. 19: ‘Bats, pangolins, minks and other animals – villains or victims of SARS-CoV-2?’ Veterinary Research Communications

Jan. 18: ‘Gorillas at San Diego Zoo test positive for COVID-19,’ AmoMama

Jan. 18: ‘ASK THE VETS: COVID-19 and our pets: An update,’ Culpeper Star-Exponent

Jan. 18: ‘Coronavirus coverup? Footage shows Wuhan scientists handling bats before Covid pandemic,’ Daily Express

Jan. 18: ‘Wuhan lab researchers became sick before first reported COVID-19 cases, Says US,’ International Business Times

Jan. 17: ‘India tests vaccine superpowers with COVID-19 inoculation drive,’ The Wall Street Journal

Jan. 16: ‘US slams Beijing for continuous withholding of COVID-19 information,’ ANI

Jan. 16: ‘America points finger at Chinese lab: US claims researchers at Chinese institute in Wuhan fell ill WEEKS before the world knew of Covid,’ Daily Mail

Jan. 15: ‘Pets highly unlikely to spread COVID-19,’ Albuquerque Journal

Jan. 15: ‘COVID-19 is bad news for wild gorillas, and not just because they can catch it,’ Forbes

Jan. 15: ‘Existing vaccines should work against new coronavirus variants—for now,’ National Geographic

Jan. 15: ‘Coronavirus | Indian scientists divided over nod for Covaxin,’ The Hindu

Jan. 15: ‘Ashford and St. Peter’s Hospitals NHS Foundation Trust commence clinical trial to evaluate nasal spray that stops COVID-19,’ TrialSite News

Jan. 15: ‘Ensuring a transparent, thorough investigation of COVID-19’s origin,’ U.S. Department of State

Jan. 15: ‘Fact sheet: Activity at the Wuhan Institute of Virology,’ U.S. Embassy in Georgia

Jan. 15: ‘Pompeo: US “has reason to believe” Wuhan lab staff caught COVID-19 months before pandemic,’ Washington Examiner

Jan. 14: ‘COVID-19 vaccine development: What’s the progress?’ DW

Jan. 14: ‘How were researchers able to develop COVID-19 vaccines so quickly?’ University of Chicago Medicine

Jan. 13: ‘3 mink caught outside quarantined farm; 2 test SARS-CoV-2 positive,’ KOIN

Jan. 13: ‘Army’s COVID-19 vaccine may hold key to beating coronavirus mutations,’ McClatchy DC

Jan. 13: ‘On the origins of SARS-CoV-2,’ Nature Medicine

Jan. 13: ‘J&J vaccine on track for March rollout with target to deliver 1 billion doses this year: Exec,’ Reuters

Jan. 13: ‘Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up,’ STAT News

Jan. 13: ‘Oxford scientists: How we developed our COVID-19 vaccine in record time,’ The Conversation

Jan. 13: ‘Explained: What does COVID-19 in gorillas tell us?’ The Indian Express

Jan. 13: ‘Pfizer CEO says there is “encouraging” data on whether its vaccine stops Covid transmission,’ TheJournal.ie

Jan. 13: ‘US report into Covid origins expected to say Chinese army grew “dangerous coronaviruses” in Wuhan,’ The Telegraph

Jan. 12: ‘Swissmedic authorizes COVID-19 vaccine Moderna for use in Switzerland,’ Business Wire

Jan. 12: ‘Corona protection for mink: vaccine under development in Finland,’ dpa-AFX

Jan. 12: ‘iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19,’ iosBio

Jan. 12: ‘How COVID unlocked the power of RNA vaccines,’ Nature

Jan. 12: ‘Can flu vaccine improve COVID danger?’ Newsarm.info

Jan. 12: ‘Captive gorillas test positive for coronavirus,’ Science

Jan. 12: ‘We’re not the only apes who can catch COVID-19,’ WCPO

Jan. 11: ‘Several gorillas test positive for COVID-19 at California zoo—first in the world,’ National Geographic 

Jan. 11: ‘2 gorillas in California contract the coronavirus,’ NPR

Jan. 11: ‘San Diego Zoo gorillas test positive for coronavirus,’ Politico

Jan. 11: ‘Could antidepressant slow the progression of COVID-19, ask researchers,’ Radio Canada International

BREAKING NEWS: Jan. 11: ‘CureVac’s COVID-19 vaccine shows promise in preclinical study,’ Seeking Alpha

Jan. 11: ‘Gorillas test positive for coronavirus at San Diego park,’ The Associated Press

Jan. 11: ‘UC Davis researchers run COVID-19 childhood vaccine trials on infant primates,’ The California Aggie

Jan. 11: ‘Fixing the vaccine distribution system in United States must be top priority, experts say,’ The Washington Post

Jan. 10: ‘Coronavirus: Virus provides leaps in scientific understanding,’ BBC News

Jan. 10: ‘COVID-19 vaccine race: Main candidates and where they stand,’ Press Trust of India

Jan. 10: ‘Intranasal vaccine excels in animal studies: Bharat Bio,’ The Times of India

Jan. 10: ‘Intranasal vax shows superior protection in animals: Biotech,’ The Times of India

Jan. 8: ‘Study: Pfizer/BioNTech vaccine appears effective against 501 mutation,’ BioPharma-Reporter

Jan. 8: ‘ExpreS2ion announces submission of the COUGH-1 clinical trial application by the Prevent-nCoV consortium and Bavarian Nordic to review ABNCoV2,’ ExpreS2ion Biotechnologies

Jan. 8: ‘COVID-19: Research points to long-term neurological effects,’ Medical News Today

Jan. 8: ‘Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans,’ Science

Jan. 8: ‘A smartphone-read ultrasensitive and quantitative saliva test for COVID-19,’ Science Advances

BREAKING NEWS: Jan. 8: ‘Pfizer-BioNTech vaccine protects against key mutation found in fast-spreading virus variants, study shows,’ The Washington Post

Jan. 7: ‘Wondering about COVID-19 vaccines if you’re pregnant or breastfeeding?’ Harvard Health Blog

Jan. 7: ‘Could new COVID variants undermine vaccines? Labs scramble to find out,’ Nature

Jan. 7: ‘The wild world of mink and coronavirus,’ Sierra

Jan. 6: ‘Oxford-AstraZeneca COVID-19 vaccine granted emergency use authorization in multiple countries,’ BioPharma-Reporter

Jan. 6: ‘European Commission authorizes COVID-19 vaccine Moderna in Europe,’ Business Wire

Jan. 6: ‘Macaques and baboons show success as models to study SARS-CoV-2,’ Drug Target Review

Jan. 6: ‘Inside the two biotech companies working together on a COVID-19 vaccine for cats,’ Forbes

Jan. 6: ‘Thank animal research for COVID-19 vaccines,’ Houston Chronicle
(Read Matt Bailey’s Houston Chronicle op-ed on the FBR Blog)

Jan. 6: ‘Veterinarians try to protect teams, maintain services during pandemic,’ Journal of the American Veterinary Medical Association

Jan. 6: ‘What the data show about allergic reactions to COVID-19 vaccines,’ National Geographic

Jan. 6: ‘Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study,’ News Medical

Jan. 6: ‘Activists question panel’s change in stance on Covaxin in four days,’ The Times of India

Jan. 6: ‘Politics frustrate WHO mission to search for origins of coronavirus in China,’ The Washington Post

Jan. 6: ‘Study finds pigs susceptible to novel coronavirus, contradicting previous reports,’ WZTV

Jan. 5: ‘Akston ramps up efforts for room temperature COVID-19 vaccine: “A vaccine for everywhere and everyone in the world,”’ BioPharma-Reporter

Jan. 5: ‘Bharat Biotech’s Covaxin cleared based on non-human primate study: Expert panel,’ CNBC-TV18

Jan. 5: ‘WHO’s SARS-CoV2 investigative team members turned away by China in last minute foulup over visa approvals,’ Health Policy Watch

Jan. 5: ‘Animal clinical trials relevant, quantifiable for vaccine development: Study,’ Mint

Jan. 5: ‘In just one day, India’s vaccine somehow gained approval to fight the new coronavirus strain,’ Quartz

Jan. 5: ‘Scientists criticize “rushed” approval of Indian COVID-19 vaccine without efficacy data,’ Science

Jan. 5: ‘Stanford single-dose nanoparticle vaccine for COVID-19,’ Stanford

Jan. 5: ‘China blocks entry to WHO team studying Covid’s origins,’ The Guardian

Jan. 5: ‘Coronavirus live updates | “Healthcare professionals, frontline workers need not register on Co-WIN platform,”’ The Hindu

Jan. 4: ‘Zoonotics draw greater public attention,’ Agweek

Jan. 4: ‘Israeli Ministry of Health authorizes COVID-19 vaccine Moderna for use in Israel,’ Business Wire

Jan. 4: ‘Moderna provides COVID-19 vaccine supply update,’ Business Wire

Jan. 4: ‘Rhesus macaques, baboons and marmosets as models for SARS-CoV-2 virus in humans,’ Contagion Live 

Jan. 4: ‘U.S. may stretch out COVID-19 vaccine supply with half-doses,’ Gizmodo

Jan. 4: ‘The Lab-Leak Hypothesis: For decades, scientists have been hot-wiring viruses in hopes of preventing a pandemic, not causing one. But what if …?’ Intelligencer – New York Magazine

Jan. 4: ‘Heading off the next pandemic,’ Kaiser Health News

Jan. 4: ‘Jackson Lab researches connection between genetics and COVID-19,’ NEWS CENTER Maine

Jan. 4: ‘Experimental COVID-19 vaccine reaches America’s endangered ferrets,’ Smithsonian Magazine

Jan. 3: ‘As COVID-19 enters 2021, here’s 5 questions that still need answers,’ Duluth News Tribune

Jan. 3: ‘“Ready to roll-out”: Adar Poonawala after Covishield, Covaxin win limited use nod,’ Hindustan Times

Jan. 3: ‘“Investing in basic science”: K-State research on virus mutations in animals could benefit human fight against COVID-19,’ The Manhattan Mercury

Jan. 1: ‘Fast-spreading U.K. virus variant raises alarms,’ Science

2020
December

Dec. 31 ‘New evidence COVID-19 invades the brain,’ Medscape

Dec. 31: ‘How to stay ahead of a mutating virus,’ Bloomberg

Dec. 31: ‘Moderna Announces Publication of Results from the Pivotal Phase 3 Trial of the Moderna COVID-19 Vaccine in The New England Journal of Medicine,’ BusinessWire.com

Dec. 31: ‘They spent 12 years solving a puzzle. It yielded the first COVID-19 vaccines,’ National Geographic

Dec. 31: ‘The science stories likely to make headlines in 2021,’ Science

Dec. 31: ‘Speaking of Research year in review 2020,’ Speaking of Research

Dec. 30: ‘Oxford, AstraZeneca Vaccine Gets U.K. Nod. How Is It Different From Other Shots?’ The Wall Street Journal

Dec. 30: ‘U.K. authorizes Oxford-AstraZeneca coronavirus vaccine,’ The Washington Post

Dec. 29: ‘COVID-19 pandemic 2020: The search for a vaccine,’ Medical News Today

Dec. 29: ‘Katalin Karikó, the mother of the COVID-19 vaccine, affirms “In summer we will probably be able to return to normal life,”’ San Antonio, Texas Express-News

Dec. 29: ‘Part 1 Review of the Year of the Coronavirus: The Beginning of the COVID-19 Pandemic, Its Spread and the Search for Antidotes – Knowledge,’ www.de24.news.com

Dec. 29: ‘Can there be hyper-immunity to the coronavirus?’ www.en24news.com

Dec. 29: ‘A corona drug works faster than any vaccine,’ www.newsy-today.com

Dec. 28: ‘Officials say mink recovering from virus at Oregon farm,’ Daily Astorian (Astoria, Oregon)

Dec. 28: ‘Iran set to begin human trials of its COVID vaccine,’ AlJazeera.com

Dec. 28: ‘Inovio COVID vaccine leans toward T cell responses,’ www.biocentury.com

Dec. 28: ‘How do you know a vaccine works?’ www.israelnational.news

Dec. 28: ‘Researchers wonder: Can humans transmit COVID to bats?’ Portland Press-Herald (Portland, Maine)

Dec. 27: ‘Integrative pet vet column: COVID-19 and pets, an update,’ The Glenwood Springs, CO Post-Independent

Dec. 27: ‘What you should know about the corona vaccination – health,’ www.newsylist.com

Dec. 25: ‘Mink in the second lower mainland test positive for coronavirus,’ Exbulletin.com

Dec. 25: ‘Endangered ferrets get experimental COVID-19 in Colorado,’ The Associated Press

Dec. 24: ‘Mink caught outside Oregon farm tests positive for virus,’ The Associated Press

BREAKING NEWS: Dec. 23: ‘Evidence mounts: a new coronavirus variant is more transmissible,’ The Economist

Dec. 23: ‘U.K. variant puts spotlight on immunocompromised patients’ role in the COVID-19 pandemic,’ Science

Dec. 23: ‘Health Canada authorizes Moderna COVID-19 vaccine in Canada,’ Business Wire

Dec. 23: ‘Innovative drug, Carrimycin, receives FDA approval for international, multi-country phase III clinical trial for the treatment of severe COVID-19 in hospitalized patients,’ Business Wire

Dec. 23: ‘At risk of extinction, black-footed ferrets get experimental COVID vaccine,’ Kaiser Health News

Dec. 23: ‘Moderna and BioNTech are changing pharma with drastically different business models,’ Quartz

Dec. 23: ‘How mink, like humans, were slammed by the coronavirus,’ The New York Times

Dec. 23: ‘Sorrento Therapeutics developing antibodies injection and nose drops to fight COVID-19,’ www.CNBC.com

Dec. 22: ‘Feature: Making vaccines safe – animal testing plays a vital part,’ European Animal Research Association

Dec. 22: ‘New COVID-19 immunity study finds majority of coronavirus-infected people retain antibodies for over six months,’ HospiMedica International

BREAKING NEWS: Dec. 22: ‘NIH neuroscientists isolate promising mini antibodies against COVID-19 from a llama,’ National Institutes of Health

Dec. 22: ‘What scientists still want to know about the new coronavirus variant in the U.K.,’ NBC News

Dec. 22: ‘Caltech researchers preparing for the next coronavirus pandemic,’ Pasadena Now

Dec. 22: ‘Watch: What to expect when you’re injected: Vaccine side effects explained,’ STAT News

Dec. 22: ‘I’m a pregnant doctor. Should I get the Covid vaccine?’ The New York Times

Dec. 22: ‘New coronavirus strain splits scientists, as U.K. and others act to curb spread,’ The Wall Street Journal

Dec. 21: ‘How a risky bet on experimental biotechnology led to a COVID-19 vaccine,’ 60 Minutes

Dec. 21: ‘SARS-CoV-2’s spike protein can enter the brain in mice,’ Genetic Engineering & Biotechnology News

Dec. 21: ‘UC Davis tests childhood COVID-19 vaccine on monkeys,’ iHeart Media

Dec. 21: ‘One company’s quest for an antibody drug to fight COVID-19,’ The Associated Press

Dec. 21: ‘Inside Oxford’s coronavirus vaccine development,’ The Guardian

Dec. 21: ‘Denmark to dig up millions of dead mink after botched COVID-19 cull,’ The Wall Street Journal

BREAKING NEWS: Dec. 20: ‘Mutant coronavirus in the United Kingdom sets off alarms, but its importance remains unclear,’ Science

Dec. 20: ‘New bat studies aim to prevent future pandemics,’ VOA Learning English

Dec. 19: ‘U.S. CDC Advisory Committee on Immunization Practices recommends vaccination with Moderna’s COVID-19 vaccine for persons 18 years and older,’ Business Wire

Dec. 19: ‘COVID-19 vaccine tracker: What’s the progress?’ DW

Dec. 19: ‘Best way to prevent coronavirus mutations is to reduce spread, says group of UK scientists,’ G1

Dec. 19: ‘How is the COVID-19 mRNA vaccine delivered to cells?’ Massive Science 

Dec. 19: ‘A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines,’ STAT News

Dec. 19: ‘Minks could pose risk for COVID-19 spread, but Ohio mink farms not tracked by state,’ The Columbus Dispatch

Dec. 18: ‘UC Davis testing childhood COVID-19 vaccine on monkeys, says “data looks very promising,”’ CBS Sacramento

Dec. 18: ‘Should people take more than one type of COVID-19 vaccine?’ National Geographic

Dec. 18: ‘The lightning-fast quest for COVID vaccines — and what it means for other diseases,’ Nature

Dec. 18: ‘Do we need a COVID-19 vaccine for pets?’ Science

Dec. 18: ‘After Denmark’s mink cull, questions over legality, science and what to do with “zombie minks,”’ The Washington Post

Dec. 17: ‘New rhesus macaque reference genome holds potential for human disease, evolution research,’ GenomeWeb Daily News

Dec. 17: ‘Animals on the front lines against COVID-19,’ Le Devoir

Dec. 17: ‘“None of us were ready” to manufacture genetic vaccines for a billion people,’ MIT Technology Review

Dec. 17: ‘Study shows an inflammatory response in the mice brain is responsible for severe COVID-19,’ News Medical

Dec. 17: ‘Shots of hope,’ Science

Dec. 17: ‘Research roundup: Here’s what we have learned about coronavirus recently,’ Spectrum News

Dec. 17: ‘The COVID-19 vaccine, explained by Cornell virologists,’ The Cornell Daily Sun

Dec. 17: ‘FDA vows to move “rapidly” to authorize second coronavirus vaccine,’ The Washington Post

Dec. 17: ‘Vaccines are useful tools, not the end all,’ Wisconsin State Farmer

Dec. 16: ‘Scientist’s mRNA obsession once cost her a job, now it’s key to COVID-19 vaccine,’ Agence France-Presse

Dec. 16: ‘COVID-19 vaccines are safe, even with long-term data lacking,’ CNET

Dec. 16: ‘Vaccine responses in older adults boosted by drug that helps immune cells self-clean,’ Genetic Engineering & Biotechnology News

Dec. 16: ‘WHO team to study virus jump to human,’ Global Times

Dec. 16: ‘Messenger RNA gave us a COVID-19 vaccine. Will it treat diseases, too?’ Science

Dec. 16: ‘A wild mink in Utah has COVID-19. Veterinarians fear this is just the beginning,’ Vox

Dec. 15: ‘Greenwich LifeSciences announces option agreement for pre-clinical coronavirus vaccine candidates,’ Business Wire

Dec. 15: ‘Medicine breakthrough: Robot parasites could “solve healthcare problem” as vaccines boom,’ Daily Express

Dec. 15: ‘First oral corona pill? New flu drug is said to stop transmission within 24 hours,’ Ippen Digital Media

Dec. 15: ‘Why cold weather makes it harder for the body to fight respiratory infections,’ National Geographic

Dec. 15: ‘COVID and 2020: An extraordinary year for science,’ Nature

Dec. 15: ‘New York company to start human trials of nasal drop COVID-19 vaccine,’ New York Post

Dec. 15: ‘Mink in Utah test positive for Covid in first US wild animal case of virus as over 15k critters culled since August,’ The Sun

Dec. 15: ‘Penn Medicine’s collaboration with Regeneron on COVID-19 antibody cocktail,’ University of Pennsylvania Almanac

Dec. 15: ‘Man shocked to learn his cat has feline coronavirus,’ WPEC

Dec. 14: ‘NT/ COVID-19 virus enters the brain, research strongly suggests,’ Neuroscience Biweekly/www.medium.com

Dec. 14: ‘Wild mink in Utah becomes first COVID-19 case among free-ranging animals,’ Complex Media

Dec. 14: ‘BC SPCA calls for mink farming moratorium after more than 200 animals die from COVID-19,’ CTV News

Dec. 14: ‘BC SPCA calling for ban on mink farming following COVID-19 outbreak,’ Daily Hive Vancouver

Dec. 14: ‘When will we have a COVID-19 vaccine?’ DW

Dec. 14: ‘ImmunityBio shares data on oral COVID-19 vaccine, plans phase 1,’ FiercePharma

Dec. 14: ‘First case of the coronavirus detected in the wild,’ National Geographic

Dec. 14: ‘Vaxart COVID-19 oral vaccine,’ Precision Vaccinations

Dec. 14: ‘Russia trials COVID-19 vaccine for domestic animals, including mink,’ Reuters

Dec. 14: ‘A guide to who can safely get the Pfizer/BioNTech COVID-19 vaccine,’ STAT News

Dec. 14: ‘Scientists focus on bats for clues to prevent next pandemic,’ The Associated Press

Dec. 14: ‘How science beat the virus,’ The Atlantic

Dec. 14: ‘Ohio State sells animal-tested COVID-19 vaccine technology to India pharmaceutical company,’ The Columbus Dispatch

Dec. 14: ‘A wild mink in Utah is the first wild animal anywhere to test positive for COVID-19, researchers say,’ The Salt Lake Tribune

Dec. 13: ‘Coronavirus: COVID-19 scientists seek the invisible in Wuhan investigation into deadly pathogen,’ South China Morning Post

Dec. 13: ‘“Autoantibodies” may be driving severe Covid cases, study shows,’ The Guardian

Dec. 11: ‘Michigan officials: COVID vaccine to be distributed in 4 phases, prioritize frontline workers,’ ClickOnDetroit

Dec. 11: ‘Three snow leopards test positive for coronavirus, making it the sixth confirmed animal species,’ CNN

Dec. 11: ‘Inhaled vaccine induces strong immune response in animal models,’ Drug Target Review

Dec. 11: ‘We’re probably hours away from a COVID vaccine,’ Lifehacker

BREAKING NEWS: Dec. 11: ‘Louisville Zoo snow leopard becomes first ever to test positive for SARS-CoV-2 virus,’ Louisville Courier Journal

Dec. 11: ‘The COVID vaccine is almost here — and we have monkeys to thank,’ Miami New Times

Dec. 11: ‘China’s vaccine gambit,’ Science

Dec. 11: ‘Sanofi suffers major setback in development of a COVID-19 vaccine,’ STAT News

Dec. 11: ‘Sanofi, GSK say COVID-19 shot won’t be ready until late 2021,’ The Associated Press

Dec. 11: ‘How Pfizer delivered a Covid vaccine in record time: Crazy deadlines, a pushy CEO,’ The Wall Street Journal

Dec. 11: ‘“A historic event for humanity”: US reaches turning point in fight against COVID-19 as FDA authorizes Pfizer vaccine,’ USA Today

Dec. 11: ‘Confirmation of COVID-19 in a snow leopard at a Kentucky zoo,’ USDA Animal and Plant Health Inspection Service

Dec. 11: ‘Snow leopard at Louisville Zoo tests positive for SARS-CoV-2, the virus causing COVID-19 in humans,’ WDRB

Dec. 10: ‘ImmunityBio’s hAd5 T-cell COVID-19 vaccine candidate shows complete protection of airways in non-human primates,’ Business Wire

Dec. 10: ‘Ferrets, cats and civets most susceptible to coronavirus infection after humans,’ Center for Genomic Regulation

Dec. 10: ‘Dogs can be trained to detect COVID-19 by sniffing human sweat, study suggests,’ CNN

Dec. 10: ‘Kanpur emerges as key centre for Covid vaccine trials,’ IANS

Dec. 10: ‘Baricitinib effectively reduces COVID-19 lung inflammation in NHP model,’ Lab Land

BREAKING NEWS: Dec. 10: ‘Pfizer’s COVID-19 vaccine gets nod from scientists, paving way for FDA authorization,’ Los Angeles Times

Dec. 10: ‘Rutgers research identifies safe and effective method of delivering medicines to the lungs,’ Rutgers Cancer Institute of New Jersey

Dec. 10: ‘Pfizer vaccine gets green light from FDA committee,’ The Verge

Dec. 9: ‘Complete protection of nasal and lung airways against SARS-CoV-2 challenge by antibody plus Th1 dominant N- and S-specific T-cell responses to subcutaneous prime and thermally-stable oral boost bivalent hAd5 vaccination in an NHP study,’ bioRxiv

Dec. 9: ‘Minks at farm in B.C.’s Fraser Valley test positive for coronavirus,’ CBC News

Dec. 9: ‘Answering COVID questions: What is the science behind these vaccines?’ ClickOnDetroit

Dec. 9: ‘Vaccination anticipation,’ Comstock’s

Dec. 9: ‘India’s first mRNA vaccine receives approval for clinical trials,’ Indo-Asian News Service

Dec. 9: ‘UC Irvine researchers develop rapid antibody generation technology that could target COVID-19,’ Los Angeles Times

Dec. 9: ‘Gennova Biopharmaceuticals granted conditional permission for human clinical trial of its COVID-19 vaccine,’ Press Trust of India

Dec. 9: ‘Minks test positive for COVID-19 on B.C. farm where workers sick,’ The Canadian Press

Dec. 8: ‘New Corona active ingredient discovered next to BioNTech vaccine: Scientists with,’ AlKhaleej Today

Dec. 8: ‘Four lions at Spanish zoo test positive for COVID-19,’ Reuters

Dec. 8: ‘Here’s why vaccinated people still need to wear a mask,’ The New York Times

Dec. 8: ‘Veterinarians at OSU develop vaccine technology that could protect against COVID-19 and measles at the same time,’ WBNS-TV

Dec. 7: ‘Animal tests reveal synthetic decoy protein protects against coronavirus,’ Chemistry World

Dec. 7: ‘We had the vaccine the whole time,’ Intelligencer – New York Magazine

Dec. 7: ‘Topoisomerase 1 inhibition prevents SARS-CoV-2-induced inflammation and death in animal models,’ News Medical

Dec. 7: ‘Eight people test positive for COVID-19 at B.C. mink farm, outbreak declared,’ The Canadian Press

Dec. 6: ‘Antibody clues in animal trials raise vaccine hope,’ Hindustan Times

Dec. 6: ‘A gamble pays off in “spectacular success”: How the leading coronavirus vaccines made it to the finish line,’ The Washington Post

Dec. 5: ‘[PangyoTechnoValley] SK bioscience’s COVID-19 vaccine enters clinical trials,’ 24-7 Press Release

Dec. 5: ‘University of Pennsylvania and Regeneron are working on an anti-COVID-19 nasal spray,’ Gilmore Health

Dec. 5: ‘Oral antiviral successfully blocks SARS-CoV-2 transmission,’ Precision Vaccinations

Dec. 4: ‘Arizona company tests possible short-term COVID-19 vaccine alternative,’ Arizona Republic

Dec. 4: ‘How safe are the new COVID vaccines?’ HealthDay News

Dec. 4: ‘Cats susceptible to SARS-CoV-2; pigs are not,’ Kansas Farmer

Dec. 4: ‘Immune response in animals good news for COVID-19 vaccine development,’ National Public Radio

Dec. 4: ‘Correlates of protection against SARS-CoV-2 in rhesus macaques,’ Nature

Dec. 4: ‘Doctors are skeptical of pricey drug given emergency approval for Covid,’ The New York Times

Dec. 3: ‘COVID patient with sepsis makes “remarkable” recovery following megadose of vitamin C,’ Australian Broadcasting Corporation

Dec. 3: ‘A timeline of COVID-19 vaccine development,’ BioSpace

Dec. 3: ‘Moderna provides updates on the clinical development and production of its COVID-19 vaccine candidate,’ Business Wire

Dec. 3: ‘Here’s which COVID vaccines are produced, tested using aborted baby cells, according to a pro-life institute,’ Daily Caller News Foundation 

Dec. 3: ‘Georgia State researchers say oral antiviral stopped spread of coronavirus in animal study,’ FOX 5 Atlanta

Dec. 3: ‘Cats, dogs, anteaters among critters tested for COVID-19 at WSU,’ KXLY 

Dec. 3: ‘GSU researchers say new drug completely suppresses COVID-19 transmission,’ WSB-TV

Dec. 3: ‘Oral drug blocks SARS-CoV-2 transmission, Georgia State Biomedical Sciences Researchers Find,’ www.GSU.edu

Dec. 2: ‘Hamsters genetically engineered by USU researchers are on the front lines of COVID-19 vaccine trials in Belgium,’ Deseret News

Dec. 2: ‘COVID-19 pandemic drives RNA therapeutics into the mainstream,’ Labiotech

Dec. 2: ‘Monkeys and apes in Africa and Asia are also susceptible to SARS-CoV-2,’ Massive Science

Dec. 2: ‘What social distancing does to a brain,’ Max Planck Institute for Brain Research

Dec. 2: ‘Meet the scientists investigating the origins of the COVID pandemic,’ Nature

Dec. 2: ‘The COVID-19 vaccines are a marvel of science. Here’s how we can make the best use of them,’ STAT News

Dec. 2: ‘Penn Med partners with Regeneron to research method of delivering antibody cocktail,’ The Daily Pennsylvanian

Dec. 1: ‘US scientists developing nasal spray to prevent COVID-19,’ Agence France-Presse

Dec. 1: ‘COVID-19 vaccine candidate is 96.4 percent effective in mice, study shows,’ Drug Target Review

Dec. 1: ‘A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate,’ Nature

Dec. 1: ‘Here’s why Denmark culled 17 million minks and now plans to dig up their buried bodies. The Covid mink crisis, explained,’ NBC News

Dec. 1: ‘Potential single-dose COVID-19 vaccine trial published in Nature,’ Utah State University

November

Nov. 30: ‘Escaped mink could spread the coronavirus to wild animals,’ Live Science

Nov. 30: ‘Moderna announces primary efficacy analysis in Phase 3 COVE study for its COVID-19 vaccine candidate and filing today with U.S. FDA for Emergency Use Authorization,’ Moderna

Nov. 30: ‘A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine,’ Proceedings of the National Academy of Sciences of the United States of America

Nov. 30: ‘Do any mink in Poland have COVID-19? New findings raise doubts,’ Reuters

Nov. 30: ‘Fourth state confirms mink farm coronavirus outbreaks as U.S. looks to avoid Denmark’s disaster,’ The Washington Post

Nov. 30: ‘APLIF: Joins consortium to develop favipiravir as COVID-19 treatment,’ Zacks Small Cap Research

Nov. 29: ‘Moderna designed a COVID-19 vaccine in just two days thanks to mRNA technology,’ Entrepreneur

Nov. 29: ‘Coronavirus: The story behind the game-changing Oxford Covid vaccine,’ The Herald

Nov. 27: ‘Coronavirus is striking American mink farms, but Illinois’ shrinking fur industry has so far escaped the virus,’ Chicago Tribune

Nov. 27: ‘COVID-19 virus confirmed in mink at Oregon fur farm,’ KOIN

Nov. 27: ‘Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2,’ News Medical

Nov. 27: ‘REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters,’ Science

Nov. 27: ‘An Oregon mink farm has a COVID-19 outbreak among animals and workers,’ Salem Statesman Journal

Nov. 27: ‘Escaped infected Danish mink could spread Covid in wild,’ The Guardian

Nov. 27: ‘Danish government may exhume hundreds of thousands of dead minks and burn them,’ The Washington Post

Nov. 27: ‘WHO sends another team of scientists to investigate origins of coronavirus in Wuhan,’ Zero Hedge

Nov. 26: ‘Lithuanian authorities find first coronavirus cases at a mink farm,’ Euronews

Nov. 26: ‘Large animal veterinarians practice as normal during COVID,’ Westfield Free Press-Courier

Nov. 25: ‘Mink: COVID-19 shakes up the entire industry,’ Pressfrom

Nov. 25: ‘After dosing mix-up, latest COVID-19 vaccine success comes with big question mark,’ Science

Nov. 25: ‘India needs more transparency in its COVID-19 vaccine trials, critics say,’ Science

Nov. 25: ‘The promise of mRNA vaccines,’ The Scientist

Nov. 24: ‘Twist Bioscience’s COVID-19 “nanobodies,” inspired by llamas, show promise in hamsters,’ FierceBiotech

Nov. 24: ‘Poland finds eight coronavirus cases in farmed mink,’ Reuters

Nov. 24: ‘Evidence builds that an early mutation made the pandemic harder to stop,’ The New York Times

Nov. 23: ‘Oxford vaccine: How did they make it so quickly?’ BBC News

Nov. 23: ‘This Gates-backed, MIT-based biotech company solves a key vaccination problem,’ Fast Company

Nov. 23: ‘Endangered primates face high risk of catching COVID-19,’ National Geographic

Nov. 23: ‘Can dogs smell COVID? Here’s what the science says,’ Nature

Nov. 23: ‘Coronaviruses closely related to the pandemic virus discovered in Japan and Cambodia,’ Nature

Nov. 23: ‘Why Oxford’s positive COVID vaccine results are puzzling scientists,’ Nature

Nov. 23: ‘Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates,’ Nature Medicine

Nov. 23: ‘Incannex says cannabidiol-hydroxychloroquine cocktail shows promise in new animal study,’ Stockhead

Nov. 23: ‘COVID-19-like symptoms reported in North Carolina cats and dogs. What’s going on?’ The Charlotte Observer

Nov. 23: ‘New guidance for ferret owners amid fears more animals could catch coronavirus mutation,’ The Independent

BREAKING NEWS: Nov. 23: ‘Pfizer and Moderna use mRNA in their COVID-19 vaccines. This never-before-used technology could transform how science fights diseases,’ USA Today

Nov. 23: ‘The Egyptian corona vaccine reaches its final stages … and the National Research Center: We are awaiting the approval of the Drug Authority,’ Youm7

Nov. 22: ‘France finds COVID-19 in mink at one farm, ministry says,’ Reuters

Nov. 22: ‘Denmark says mutated coronavirus from mink farms “most likely eradicated,”’ Steelers Lounge

Nov. 22: ‘Machine-made molecules fight the coronavirus in lab animals,’ The New York Times

Nov. 21: ‘COVID-19: Phase 3 of COVAXIN to check its effectiveness to prevent disease,’ ANI

Nov. 21: ‘FDA authorizes Regeneron’s Covid treatment, taken by Trump, for emergency use,’ CNBC

Nov. 21: ‘Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate,’ EBioMedicine

Nov. 21: ‘Italian labs shape-shift to fight the pandemic,’ Nature

Nov. 21: ‘FDA allows emergency use of antibody drug Trump received,’ The Associated Press

Nov. 21: ‘Politics, science and the remarkable race for a coronavirus vaccine,’ The New York Times

Nov. 21: ‘Steve Ackerman and Jon Levine: Humane research will help stop the virus,’ Wisconsin State Journal

Nov. 20: ‘What is mRNA What you should know about vaccines – Nuremberg,’ AlKhaleej Today

Nov. 20: ‘Cats can easily spread COVID-19 to other cats, and possibly humans,’ ConsumerAffairs

Nov. 20: ‘1st animal study in India on coronavirus moves to its final stage: AYUSH Ministry,’ Press Trust of India

Nov. 20: ‘Poland finds COVID-19 cases among mink farm workers,’ Reuters

Nov. 20: ‘COVID-19 outbreaks at US mink farms raise alarm after mutant strain spreads to humans in Denmark,’ Salem Statesman Journal

Nov. 20: ‘Minks spreading COVID to humans; Oregon may not be safe,’ The Corvallis Advocate

Nov. 20: ‘What has to happen before a Covid vaccine can be used?’ The Guardian

Nov. 19: ‘Covid: Oxford vaccine shows “encouraging” immune response in older adults,’ BBC News

Nov. 19: ‘New findings support current and planned clinical trials of Janssen SARS-CoV-2 vaccine,’ News Medical

Nov. 19: ‘Global foundation awards Texas Biomed $1 million to conduct large-scale rodent testing of human monoclonal antibodies to combat SARS-CoV-2,’ Texas Biomedical Research Institute

Nov. 19: ‘Coronavirus latest news: Results from late-stage Oxford vaccine trials expected by Christmas,’ The Telegraph

Nov. 19: ‘Wayne State researchers identify cornea as a potential carrier of COVID-19,’ Wayne State University School of Medicine

Nov. 19: ‘How a medication for OCD ended up in a COVID-19 trial,’ WIRED

Nov. 18: ‘When will we have a COVID-19 vaccine?’ DW

Nov. 18: ‘Two K-State studies focus on SARS-CoV-2 transmission in domestic cats, pigs,’ Kansas State University

Nov. 18: ‘2 K-State studies focus on coronavirus disease transmission in domestic cats, pigs,’ KSNT

Nov. 18: ‘Could the next coronavirus outbreak come from pigs?’ Massive Science

Nov. 18: ‘Engineered antibodies to combat viral threats,’ Nature

Nov. 18: ‘Pfizer and BioNTech to submit COVID-19 vaccine data to FDA as full results show 95% efficacy,’ STAT News

Nov. 18: ‘In the lab, St. Jude scientists identify possible COVID-19 treatment,’ St. Jude Children’s Research Hospital

Nov. 18: ‘Cats can give other cats COVID quite easily,’ Veterinary Practice News

Nov. 18: ‘K-State studies focus on COVID-19 transmission in cats, pigs,’ WIBW

Nov. 17: ‘Immunogenicity of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques,’ bioRxiv

Nov. 17: ‘How a lung injury study helped inspire new COVID-19 drug trials,’ Broad Institute of MIT and Harvard

Nov. 17: ‘Primate study reveals SARS-CoV-2 immunosuppressive effects for development of COVID-19 treatments and vaccines,’ HospiMedica International

Nov. 17: ‘Moderna announces supply agreement with United Kingdom government to supply mRNA vaccine against COVID-19 (mRNA-1273) if approved for use,’ Moderna

Nov. 17: ‘Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin,’ Nature

Nov. 17: ‘What is mRNA? How Pfizer and Moderna tapped new tech to make coronavirus vaccines,’ NBC News

Nov. 17: ‘She was principal investigator of Moderna COVID-19 vaccine trial in Newark. Her insights will inform you,’ ROI-NJ

Nov. 17: ‘Moderna and Pfizer are reinventing vaccines, starting with Covid,’ The Wall Street Journal

Nov. 16: ‘There’s only one animal that we know can give humans COVID-19,’ BGR

Nov. 16: ‘Research behind COVID-19 vaccine development began at Penn lab decades ago,’ KYW Newsradio

Nov. 16: ‘Moderna announces longer shelf life for its COVID-19 vaccine dandidate at refrigerated temperatures,’ Moderna

BREAKING NEWS: Nov. 16: ‘Moderna’s COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study,’ Moderna

Nov. 15: ‘This new COVID-19 mutated strain could be more infectious yet susceptible to a vaccine,’ The Science Times

Nov. 14: ‘This is the only animal we know for sure can give you COVID, experts say,’ Best Life

Nov. 13: ‘Shortage of monkeys slowed down Eli Lilly’s COVID-19 antibody partner. And it’s a problem for everyone,’ Endpoints News

Nov. 13: ‘India’s mRNA-based Covid vaccine won’t need ultra cold conditions for storage — Pune firm,’ ThePrint

Nov. 13: ‘Q&A: Minks can transmit SARS-CoV-2 to humans, study shows,’ The Scientist

Nov. 13: ‘UM School of Medicine and School of Pharmacy researchers identify promising new compounds to potentially treat novel coronaviruses,’ University of Maryland School of Medicine

Nov. 12: ‘International Ultraviolet Association: UVC disinfection and COVID-19,’ Health Europa 

Nov. 12: ‘Matthew R. Bailey: Shortage of animals could delay a vaccine,’ Pittsburgh Post-Gazette  

Nov. 12: ‘Vaccine works against mutated mink coronavirus in early animal trials: Danish scientist,’ Reuters

Nov. 12: ‘Vaxart reports more positive data from animal testing of its coronavirus vaccine candidate,’ The Motley Fool

Nov. 11: ‘Rapid generation of potent antibodies by autonomous hypermutation in yeast,’ bioRxiv

Nov. 11: ‘Where did COVID come from? WHO investigation begins but faces challenges,’ Nature

Nov. 11: ‘Mutant coronaviruses found in mink spark massive culls and doom a Danish group’s research,’ Science

Nov. 11: ‘The strange and twisted tale of hydroxychloroquine,’ WIRED

Nov. 10: ‘Denmark rolls back order for mink cull amid legal dispute,’ CNN

Nov. 10: ‘People started coronavirus back-and-forth on mink farms, Dutch study shows,’ CNN

Nov. 10: ‘Testing begins for mutant Covid virus in Irish mink,’ Irish Independent

Nov. 10: ‘Pfizer vaccine results are promising, but lack of data “very concerning,” experts say,’ National Geographic

Nov. 10: ‘Poland looks into coronavirus risks at mink farms,’ Reuters

Nov. 10: ‘Can a nose-full of chicken antibodies ward off coronavirus infections?’ Science

Nov. 10: ‘Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans,’ Science

Nov. 10: ‘The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race,’ STAT News

Nov. 10: ‘A COVID-19 mutation belatedly forces Denmark to halt mink farming,’ The Economist

Nov. 10: ‘India’s m-RNA vaccine could be ready in March,’ The Hindu

Nov. 10: ‘Penn Medicine researcher laid groundwork for Pfizer, Moderna vaccines,’ WPVI

Nov. 9: ‘A coronavirus-fighting nasal spray protects ferrets from infection, early research shows. But it has a ways to go before reaching people,’ Business Insider

BREAKING NEWS: Nov. 9: ‘“Great day for science”: Pfizer shares early Covid vaccine analysis,’ FBR Blog

Nov. 9: ‘Search for a snakebite drug might lead to a COVID treatment, too,’ Kaiser Health News

Nov. 9: ‘Pfizer, Texas Biomed see promising results in prototype vaccine,’ KSAT

Nov. 9: ‘COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice,’ Nature

Nov. 9: ‘What Pfizer’s landmark COVID vaccine results mean for the pandemic,’ Nature

Nov. 9: ‘Pfizer claims 90 percent effectiveness, EU wants to buy vaccine,’ News1 English

Nov. 9: ‘Texas Biomed helps Pfizer successfully test Covid-19 vaccine by using monkeys,’ News 4 San Antonio

Nov. 9: ‘Millions of minks to be killed, as officials say they pose COVID risk to humans,’ The Beet

Nov. 9: ‘Pfizer’s early data shows vaccine is more than 90% effective,’ The New York Times

Nov. 9: ‘Eli Lilly’s COVID-19 antibody drug gets FDA green light,’ The Wall Street Journal

Nov. 9: ‘Validity of key studies on origin of coronavirus in doubt; science journals investigating,’ U.S. Right to Know

Nov. 9: ‘Do your clients have a contingency COVID pet-care plan?’ Veterinary Practice News

Nov. 8: ‘Researchers compare rhesus and cynomolgus macaques for SARS-CoV-2 vaccine trials,’ News Medical

Nov. 8: ‘Covid infections in animals prompt scientific concern,’ The New York Times

Nov. 6: ‘SARS-CoV-2 mink variant spreads to humans, raises concern about future vaccine efficacy,’ BioWorld

Nov. 6: ‘WHO looking at how a Covid mutation among minks may affect a future vaccine,’ CNBC

Nov. 6: ‘Nasal spray blocks coronavirus in animals,’ HealthDay News

Nov. 6: ‘Two Taylor County mink farms under quarantine after more than 5,000 animals died from COVID-19,’ Milwaukee Journal Sentinel

Nov. 6: ‘The WHO is hunting for the coronavirus’s origins. Here are the new details,’ National Geographic

Nov. 6: ‘Denmark: COVID mutation has spread from minks to humans,’ Newburgh Gazette

Nov. 6: ‘Denmark: COVID mutation has spread from minks to humans,’ New York South East Post 

Nov. 6: ‘Danish Covid mink cull and future disease fears will kill fur trade, say farmers,’ The Guardian

Nov. 6: ‘How WHO is working to track down the animal reservoir of the SARS-CoV-2 virus,’ World Health Organization

Nov. 5: ‘Denmark to cull up to 17 million mink amid coronavirus fears,’ BBC News

Nov. 5: ‘Denmark is culling millions of furry minks to extinguish a worrying COVID-19 outbreak,’ Fortune

Nov. 5: ‘Pitt researchers discover llama “nanobodies” are powerful new coronavirus treatment,’ KDKA

Nov. 5: ‘Speeding COVID-19 drug discovery with quantum dots,’ NIH Director’s Blog

Nov. 5: ‘Exclusive: India-made COVID-19 vaccine could be launched as early as February – government scientist,’ Reuters

Nov. 5: ‘Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2,’ Science

Nov. 5: ‘Coronavirus: Millions of mink to be culled after passing COVID mutation to humans,’ Sky News

Nov. 5: ‘Spread of mutated coronavirus in Danish mink “hits all the scary buttons,” but fears may be overblown,’ STAT News

Nov. 5: ‘Denmark seeks to kill 15 million minks to limit coronavirus,’ The Hill

Nov. 5: ‘Nasal spray prevents Covid infection in ferrets, study finds,’ The New York Times

Nov. 5: ‘Denmark to cull 17 million mink after coronavirus mutation found,’ The Wall Street Journal

Nov. 5: ‘Llama nanobodies could be a powerful weapon against COVID-19,’ University of Pittsburgh

Nov. 5: ‘More than 3K mink dead from coronavirus at Taylor County mink farm,’ Wisconsin Public Radio

Nov. 4: ‘Denmark to cull 15 million mink after coronavirus spillover into humans,’ National Geographic

Nov. 4: ‘Continued impact of COVID-19 on biomedical research,’ National Institutes of Health

Nov. 4: ‘Prospects for a safe COVID-19 vaccine,’ Science

Nov. 4: ‘Denmark wants to cull 15 million minks over COVID fears,’ The Associated Press

Nov. 4: ‘Denmark announces cull of 15 million mink over Covid mutation fears,’ The Guardian

Nov. 4: ‘Denmark will kill all farmed mink, citing coronavirus infections,’ The New York Times

Nov. 4: ‘Denmark to kill all farmed mink due to coronavirus infections,’ The Science Times

Nov. 4: ‘The many model systems of COVID-19,’ The Scientist

Nov. 3: ‘Highly potent nanoparticle COVID-19 vaccine designed using computer,’ European Pharmaceutical Review

Nov. 3: ‘Nanoparticle based COVID-19 vaccine candidate shows promising results in mice: Study,’ Indo-Asian News Service

Nov. 3: ‘Scientists develop “ultrapotent” COVID-19 vaccine candidate,’ Press Trust of India

Nov. 3: ‘Will a small, long-shot U.S. company end up producing the best coronavirus vaccine?’ Science

Nov. 2: ‘Scientists develop a “nanoparticle” COVID-19 vaccine that could trigger a 10-times stronger immune response than the reaction seen in survivors and protect against future mutated strains,’ Daily Mail

Nov. 2: ‘Can a darkhorse synthetic biology COVID-19 vaccine one-up the frontunners? The Gates Foundation, Amgen bet “yes,”’ Endpoints News

Nov. 2: ‘Chinese virologist claiming Covid was lab-made teases another reveal on Twitter,’ Newsweek

Nov. 2: ‘How the coronavirus hacks the immune system,’ The New Yorker

Nov. 2: ‘Rapid method finds potent COVID-19 monoclonal antibody,’ University of Pittsburgh Medical Center

Nov. 1: ‘An explorer tours the planet of the viruses,’ Discover Magazine

October

Oct. 30: ‘Small particles, big change: Iowa scientists awarded $2 million in CARES funding for COVID-19 nanovaccine,’ Des Moines Register

Oct. 30: ‘COVID-19 tests given to cats, dogs, dolphins and more animal species by US scientists,’ Kaiser Health News

Oct. 30: ‘Texas A&M study examines COVID-19 and pets,’ KTRK

 

Oct. 30: ‘Scientists testing animals in effort to understand COVID-19,’ Newsmax

 

Oct. 30: ‘Hamsters and dolphins can get COVID-19 tests now,’ New York Post

 

Oct. 30: ‘How two immune system chemicals may trigger COVID-19’s deadly cytokine storms,’ Science News

 

Oct. 30: ‘2nd study testing a COVID-19 antibody drug has a setback,’ The Associated Press

 

Oct. 30: ‘Ultrapotent COVID-19 vaccine designed via computer,’ UW Medicine

 

Oct. 30: ‘Zoo Knoxville tiger tests positive for COVID-19 virus; two others presumed infected,’ WBIR

 

Oct. 29: ‘Primates also need protection from COVID-19: Calgary-led study,’ 660 NEWS

 

Oct. 29: ‘Mimicking coronavirus could be key for COVID-19 vaccine,’ Futurity

 

Oct. 29: ‘Gilead’s COVID-19 drug is mediocre. It will be a blockbuster anyway,’ The New York Times

 

Oct. 28: ‘U of C researchers say some non-human primates face similar COVID-19 risks as humans,’ CTV News

 

Oct. 28: ‘Exploring human drug for feline coronavirus,’ DVM 360

 

Oct. 28: ‘Controlling monkey brains with light could get easier thanks to open data project,’ Science

 

Oct. 28: ‘SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with COVID-19,’ The New England Journal of Medicine

 

Oct. 28: ‘Argentinian preclinical animal research reveals potential ivermectin-based nasal spray targeting SARS-CoV-2,’ TrialSite News

 

Oct. 28: ‘Transforming coronavirus protein into a nanoparticle could be key to effective vaccine,’ University at Buffalo

 

Oct. 28: ‘Some non-human primates bear similar risk as humans for COVID-19 infection,’ University of Calgary

 

Oct. 27: ‘Vaccine developed against COVID-19 started to be administered to volunteers,’ Corona 24 News

 

Oct. 27: ‘“Every minute counts.” This immunologist rapidly reshaped her lab to tackle COVID-19,’ Science

 

Oct. 26: ‘AstraZeneca resumes US COVID-19 vaccine trial; expects results later this year,’ www.biopharma-reporter.com

 

Oct. 26: ‘Israeli vaccine for corona: The experimental phase in humans is underway,’ AlKhaleej Today

 

Oct. 26: ‘Ontario dog first in Canada to test positive for COVID-19, but researcher says there are likely more,’ CBC News

 

Oct. 26: ‘Could ASPIRIN be the first over the counter treatment for coronavirus? Hospitalized patients already taking the drug daily were 47% less likely to die of COVID-19,’ Daily Mail

 

Oct. 26: ‘How a virus can trigger diabetes,’ Genetic Engineering & Biotechnology News

 

Oct. 26: ‘Texas Biomed teams up with scientists nationwide to fight coronavirus,’ KENS5

 

Oct. 26: ‘The tale of a mouse-lab mastermind,’ Nature

 

Oct. 26: ‘Nasal spray formulation of ivermectin for COVID-19 shows promise in pigs,’ News Medical

 

Oct. 26: ‘Phase 1 trial results of gorilla adenovirus vaccine for COVID-19,’ News Medical

 

Oct. 26: ‘Study suggests 5’UTR of SARS-CoV-2 might be of pangolin coronavirus origin,’ News Medical

 

Oct. 26: ‘The global push for a COVID-19 vaccine,’ Technology Networks

 

Oct. 26: ‘Lilly antibody drug fails in a COVID-19 study; others go on,’ The Associated Press

 

Oct. 26: ‘Niagara-area dog tests positive for COVID-19 but most pets are still safe,’ The Canadian Press

 

Oct. 26: ‘Rare likelihood of pets contracting COVID-19,’ The Garden Island

 

Oct. 23: ‘DCGI’s expert panel recommends phase 3 clinical trial nod for Bharat Biotech’s COVID-19 vaccine,’ Mid-Day

 

Oct. 23: ‘The race to make COVID antibody therapies cheaper and more potent,’ Nature

 

Oct. 23: ‘Covaxin, Bharat Biotech’s coronavirus vaccine, cleared for Phase 3 trials,’ NDTV

 

Oct. 23: ‘Placebo group: What happens after a Covid vaccine is authorized?’ Newburgh Gazette

 

Oct. 23: ‘CureVac posts positive pre-clinical data for COVID-19 vaccine,’ Reuters

 

Oct. 23: ‘Vaxart: A strong buy for their oral tablet COVID-19 vaccine,’ Seeking Alpha

 

Oct. 22: ‘Tetra Bio-Pharma, Targeted Pharmaceutical & the George Mason University Partner on ARDS-003 to prevent & treat COVID-19,’ Accesswire

 

Oct. 22: ‘Susceptibility of raccoon dogs for experimental SARS-CoV-2 infection,’ Emerging Infectious Diseases

 

Oct. 22: ‘CDSCO panel recommends granting permission to conduct phase 3 clinical trials of COVID-19 vaccine,’ Press Trust of India

 

Oct. 22: ‘Arizona based biotech company finds preliminary success developing an intranasal COVID-19 vaccine alternative,’ PR Newswire

 

Oct. 22: ‘Coronavirus: Which treatments work and which don’t?’ The Conversation

 

Oct. 21: ‘Where the Romanian vaccine against SARS-CoV-2 got stuck. “Some just don’t understand what we’re doing,”’ Box24 News

 

Oct. 21: ‘Animal trials of domestic COVID-19 vaccine completed,’ Corona 24 News

 

Oct. 21: ‘New study shows antibodies help in fight against COVID-19,’ KSAT

 

Oct. 21: ‘COVID-19 antibodies on trial,’ Nature Biotechnology

 

Oct. 21: ‘Oxford developed Covid vaccine, then scholars clashed over money,’ The Wall Street Journal

 

Oct. 20: ‘Fauci “cautiously optimistic” about safe, effective COVID-19 vaccine by end of year,’ Healio

 

Oct. 20: ‘Research in the time of covid,’ MIT Technology Review

 

Oct. 20: ‘Commercial antibodies: Alternative grading for research,’ Nature

 

Oct. 20: ‘Non-animal-derived antibodies: Pharma companies respond,’ Nature

 

Oct. 20: ‘Androgen deprivation strategies could help mitigate SARS-CoV-2 infection,’ News Medical

 

Oct. 20: ‘Veterinary experts offer advice after pet cat tests positive for COVID-19 in Pa.,’ Pennsylvania State University

 

Oct. 20: ‘US Army launches early-stage COVID-19 vaccine study,’ Precision Vaccinations

 

Oct. 20: ‘Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity,’ Science

 

Oct. 20: ‘Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate,’ Science

 

Oct. 20: ‘Pennsylvania confirms its first COVID-19-positive cat,’ WGAL

 

Oct. 20: ‘Your pets and coronavirus, tips from an expert for protection,’ WOLF

 

Oct. 20: ‘Emergency COVID-19 vaccine aims to protect high-risk groups,’ Xinhua

 

Oct. 19: ‘Covid vaccine hopeful Vaxart starts study amid DOJ investigation and shareholder lawsuits,’ San Francisco Business Times

 

Oct. 19: ‘Use of adenovirus type-5 vectored vaccines: A cautionary tale,’ The Lancet

 

Oct. 19: ‘Preclinical testing of inhaled monoclonal antibody for COVID-19 shows therapeutic efficacy,’ University of Alabama at Birmingham

 

Oct. 19: ‘A COVID-19 vaccine is coming—will it be safe?’ Yale Medicine

 

Oct. 18: ‘Coronavirus could drive the last nail into the mink fur trade,’ CNN

 

Oct. 18: ‘COVID-19 vaccine company under federal investigation after allegedly misrepresenting its role in government program Operation Warp Speed,’ CNN Business

 

Oct. 18: ‘New research: Anti-ulcer drug shows promise in suppressing coronavirus,’ Express News Service

 

Oct. 16: ‘Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates,’ bioRxiv

 

Oct. 16: ‘SARS-CoV-2 vaccine development, access, and equity,’ Journal of Experimental Medicine

 

Oct. 16: ‘A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity,’ medRxiv

 

Oct. 16: ‘High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys,’ News Medical

 

Oct. 16: ‘Sanofi and Translate Bio eye launch of phase 1/2 COVID-19 vaccine study,’ PMLive

 

Oct. 16: ‘How San Antonio researchers played a key role in President Donald Trump’s experimental COVID-19 treatment,’ San Antonio Report

 

Oct. 16: ‘Sanofi’s mRNA vaccine for coronavirus to enter clinical stage,’ Zacks Equity Research 

 

Oct. 15: ‘Sanofi plans human trial after mRNA vaccine works with animals,’ Bloomberg

 

Oct. 15: ‘FDA authorizes Phase 1 trial of ImmunityBio’s novel COVID-19 vaccine candidate hAd5; dual construct is designed to drive both T cell and antibody immunity,’ Business Wire

 

Oct. 15: ‘Timeline: Vaccines,’ Cell

 

Oct. 15: ‘What it’s really like to do science amid COVID-19,’ Nature

 

Oct. 15: ‘Sanofi reports positive animal test results for potential COVID-19 vaccine,’ Reuters

 

Oct. 15: ‘New study highlights risks associated with the sequential infection of influenza followed by COVID-19,’ University of Liverpool

 

Oct. 14: ‘BioNTech analyst breaks down coronavirus vaccine readout timeline,’ Benzinga

 

Oct. 14: ‘Vaxart ups production as oral COVID-19 vaccine dosing begins,’ BioProcess International

 

Oct. 14: ‘Did oral COVID-19 vaccine maker Vaxart exaggerate Warp Speed role to benefit insiders? DOJ wants to find out,’ FiercePharma

 

Oct. 14: ‘Influenza drug shows promise against SARS-CoV-2,’ Medical News Today

 

Oct. 14: ‘AUSA NEWS: Army COVID-19 vaccine to enter clinical trials,’ National Defense Magazine

 

Oct. 14: ‘How anti-ageing drugs could boost COVID vaccines in older people,’ Nature

 

Oct. 14: ‘New kind of coronavirus that affects pigs has the potential of jumping from swines to humans,’ Press Trust of India

 

Oct. 14: ‘Cows to COVID: How a veterinary lab became key to UW-Madison’s pandemic response,’ Spectrum News

 

Oct. 13: ‘Covid: Why bats are not to blame, say scientists,’ BBC News

 

Oct. 13: ‘Why are so many minks dying of COVID-19?’ Forbes

 

Oct. 13: ‘Regeneron’s antibodies prevent and treat SARS-CoV-2 infection in monkeys,’ Genetic Engineering & Biotechnology News

 

Oct. 13: ‘Favipiravir at high doses works to curb COVID-19 in hamsters, HCQ ineffective: Study,’ Firstpost

 

Oct. 13: ‘To end this pandemic, we must trust science,’ National Geographic

 

Oct. 13: ‘Possible safety issue spurs pause of COVID-19 antibody study,’ The Associated Press

 

Oct. 13: ‘Scientists have a powerful new tool for controlling the coronavirus: Its own genetic code,’ The Washington Post

 

Oct. 12: ‘Hong Kong scientists say anti-microbe drug successful against coronavirus,’ Agence France-Presse

 

Oct. 12: ‘An airport in Finland already uses dogs to detect COVID-19,’ Entrepreneur

 

Oct. 12: ‘Experimental COVID-19 treatment given to Trump found to relieve symptoms in macaques and hamsters,’ Medical Xpress

 

Oct. 12: ‘Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does,’ Medical Xpress

 

Oct. 12: ‘Nasal spray COVID-19 vaccine shows promising results in mice,’ News Medical

 

Oct. 12: ‘Stopping lethal lung damage from the flu with a natural human protein,’ Ohio State News

 

Oct. 12: ‘Lab-made “miniproteins” could block the coronavirus from infecting cells,’ Scientific American

 

Oct. 12: ‘Danes start culling 2.5 million minks after virus hits farms,’ The Associated Press

 

Oct. 12: ‘COVID-19 masks FAQs: How can cloth stop a tiny virus? What’s the best fabric? Do they protect the wearer?’ The Conversation

 

Oct. 12: ‘Inhaled coronavirus vaccines are under development — and could be more effective than an injection,’ The Week

 

Oct. 12: ‘Thousands of mink dead after COVID-19 outbreak at Wisconsin mink farm,’ WORT

 

Oct. 11: ‘Inhaled vaccines aim to fight coronavirus at its point of attack,’ Bloomberg

 

Oct. 10: ‘South Dakota developing a vaccine for pets,’ KTIV

 

Oct. 10: ‘Coronavirus | Antibody cocktail given to Donald Trump may protect against COVID-19, says study,’ Press Trust of India

 

Oct. 10: ‘At least 12,000 minks in Utah, Wisconsin die after contracting COVID-19 from humans,’ Tech Times

 

Oct. 10: ‘Regulation of animal subjects research,’ The Regulatory Review

 

Oct. 9: ‘UC Health Conducts Clinical Trials for Regeneron Antibody Treatment Given to President Trump,’ CBS 4 TV (Denver, CO)

 

Oct. 9: ‘10,000 mink are dead in COVID-19 outbreaks at US fur farms after virus believed spread by humans,’ CNN

 

Oct. 9: ‘Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity,’ Proceedings of the National Academy of Sciences of the United States of America

 

Oct. 9: ‘REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters,’ Science

 

Oct. 9: ‘Horse plasma can be used to treat Covid-19 patients, says ICMR study,’ Hindustan Times

 

Oct. 9: ‘Scientists warn of human-to-wildlife COVID-19 transmission risk,’ UPI

 

Oct. 8: ‘Dual flu-Covid nasal spray vaccine to start trial in Hong Kong,’ Bloomberg

 

Oct. 8: ‘SARS-CoV-2 may be able to infect a significant number of mammals,’ Medical News Today

 

Oct. 8: ‘Winter will make the pandemic worse. Here’s what you need to know,’ MIT Technology Review

 

Oct. 8: ‘Antibody drugs are no cure but seem promising for COVID-19,’ The Associated Press

 

Oct. 8: ‘“Significant” Covid-19 drug breakthrough,’ University of St Andrews

 

Oct. 8: ‘Hundreds of mink die from coronavirus at Wisconsin farm,’ WISN ABC12 TV (Milwaukee, WI)

 

Oct. 7: ‘Domestic COVID-19 DNA vaccine is counting days for phase 1 trials Ege University has switched to animal experiments on COVID-19 DNA vaccine,’ Corona 24 News

 

Oct. 7: ‘Brookings lab develops COVID-19 vaccine for pets,’ Dakota News Now

 

Oct. 7: ‘Saying human trials aren’t enough, researchers call for comparison of COVID-19 vaccines in monkeys,’ Science

 

Oct. 7: ‘COVID-19: Nitric oxide shows promise as antiviral treatment,’ Medical News Today

 

Oct. 6: ‘COVID-19 ravages Utah mink farms. Utah’s State Veterinarian tells nearby humans not to worry,’ Daily Kos

 

Oct. 6: ‘Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines,’ Proceedings of the National Academy of Sciences of the United States of America 

 

Oct. 6: ‘EU reviewing Pfizer-BioNTech COVID-19 vaccine in real time,’ Reuters

 

Oct. 6: ‘President Trump’s Covid cocktail therapy was tested in San Antonio,’ San Antonio Business Journal

 

Oct. 6: ‘Reliance Life Sciences joins hunt for COVID-19 vaccine,’ The Times of India

 

Oct. 6: ‘Vanderbilt researchers develop publicly available COVID-19 animal susceptibility prediction tool; suggests increased risk to horses,’ Vanderbilt

 

Oct. 6: ‘Face masks: what the data say,’ Nature journal

 

Oct. 6: ‘San Antonio lab clones COVID-19 in race for a cure,’ KENS TV (San Antonio, TX)

 

Oct. 5: ‘China Biotech Services (8037.HK) and National Institute for Viral Disease Control and Prevention (NIVDC) to develop genetically engineered recombinant vaccine for COVID-19,’ ACN Newswire

 

Oct. 5: ‘Pigs, horses and rabbits could all be at at risk of coronavirus, study shows,’ Daily Star

 

Oct. 5: ‘Could a common antioxidant enzyme help treat COVID-19?’ Medical News Today

 

Oct. 5: ‘Eli Lilly’s LY-CoV555 antibody shows potential as COVID-19 treatment,’ News Medical

 

Oct. 5: ‘FDA grant to study immune correlates for SARS-CoV-2,’ RT

 

Oct. 5: ‘Update: Here’s what is known about Trump’s COVID-19 treatment,’ Science

 

Oct. 5: ‘Dozens of mammals including pigs and horses could be susceptible to coronavirus, study shows,’ The Independent

 

Oct. 5: ‘26 animals “regularly in contact with people may be susceptible to coronavirus,” study suggests,’ Yahoo

 

Oct. 5: ‘Could an Intranasal COVID-19 Vaccine Be More Efficient and Effective Than Traditional Approach?,’ BioSpace

 

Oct. 5: ‘Blood of the horseshoe crab may aid in coronavirus vaccine, but CT researchers worry about species,’ New Haven Register (New Haven, CT)

 

Oct. 4: ‘Mayo Clinic studying President Trump’s experimental treatment,’ KARE 11

 

Oct. 3: ‘Donald Trump, thank cats for remdesivir,’ Steve Dale Pet World

 

Oct. 2: ‘Trump hospitalized at Walter Reed after COVID-19 diagnosis,’ CNN

 

Oct. 2: ‘Regeneron stock surges 3.4% in after-hours trading after White House doctor revealed Trump is receiving its “antibody cocktail” to treat COVID-19,’ Daily Mail

 

Oct. 2: ‘Thousands of minks dead as COVID outbreak escalates on Utah farms,’ Kaiser Health News

 

Oct. 2: ‘Experimental antibody cocktail used by Trump following COVID-19 diagnosis was tested in San Antonio labs,’ KENS 5

 

Oct. 2: ‘Donald Trump should be better in a week after taking experimental drug, Regeneron CEO says,’ Newsweek

 

Oct. 2: ‘Denmark to cull up to one million mink due to risk of coronavirus contagion,’ Reuters

 

Oct. 2: ‘Trump treated with Westchester pharmaceutical’s promising experimental COVID breakthrough,’ Rockland/Westchester Journal News

 

Oct. 2: ‘Trump gets experimental drug aimed at curbing severe illness,’ The Associated Press

 

BREAKING NEWS: Oct. 2: ‘Trump flown to Walter Reed after COVID-19 diagnosis and getting an experimental Regeneron treatment,’ STAT News

 

President Trump’s experimental monoclonal antibody treatment, produced by Regeneron Pharmaceuticals, Inc. and in late-stage clinical testing, has proven effective in laboratory and animal tests.

 

Oct. 1: ‘LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection,’ bioRxiv

 

Oct. 1: ‘We will have trouble for another 6 months; miracle spray to COVID-19,’ Corona 24 News

 

Oct. 1: ‘How will we know if a coronavirus vaccine is safe?’ Spectrum News 1

 

September

 

Sept. 30: ‘Early data shows Regeneron’s COVID-19 antibody cocktail helps patients recover faster,’ BioSpace

 

Sept. 30: ‘Study: THC in marijuana could help avert fatal COVID-19 complications,’ FOX TV Stations

 

Sept. 30: ‘OSU’s COVID-19 testing lab moves to new home,’ KOKH

 

Sept. 30: ‘“Provocative results” boost hopes of antibody treatment for COVID-19,’ Science

 

Sept. 30: ‘These laboratory-made antibodies are a best bet for a coronavirus treatment, but there won’t be enough,’ The Washington Post

 

Sept. 29: ‘Cats could help researchers unlock a COVID-19 vaccine, research suggests,’ CTV News

 

Sept. 29: ‘Nasal spray could prevent COVID-19, new research shows,’ Healthcare Global

 

Sept. 29: ‘Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats,’ Proceedings of the National Academy of Sciences of the United States of America

 

Sept. 29: ‘Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults,’ The New England Journal of Medicine

 

Sept. 29: ‘Cats shed more than dogs. The coronavirus, not fur,’ The New York Times

 

Sept. 28: ‘Novel nasal spray reduces viral replication by up to 96%: according to COVID-19 challenge study,’ BioPharma-Reporter

 

Sept. 28: ‘J&J’s single-dose COVID-19 vaccine generates strong immune response, early data shows,’ BioSpace

 

Sept. 28: ‘Whither COVID-19 vaccines?’ Nature Biotechnology 

 

Sept. 28: ‘Hamsters and ferrets clear low dose SARS-CoV-2 infection in 14 days,’ News Medical

 

Sept. 28: ‘Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study,’ PR Newswire

 

Sept. 28: ‘Pregnant and lactating women should not be excluded from COVID-19 drug, vaccine trials,’ STAT News

 

Sept. 28: ‘Cambodia’s beautiful gibbons could be vulnerable to COVID-19, study warns,’ VICE News

 

Sept. 27: ‘Bacteria-free method for making SARS-CoV-2 infectious clones,’ News Medical

 

Sept. 27: ‘Australian firm says its nasal spray reduced coronavirus growth in animal study,’ Reuters

 

Sept. 25: ‘The hunt for the “holy grail”: N.J. pharmaceutical companies look to develop lifesaving COVID-19 vaccine,’ Jersey’s Best

 

Sept. 25: ‘Study suggests eyeglasses may reduce risk of COVID infection,’ KGTV

 

Sept. 25: ‘China’s Clover says its coronavirus vaccine candidate showed promise in animal test,’ Reuters

 

Sept. 24: ‘Doctor who developed tetanus vaccine is now working for COVID-19 vaccine,’ Corona 24 News

 

Sept. 24: ‘Leiden corona vaccine seems to work: “so far only good news,”’ Corona 24 News

 

Sept. 24: ‘With a $4M federal grant, Lumen jumps into the COVID-19 treatment race,’ Endpoints News

 

Sept. 24: ‘Farm-to-plate study to investigate SARS-CoV-2 in beef production,’ Feedstuffs

 

Sept. 24: ‘T-cell-based vaccine effective against multiple influenza virus strains,’ Genetic Engineering & Biotechnology News

 

Sept. 24: ‘Dozens of COVID-19 vaccines are in development. Here are the ones to follow,’ National Geographic

 

Sept. 24: ‘Johnson & Johnson vaccine candidate to begin phase 3 of human trials,’ The Science Times

 

Sept. 23: ‘Avigan maker to seek virus treatment approval after trials,’ Agence France-Presse

 

Sept. 23: ‘Bharat Biotech inks licencing deal with Washington University School of Medicine for Covid intranasal vaccine,’ Hindustan Times

 

Sept. 23: ‘SARS-CoV-2 vaccines in development,’ Nature

 

Sept. 23: ‘J&J kicks off study of single-shot COVID-19 vaccine in 60,000 volunteers,’ Reuters

 

Sept. 23: ‘COVID vaccine update: Johnson & Johnson begins trials of one-shot drug,’ Tech Times

 

Sept. 23: ‘Stopping SARS-CoV-2 along the farm-to-plate supply chain,’ Texas A&M AgriLife

 

Sept. 23: ‘Australia’s just signed up for a shot at 9 COVID-19 vaccines. Here’s what to expect,’ The Conversation

 

Sept. 23: ‘Johnson & Johnson’s vaccine advances, sparking optimism in race,’ The New York Times

 

BREAKING NEWS: Sept. 23: ‘A single-shot coronavirus vaccine from Johnson & Johnson will be tested in 60,000 people,’ The Washington Post

 

Johnson & Johnson’s single-shot vaccine moved into the final stages of testing after research with monkeys.

 

“With a larger trial, it also increases the safety data set,” said Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center. “Safety has been a lot in the public eye, and increasing the size of trials increases the safety data set, as well.”

 

BREAKING NEWS: Sept. 22: ‘Pfizer is on track to be first to find out if its Covid vaccine works,’ Bloomberg

 

“Pfizer’s trial was designed to evaluate its vaccine candidate ‘as fast as possible,’ said Amy Rose, a spokeswoman, in an email. The company has worked with government scientists to develop best practices for testing and based its schedule for interim analyses on the vaccine’s ‘strong profile’ in early human trials and animal tests, she said,” the report noted.

 

Sept. 22: ‘How and when will we know that a COVID-19 vaccine is safe and effective?’ The Conversation

 

Sept. 22: ‘The state of COVID antibody tests,’ The Corvallis Advocate

 

Sept. 22: ‘Finland to deploy coronavirus-sniffing dogs at Helsinki Airport,’ The Washington Post

 

Sept. 22: ‘COVID-19 vaccines could end up with bias built right in,’ WIRED

 

Sept. 21: ‘How the COVID-19 pandemic highlights the necessity of animal research,’ Current Biology

 

Sept. 21: ‘An ancient animal off the coast of SC holds a key element for coronavirus vaccine testing,’ Greenville News

 

Sept. 21: ‘Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years,’ Science

 

Sept. 21: ‘Explainer: How clinical trials test COVID-19 vaccines,’ The Conversation

 

Sept. 20: ‘Pets, vets and protocols: Animal attraction bringing out the best, and beast, in us,’ NNY360

 

Sept. 19: ‘Quarantine area for COVID-19 infected animals. It’s incredible what country made this decision!’ Corona 24 News

 

Sept. 18: ‘COVID-19 likely spreading from people to animals—and vice versa,’ CIDRAP News

 

Sept. 18: ‘Why misinformation about COVID-19’s origins keeps going viral,’ National Geographic

 

Sept. 18: ‘SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts,’ PLOS Pathogens

 

Sept. 18: ‘Scientists discover potential coronavirus remedy — at least, for mice and hamsters,’ The Associated Press

 

Sept. 17: ‘Study suggests substantial proportion of pet cats and dogs are infected with SARS-CoV-2 by their owners, due to presence of antibodies in their blood,’ European Society of Clinical Microbiology and Infectious Diseases

 

Sept. 17: ‘More pets may be getting COVID-19 than realized,’ HealthDay News

 

Sept. 17: ‘Animal data supports efficacy of baricitinib vs SARS-COV-2,’ News Medical

 

Sept. 17: ‘SARS-CoV-2 spike D614G mutant is more transmissible than other mutants,’ News Medical

 

Sept. 17: ‘Animals’ susceptibilty to coronavirus subject of U of I research,’ University of Idaho

 

Sept. 17: ‘“Substantial” portion of pets catch SARS-CoV-2, study finds,’ VIN News Service

 

Sept. 17: ‘The NIH launches a global hunt for animal-to-human diseases,’ WIRED

 

Sept. 16: ‘Pfizer says its Covid vaccine is just the first in a new wave of preventives,’ Barron’s

 

Sept. 16: ‘In possible major breakthrough, researchers develop drug that completely neutralizes COVID,’ CBSNew York

 

Sept. 16: ‘New COVID-19 Breakthrough at the University of Pittsburgh,’ Erie News Now

 

Sept. 16: ‘Applied DNA to initiate clinical trial of COVID-19 vaccine for cats,’ Reuters

 

Sept. 16: ‘More cats may be COVID-positive than thought, scientists suggest,’ Study Finds

 

Sept. 16: ‘Study hints antibody drug may cut COVID-19 hospitalizations,’ The Associated Press

 

BREAKING NEWS: Sept. 16: ‘An experimental drug protects COVID-19 patients, Eli Lilly claims,’ The New York Times

 

Eli Lilly’s monoclonal antibody treatment for COVID-19 reduced levels of the virus in pateints, the company said.

 

Sept. 16: ‘Vaxart can still be a major force in the COVID-19 vaccine landscape, says analyst,’ TipRanks

 

Sept. 15: ‘Researchers discover antibody molecule they say can prevent, treat COVID-19,’ Just The News

 

Sept. 15: ‘Drug that could treat and prevent COVID-19 licensed by new UPMC-backed company for worldwide development,’ KDKA

 

Sept. 15: ‘University Of Pittsburgh scientists discover biomolecule that may neutralize coronavirus,’ KDKA

 

Sept. 15: ‘UPMC doctors tout “breakthrough” COVID-19 drug which could prove valuable if vaccine fails,’ PennLive.com

 

Sept. 15: ‘You had COVID-19. Should you take the vaccine anyway? Scientists search for an answer,’ McClatchy DC

 

Sept. 15: ‘Breakthrough in potential drug to treat and prevent COVID-19,’ WHTM

 

Sept. 15: ‘Pitt, UPMC scientists discuss drug discovery that could treat, prevent COVID-19,’ WTAE-TV

 

Sept. 15: ‘Vaxart gets FDA nod for phase I study on coronavirus vaccine,’ Zacks

 

Sept. 14: ‘Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review,’ BMJ Open 

 

Sept. 14: ‘University of Pittsburgh scientists discover antibody that “neutralizes” virus that causes COVID-19,’ Fox News

 

Sept. 14: ‘Vaxart announces FDA clearance of IND application for oral COVID-19 vaccine and provides update on COVID-19 program,’ Globe Newswire

 

Sept. 14: ‘Army COVID-19 vaccine may produce a side benefit: Cure for the common cold,’ McClatchy DC

 

Sept. 14: ‘Pitt/UPMC breakthrough could help treat, protect against COVID-19,’ Pittsburgh Business Times

 

Sept. 14: ‘“Trained Immunity” Offers Hope in Fight Against Coronavirus,’ Quanta Magazine

 

Sept. 14: ‘Covid vaccine developer to start clinical trial this month,’ San Francisco Business Times

 

Sept. 12: ‘Animal trials of coronavirus vaccine Covaxin have been successful, announces Bharat Biotech,’ News18

 

Sept. 12: ‘Bharat Biotech’s Covid vaccine generated “robust immune response” on animals,’ Healthworld.com

 

Sept. 12: ‘Animal study proved Covid vaccine’s efficacy: Bharat Biotech,’ The Times of India

 

Sept. 12: ‘Indian vaccine maker says Covaxin animal trials generate “robust immune response,”’ Xinhua News Agency

 

Sept. 11: ‘Animal study proved Covid vaccine’s efficacy: Bharat Biotech,’ Indo-Asian News Service

 

Sept. 11: ‘Inside Oxford’s vaccine saga: From wild hype to sobering reality,’ Politico Magazine

 

Sept. 11: ‘Cats saving the day, helping humans to deal with COVID-19,’ Steve Dale Pet World

 

Sept. 11: ‘Safety first: How to run a COVID-19 vaccine clinical trial,’ Wellcome

 

BREAKING NEWS: Sept. 10: ‘America is facing a monkey shortage as demand skyrockets for COVID-19 research, experts say,’ USA Today

 

American research is facing a critical primate shortage in the midst of important COVID-19 work.

 

Sept. 9: ‘One leading coronavirus vaccine might be ready next month,’ BGR

 

Sept. 9: ‘African green monkey helps battle against COVID-19,’ BioMedWire

 

Sept. 9: ‘Pfizer and BioNTech announce data from preclinical studies of mRNA-based vaccine candidate against COVID-19,’ Business Wire

 

Sept. 9: ‘Cats may be contracting COVID-19 at a higher rate than thought before: Study,’ CTV News

 

BREAKING NEWS: Sept. 9: ‘Pfizer touts nonhuman preclinical trial results for COVID-19 vaccine candidate,’ Drug Discovery & Development

 

“The data we have shared today include the characterization of our lead candidate BNT162b2, as well as key animal studies that were the basis for our clinical programs. They have enabled us to advance BNT162b2 into Phase 3 evaluation,” BioNTech founder & CEO Dr. Ugur Sahin said. “This is another development milestone for providing a safe and effective potential vaccine to the global community to help end this pandemic.”

 

Sept. 9: ‘Could your masks be a type of vaccine towards COVID-19?’ HealthDay

 

Sept. 9: ‘A leading coronavirus vaccine trial is on hold: Scientists react,’ Nature

 

Sept. 9: ‘The underdog coronavirus vaccines that the world will need if front runners stumble,’ Nature

 

Sept. 9: ‘Creating a COVID-19 vaccine,’ Your Fantastic Mind

 

Sept. 8: ‘The coronavirus is mutating — does it matter?’ Nature

 

Sept. 8: ‘It will take more than a vaccine to beat COVID-19,’ The New Yorker

 

Sept. 8: ‘Trio of medications showing early promise against coronavirus, UF Health researchers find,’ UF Health

 

Sept. 8: ‘Veterinary college partners with Humane Genomics Inc. on COVID-19 vaccine development,’ WLTZ

 

Sept. 7: ‘J&J’s lead COVID-19 vaccine candidate prevents severe disease in pre-clinical studies,’ HospiMedica International

 

Sept. 7: ‘When antibodies mislead: The quest for validation,’ Nature

 

Sept. 7: ‘Bold hopes for virus antibody tests still unfulfilled,’ The Associated Press

 

Sept. 7: ‘Can you get COVID-19 from your dog? Here’s what disease experts say,’ The Wall Street Journal

 

Sept. 5: ‘COVID-19 ends Dutch mink farming,’ The Economist

 

Sept. 4: ‘Johnson & Johnson’s COVID-19 vaccine prevents illness in hamsters,’ Financial Buzz

 

Sept. 4: ‘Johnson & Johnson Covid vax prevents severe clinical illness in hamsters,’ Telangana Today

 

Sept. 4: ‘Animals in the fight against COVID-19,’ Harvard University Blog

 

Sept. 4: ‘Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia,’ The Lancet

 

Sept. 4: ‘Tiffany Haddish discusses her positive coronavirus test with Dr. Anthony Fauci,’ Vulture

 

Sept. 3: ‘BIDMC-led research team reports vaccine protection against severe COVID-19-related pneumonia and death,’ Beth Israel Deaconess Medical Center

 

Sept. 3: ‘Johnson & Johnson says coronavirus vaccine prevents severe illness in hamsters,’ CNBC

 

BREAKING NEWS: Sept. 3: ‘Johnson & Johnson : Announces that Janssen’s COVID-19 Investigational Vaccine Candidate Prevents Severe Clinical Disease in Pre-clinical Studies,’ MarketScreener.com

 

“In the pre-clinical study, researchers first immunized Syrian golden hamsters with a single injection of the Ad26-based SARS-CoV-2 vaccine, which induced neutralizing antibodies in all the vaccinated animals. Four weeks later, the animals were exposed to a high dose of SARS-CoV-2 virus,” the press release said. “These vaccinated animals lost less weight and had less virus in their lungs and other organs than unvaccinated control animals. Mortalities were absent in vaccinated animals. Moreover, the researchers found that neutralizing antibody responses were inversely correlated with weight loss and viral replication in the lung.”

 

Sept. 3: ‘Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters,’ Nature Medicine 

 

Sept. 3: ‘COVID-19 vaccine study shows severe disease preventable in hamsters,’ OHSU

 

Sept. 3: ‘Leader of U.S. vaccine push says he’ll quit if politics trump science,’ Science

 

Sept. 2: ‘Do animals get C0VID 19? Can they pass it to us?’ The Daily Reporter

 

Sept. 1: ‘APG researchers, UPenn training dogs to detect asymptomatic coronavirus carriers; further testing coming,’ The Baltimore Sun

 

Sept. 1: ‘Women leading COVID-19 research at UC Davis: JoAnn Yee, manager of the Primate Assay Laboratory,’ The California Aggie

 

Sept. 1: ‘Who’s to blame for the pandemic?’ The New York Times

 

Sept. 1: ‘Past vaccine disasters show why rushing a coronavirus vaccine now would be “colossally stupid,”’ The East Bay Times

 

Sept. 1: ‘Research suggests coronavirus vaccine will likely require 2 shots to be effective,’ WTTG FOX 5

 

Sept. 1: ‘Drug Used For Cat Coronavirus Infections Fast-Tracked For Clinical Trial In Humans With Covid-19,’ Forbes.com

 

August

 

Aug. 31: ‘America Is Running Low on a Crucial Resource for COVID-19 Vaccines,’ The Atlantic

 

Aug. 31: ‘US ‘hit with monkey shortage for coronavirus trials’ as China hoards animals,’ The U.K. Daily Star

 

Aug. 31: ‘NIAID awards BioCryst new $44 million contract to advance development of Galidesivir,’ Marketwire

 

Aug. 31: ‘NIAID awards BioCryst new $44 million contract to advance development of Galidesivir,’ Marketwire

 

Aug. 31: ‘New federal certification streamlines OSU veterinary lab’s COVID-19 testing process,’ Oregon State University

 

Aug. 31: ‘There is hope: 16 innovations that could put an end to COVID,’ Home Health Choices

 

Aug. 31: ‘Cats point the way to potential COVID-19 remedies,’ Fierce Biotech

 

Aug. 29: ‘Gratifying progress in domestic COVID-19 study,’ Corona 24 News

 

Aug. 29: ‘California university scientists find hundreds of animal species potentially vulnerable to COVID-19,’ International Business Times

 

Aug. 29: ‘Drug used to treat coronavirus in cats may be effective for humans too: study,’ CTV News

 

Aug. 27: ‘Coronavirus tracker: Pfizer, BioNTech hit halfway mark on phase 3 enrollment; J&J plots phase 3 trials in Chile, Argentina and Peru,’ Fierce Pharma

 

Aug. 27: ‘Coronavirus vaccine tracker,’ The New York Times

 

Aug. 26: ‘Moderna’s COVID-19 vaccine may work better in the elderly than competitors,’ BioCentury

 

Aug. 26: ‘State, local public health veterinarians work long hours to protect the public,’ Journal of the American Veterinary Medical Association

 

Aug. 26: ‘COVID-19: Nasal vaccine shows promise in mouse study,’ Medical News Today

 

Aug. 26: ‘Moscow announces advanced trials for new COVID-19 vaccine,’ The Associated Press

 

Aug. 26: ‘Hydroxychloroquine does not inhibit SARS-CoV-2 infection in preclinical models,’ Wyss Institute

 

Aug. 25: ‘Alabama research into nasal spray vaccine for coronavirus posts promising results,’ AL.com

 

Aug. 25: ‘Animal testing: That is why there can be no quick exit,’ Archyde

 

Aug. 25: ‘More positive results from COVID-19 vaccine research at UAB,’ Birmingham Business Journal

 

Aug. 25: ‘Australian COVID-19 vaccine produces ZERO side effects in human trials and provides protection against the virus in animals while reducing symptoms,’ Daily Mail Australia

 

Aug. 25: ‘COVID-19’s impact on the animal kingdom—so far,’ National Geographic

BREAKING NEWS: Aug. 25: ‘Translate Bio, Sanofi COVID-19 vaccine candidate produces immune response in animal studies,’ Reuters

Translate Bio and Sanofi’s vaccine candidate produced positive results in animal studies.

Aug. 25: ‘Dr. Fauci tells veterinarians diseases from animals “a perpetual challenge,”’ San Bernardino American News

Aug. 25: ‘Four scenarios on how we might develop immunity to COVID-19,’ STAT News

Aug. 25: ‘PharmAust (ASX:PAA) continues testing COVID-19 treatment,’ The Market Herald

Aug. 24: ‘Did pangolin trafficking cause the coronavirus pandemic?’ The New Yorker

 

Aug. 24: ‘Cuba surprises: Announces the start of trials of its vaccine against COVID. It’s called “Sovereign 01,”’ EFE

 

Aug. 24: ‘Pandemic threatens half-century of efforts to protect rare monkeys,’ National Geographic

 

Aug. 24: ‘China’s “insect” vaccine for COVID-19 approved for human testing,’ Pharmafile.com

 

Aug. 24: ‘Study of China “insect” vaccine for COVID-19 set to begin,’ Seeking Alpha

 

Aug. 24: ‘Urged on by scientists, NIH will study Gilead’s remdesivir-like compound against COVID-19,’ STAT News

 

Aug. 23: ‘Made-in-Canada COVID-19 vaccine effort slowed by manufacturing delay,’ CBC News

 

Aug. 23: ‘Doctors issue chilling warning over “rushed” coronavirus vaccine they say could have harmful side-effects – and reveal why government SHOULDN’T punish people who refuse the jab,’ Daily Mail Australia

 

Aug. 22: ‘China approves human testing for coronavirus vaccine grown in insect cells,’ Reuters

 

Aug. 21: ‘US FDA halts approval for plasma therapy to treat Covid: Report,’ Indo-Asian News Service

 

Aug. 21: ‘Can pets spread coronavirus?” Dr. John Howe discusses pets and COVID-19,’ WGN

 

Aug. 20: ‘Houston health institutions enrolling COVID patients in rigorous plasma studies,’ Houston Chronicle

 

Aug. 20: ‘New SARS-CoV-2 vaccine effective in macaques,’ News Medical

 

Aug. 20: ‘Viruses have big impacts on ecology and evolution as well as human health,’ The Economist

 

Aug. 20: ‘Drug pitched to Trump for COVID-19 comes from a deadly plant,’ The New York Times

 

Aug. 20: ‘Yerkes genomics research will help predict COVID-19 disease severity, inform treatment decisions,’ Woodruff Health Sciences Center

 

Aug. 19: ‘U.S.-Swiss pact to triple supply of emerging COVID-19 treatment,’ Bloomberg

 

Aug. 19: ‘FDA emergency approval on hold for blood plasma to treat COVID-19,’ HealthDay News

 

Aug. 19: ‘Poisonous plant touted by MyPillow CEO is not a “miracle cure” for COVID-19,’ KHOU

 

Aug. 19: ‘FDA suspends COVID-19 emergency approval treatment,’ Newsmax

 

Aug. 19: ‘Turkey in talks with Germany, China, Russia on vaccine trials,’ Reuters

 

Aug. 19: ‘Will COVID-19 vaccines be safe for children and pregnant women? The data, so far, are lacking,’ STAT News

 

Aug. 19: ‘CUNY med school, TechnoVax report COVID-19 vaccine breakthrough,’ The City College of New York

 

Aug. 19: ‘Pets, livestock and wildlife can all catch coronavirus – does that make them dangerous?’ The Conversation

 

Aug. 19: ‘F.D.A.’s emergency approval of blood plasma is now on hold,’ The New York Times

 

Aug. 18: ‘COVID-19 hits U.S. mink farms after ripping through Europe,’ Science

 

Aug. 18: ‘WUSM St. Louis introduces VSV-SARS-CoV-2, a COVID-19 vaccine still in preclinical: Pushing for clinical trials,’ TrialSite News

 

Aug. 17: ‘White House focus on oleandrin treatment for coronavirus would be “nonsense,” experts say,’ CNN

 

Aug. 17: ‘Costa Rica readies horse antibodies for trials as an inexpensive COVID-19 therapy,’ Scientific American

 

Aug. 17: ‘Experimental Covid vaccine prevents pneumonia, yields high antibody levels in mice,’ Study Finds

 

Aug. 17: ‘Utah mink test positive for the virus that causes COVID-19 in humans,’ The Salt Lake Tribune

 

Aug. 17: ‘USDA confirms SARS-CoV-2 in mink in Utah,’ USDA Animal and Plant Health Inspection Service

 

Aug. 14: ‘Could dogs help in the detection of COVID-19? Studies suggest it’s possible,’ Graham Media Group

 

Aug. 14: ‘SA regulatory authorities won’t license Russian vaccine without access to evidence – prof Gray,’ Health24

 

Aug. 14: ‘DNA vaccine protection against SARS-CoV-2 in rhesus macaques,’ Science

 

Aug. 14: ‘What does the COVID-19 summer surge mean for your cats and dogs?’ Science

 

Aug. 14: ‘UC Davis research pivots to take on COVID-19,’ UC Davis Health

 

Aug. 14: ‘Making a COVID-19 vaccine is hard. Making one for kids is harder,’ WIRED

 

Aug. 14: ‘LMU vet students recognized by OIE for research on COVID-19 in animals,’ WVLT

 

Aug. 13: ‘Vaccine contrasts & massive volunteer mobilization: COVID-19 vaccine race, month 8,’ Absolutely Maybe

 

Aug. 13: ‘Russia offers to help US with Covid-19 vaccine; US says no,’ CNN

 

Aug. 13: ‘These are the top coronavirus vaccines to watch,’ The Washington Post

 

Aug. 13: ‘Vaxart positioned to further advance oral COVID-19 vaccine; analyst says “buy,’ TipRanks

 

Aug. 12: ‘How AbbVie is bringing antiviral expertise to the COVID-19 battle,’ Abbvie.com

 

Aug. 12: ‘Russia claims they have a COVID-19 vaccine: Why you should be skeptical,’ Healthline

 

Aug. 12: ‘Could cat drugs treat humans with COVID-19?’ Live Science

 

Aug. 12: ‘Research looks at convalescent plasma use in COVID-19 mouse model,’ News Medical

 

Aug. 12: ‘1st U.S. dog with COVID-19 has died, and there’s a lot we still don’t know,’ NPR

 

Aug. 12: ‘Companies test antibody drugs to treat, prevent COVID-19,’ The Associated Press

 

Aug. 12: ‘The Middle East ramps up COVID-19 vaccine clinical trials and ongoing research & development,’ TrialSite News

 

Aug. 11: ‘Animal laboratories being used to process COVID-19 tests in an effort to speed up results,’ Healthline

 

Aug. 11: ‘Oral COVID-19 vaccine could activate both systemic and mucosal immunity for protection against coronavirus,’ HospiMedica International

 

Aug. 11: ‘Fauci “seriously doubts” the Russia vaccine is ready for widespread use,’ National Geographic

 

Aug. 11: ‘A singular view of COVID-19,’ Nature Biotechnology

 

Aug. 11: ‘North Carolina dog that died after “acute” illness tests positive for coronavirus,’ NBC News

 

Aug. 11: ‘VT opens new infectious disease center; job one: Coronavirus,’ Radio IQ

 

Aug. 11: ‘Antibody drugs could be one of the best weapons against COVID-19. But will they matter?’ STAT News

 

Aug. 11: ‘Inspired by llamas’ unique antibodies, scientists create a potent anti-coronavirus molecule,’ STAT News

 

Aug. 11: ‘DNA vaccine research is promising, NHRI says,’ Taipei Times

 

Aug. 11: ‘Scientists uneasy as Russia approves 1st coronavirus vaccine,’ The Associated Press

 

Aug. 11: ‘This is all beyond stupid.” Experts worry about Russia’s rushed vaccine,’ The New York Times

 

Aug. 11 : ‘UCSF researchers develop nasal spray to fight coronavirus. It could be sold in stores,’ The Sacramento Bee

 

Aug. 11: ‘Russia unveils coronavirus vaccine “Sputnik V,” claiming breakthrough in global race before final testing complete,’ The Washington Post

 

Aug. 11: ‘N.C. dog dies after testing positive for virus that causes COVID-19 in humans,’ WBTV

 

Aug. 11: ‘XpressBio assists preeminent primate research center with coronavirus research Study,’ XpressBio

 

Aug. 10: ‘BIOQUAL announces publication in The New England Journal of Medicine of nonhuman primate preclinical viral challenge study of an mRNA vaccine against COVID-19 (mRNA-1273),’ Business Wire

 

Aug. 10: ‘How the COVID-19 pandemic highlights the necessity of animal research,’ Current Biology

 

Aug. 10: ‘Decoys could trick COVID-19, keep humans safe from infection,’ Live Science 

Aug. 10: ‘BRIEF-Inovio says COVID-19 vaccine candidate to enter Phase 2/3 study in Sept – conf call,’ Reuters

Aug. 10: ‘Taiwan’s DNA-based COVID-19 vaccine passes animal testing hurdle,’ Taiwan News

 

Aug. 10: ‘Alpacas provide new hope for a COVID-19 cure,’ The Age and The Sydney Morning Herald

 

Aug. 10: ‘Coronavirus drug and treatment tracker,’ The New York Times

 

Aug. 9: ‘MRNA-1273 SARS-CoV-2 vaccine likely effective in nonhuman primates,’ 2 Minute Medicine

 

Aug. 8: ‘Japanese scientists turn to silkworms for COVID-19 vaccine,’ Nikkei

 

Aug. 7: ‘Opinion: Animal disease prevention: Critical to the nation’s public health,’ Agri-Pulse

 

Aug. 7: ‘Doctor’s note: Are vaccine efforts against COVID-19 succeeding?’ Al Jazeera

 

Aug. 7: ‘A pill that may lessen COVID-related lung damage. Miami will be first in U.S. to test it,’ Miami Herald

 

Aug. 7: ‘Why deforestation and extinctions make pandemics more likely,’ Nature

 

Aug. 7: ‘Seeds of hope in COVID-19 vaccine preliminary data,’ Nature Medicine

 

Aug. 6: ‘Texas A&M research project identifies first COVID-19 positive cats in Texas,’ KBTX

 

Aug. 6: ‘COVID-19 disrupts important research projects, shutters labs indefinitely,’ Newswise

 

Aug. 6: ‘Pets in a pandemic: How a Portland veterinarian continues to care for her furry clientele,’ Next Generation Radio 

 

Aug. 6: ‘Pets are testing positive for coronavirus,’ Route Fifty

 

Aug. 6: ‘Vaccine data from Novavax,’ Science Translational Medicine

 

Aug. 6: ‘Bad news about those COVID-sniffing dogs,’ Slate

 

Aug. 6: ‘Texas A&M research project identifies first COVID-19 positive cats in Texas,’ Texas A&M College of Veterinary Medicine & Biomedical Sciences

 

Aug. 5: ‘Elderly, minority trial recruits vital to COVID-19 vaccine success: expert,’ Agence France-Presse

 

Aug. 5: ‘Warp Speed makes J&J COVID-19 vaccine program fifth above $1B,’ BioCentury

 

Aug. 5: ‘Malaysia studying COVID-19 vaccine for animal testing,’ CodeBlue

 

Aug. 5: ‘Made-in-Canada vaccine passes animal testing hurdle, seeks government funding,’ CTV News

 

Aug. 5: ‘Could labs that test livestock ease COVID testing backlog for people? Well … maybe,’ Kaiser Health News

 

Aug. 5: ‘NIH-Moderna investigational COVID-19 vaccine shows promise in mouse studies,’ National Institutes of Health

 

Aug. 5: ‘SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness,’ Nature

 

Aug. 5: ‘Zoonotic host diversity increases in human-dominated ecosystems,’ Nature

 

Aug. 5: ‘Immunology is where intuition goes to die,’ The Atlantic

 

Aug. 5: ‘Another voice: Animal research critical in making a COVID-19 vaccine,’ The Buffalo News

 

Aug. 4: ‘Regeneron’s COVID-19 antibody looks promising in animal test,’ Barron’s

 

Aug. 4: ‘Novavax COVID-19 vaccine potently immunogenic with room to lower dose,’ BioCentury

 

Aug. 4: ‘Inovio’s COVID-19 vaccine candidate shows promise in trials,’ Homeland Preparedness News

 

Aug. 4: ‘Giroir says labs that test livestock could ease the COVID testing backlog for people,’ PolitiFact

 

Aug. 4: ‘Designer antibodies could battle COVID-19 before vaccines arrive,’ Science

 

Aug. 4: ‘Regeneron’s monoclonal antibody cocktail in primates,’ Science

 

Aug. 4: ‘Gilead faces renewed pressure to pursue remdesivir-like compound to fight COVID-19,’ STAT News

 

Aug. 4: ‘Can dogs get coronavirus? Yes, a Louisiana dog just did. Here’s what pet owners should know,’ The Advocate

 

Aug. 4: ‘UT Austin in preclinical stages of developing powerful inhalable form of remdesivir for COVID-19 patients,’ TrialSite News

 

Aug. 4: ‘First canine with COVID-19 reported in Louisiana,’ WBRZ

 

Aug. 3: ‘University of Washington (UW Medicine) and HDT Bio – HDT-301,’ Genetic Engineering & Biotechnology News

 

Aug. 3: ‘Study: “Antibody cocktail” blocks coronavirus from taking hold,’ Newsmax

 

Aug. 3: ‘Regeneron says antibody cocktail prevents and treats COVID-19 in animals,’ Reuters

 

Aug. 2: ‘Can pets catch COVID-19? Hong Kong’s City University begins testing animals for coronavirus amid owners’ concerns,’ South China Morning Post

 

Aug. 2: ‘Scientists study coronavirus outbreaks among minks in Europe,’ The Associated Press

 

Aug. 2: ‘Russia sets mass vaccination for October after shortened trial,’ The New York Times

 

Aug. 1: ‘Indian billionaires bet big on head start in coronavirus vaccine race,’ The New York Times

 

July

 

July 31: ‘BIOQUAL announces publication in Nature of nonhuman primate preclinical viral challenge study of single-shot Ad26 vaccine protects against SARS-CoV-2,’ Business Wire

 

July 31: ‘INOVIO’s COVID-19 DNA vaccine becomes only vaccine to demonstrate long-term protection in monkeys 13 weeks from vaccination,’ HospiMedica International

 

July 31: ‘Large U.S. COVID-19 vaccine trials will exclude pregnant women for now,’ Reuters

 

July 31: ‘COVID-19 vaccine candidate creates “robust protection” from virus in primates,’ Study Finds

 

July 30: ‘Inovio coronavirus vaccine study shows months of immunity in primates, sending stock higher,’ Benzinga

 

BREAKING NEWS: July 30: ‘Single-shot COVID-19 vaccine protects non-human primates,’ Beth Israel Deaconess Medical Center

 

“This vaccine led to robust protection against SARS-CoV-2 in rhesus macaques and is now being evaluated in humans,” said Barouch.

 

July 30: ‘Nonhuman primate data link higher neutralizing titers to stronger COVID-19 protection,’ BioCentury

 

July 30: ‘J&J, beginning first human trial, aims for a 1-shot coronavirus vaccine,’ BioPharma Dive

 

July 30: ‘J&J vaccine protects monkeys from COVID with single shot,’ Bloomberg

 

July 30: ‘INOVIO’s COVID-19 DNA vax effective in NHP,’ Contract Pharma

 

July 30: ‘NIAID scientists report Moderna COVID-19 vaccine boosts immune responses in primate airways,’ Homeland Preparedness News

 

July 30: ‘Moderna’s COVID-19 vaccine successfully generates robust immune response and protection against SARS-CoV-2 in monkeys,’ HospiMedica International

 

July 30: ‘Getting a COVID-19 vaccine — quickly and safely,’ Knowable Magazine

 

July 30: ‘Johnson & Johnson COVID-19 vaccine effective in animal trials,’ Local 4 News

 

July 30: ‘Johnson & Johnson starts trial of COVID-19 vaccine after producing immune response in primates,’ MarketWatch

 

July 30: ‘ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques,’ Nature

 

July 30: ‘Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques,’ Nature

 

July 30: ‘Inovio stock surges after experimental COVID-19 vaccine shows long-term protection in animals,’ Philadelphia Business Journal

 

July 30: ‘Staten Island dog, first canine in the United States to test positive for coronavirus, dies: report,’ New York Daily News

 

July 30: ‘INOVIO’s COVID-19 DNA vaccine INO-4800 provides protection with memory immune responses in nonhuman primates challenged with SARS-CoV-2 virus,’ PR Newswire

 

July 30: ‘Inovio vaccine candidate shows promise in non-human study,’ Reuters

 

July 30: ‘Johnson & Johnson starts human study of COVID-19 vaccine after promising monkey data,’ Reuters

 

July 30: ‘Coronavirus challenges in primates, compared,’ Science Translational Medicine

 

July 30: ‘A huge experiment”: How the world made so much progress on a COVID-19 vaccine so fast,’ STAT News

 

July 30: ‘Moderna COVID-19 vaccine rapidly clears virus in lungs, noses of monkeys: Study,’ The Epoch Times

 

BREAKING NEWS: July 30: ‘Johnson & Johnson’s coronavirus vaccine protects monkeys, study finds,’ The New York Times

 

Johnson & Johnson’s experimental coronavirus vaccine protected monkeys. “It’s a very reassuring level of protection we saw,” said Dr. Dan Barouch.

 

July 29: ‘Moderna and NIAID publish positive COVID-19 vaccine data in monkeys,’ BioSpace

 

July 29: ‘Moderna says cororavirus vaccine shows promise in monkeys,’ CBS

 

July 29: ‘Moderna’s mysterious coronavirus vaccine delivery system,’ Forbes

 

July 29: ‘COVID-19 vaccine candidate provides protection in animal challenge study,’ MPR

 

July 29: ‘Exclusive: Buddy, first dog to test positive for COVID-19 in the U.S., has died,’ National Geographic

 

July 29: ‘Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis,’ Nature

 

July 29: ‘Can household pets transmit coronavirus? Experts say risk is low,’ NBC

 

July 29: ‘Good news of coronavirus vaccine from Ankara,’ Star

 

July 29: ‘The next coronavirus may already be circulating in bats, study suggests,’ The Philadelphia Inquirer

 

July 29: ‘Heat Biologics: COVID-19 vaccine candidate shows promise in animal testing,’ Triangle Business Journal

 

July 28: ‘Nascent Biotech announces collaboration with Syracuse University – advancing COVID-19 research,’ Accesswire

 

July 28: ‘Face masks may make COVID-19 less severe,’ HealthDay News

 

July 28: ‘Survivors’ COVID antibodies may provide a powerful gift,’ HealthDay News

 

July 28: ‘Experimental COVID-19 vaccine protects higher and decrease airways in nonhuman primates,’ Home Health Choices

 

July 28: ‘Monkey data support Moderna COVID-19 vaccine,’ MedPage Today

 

July 28: ‘Experimental COVID-19 vaccine protects upper and lower airways in nonhuman primates,’ National Institute of Allergy and Infectious Diseases

 

July 28: ‘Animal models paved the way for Phase III testing of the COVID-19 vaccine,’ Speaking of Research

 

July 28: ‘Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates,’ The New England Journal of Medicine

 

BREAKING NEWS: July 28: ‘Moderna vaccine test in monkeys shows promise,’ The New York Times

 

“The virus was cleared very rapidly in the vaccinated animals,” said Dr. Barney S. Graham.

 

July 27: ‘COVID-19 can affect pets,’ AgriLife Today

 

July 27: ‘Cat becomes first animal in UK to test positive for COVID-19,’ CNN

 

July 27: ‘Lab-created virus can help COVID-19 research, developers say,’ HealthDay News

 

July 27: ‘Large-scale study Moderna COVID-19 vaccine to be fully enrolled in 4-6 weeks – CEO,’ Seeking Alpha

 

July 27: ‘MIT develops machine learning model to quicken release of COVID-19 vaccine,’ TechRepublic

 

July 27: ‘Yuhan-AbClon’s COVID-19 antibody therapy revs up for trials,’ The Korea Herald

 

July 27: ‘Research boosts evidence of masks’ utility, some experts say,’ The New York Times

 

July 27: ‘How a K-State research lab is fighting back against COVID-19,’ The Wichita Eagle

 

July 27: ‘RVC joins coronavirus research collaboration,’ Vet Times

 

July 27: ‘Local research center in race for COVID-19 vaccine,’ WOAI-TV

 

July 26: ‘We asked 3 Texas doctors: Will you get the first COVID-19 vaccine that becomes available?’ The Dallas Morning News

 

July 26: ‘Risk, uncertainty and fear of failure: Why scientists aren’t celebrating a coronavirus vaccine yet,’ The Telegraph

 

July 24: ‘CEL-SCI announces early results with COVID-19 LEAPS vaccine/treatment,’ Business Wire

 

July 24: ‘Another mRNA-based vaccine candidate protects animals against SARS-CoV-2,’ Cell Press

 

July 24: ‘Cheap generics might treat COVID-19, but obstacles abound,’ Medscape Medical News

 

July 24: ‘Gennova Biopharma’s vaccine candidate to undergo clinical trial before 2020 end,’ Mint

 

July 24: ‘Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing,’ Nature

 

July 24: ‘Department of Biotechnology provides seed funding for Gennova Biopharmaceuticals Ltd.’s novel mRNA based COVID-19 vaccine candidate-HGCO19,’ Press Information Bureau Delhi

 

July 24: ‘Chinese COVID-19 vaccine candidate shows promise in animal tests,’ Reuters

 

July 24: ‘Trump “owes us an apology.” Chinese scientist at the center of COVID-19 origin theories speaks out,’ Science

 

July 23: ‘Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy,’ bioRxiv

 

July 23: ‘German sniffer dogs show promise at detecting coronavirus,’ DW

 

July 23: ‘Can an animal vaccine developer be the one to tame COVID-19? MBF Therapeutics places its bet,’ Philadelphia Business Journal

 

July 23: ‘The long game of coronavirus research,’ The New Yorker

 

July 23: ‘New drugs developed by Australian researchers may help treat COVID-19 triggered blood clotting,’ Xinhua News Agency

 

July 22: ‘Novavax analyst “encouraged” by preclinical data for coronavirus vaccine candidate,’ Benzinga

 

July 22: ‘Neutralizing antibodies isolated from COVID-19 patients may suppress virus,’ Columbia University Irving Medical Center

 

July 22: ‘Hydroxychloroquine use against SARS-CoV-2 infection in nonhuman primates,’ Nature

 

July 22: ‘The hunt for the origins of SARS-CoV-2 will look beyond China,’ The Economist

 

July 21: ‘Next-gen vaccine from UW researchers shows promise in fighting COVID-19,’ GeekWire

 

July 21: ‘What is a vaccine? Types, stages for approval,’ Medical News Today

 

July 21: ‘Coronavirus vaccines get a biotech boost,’ Nature

 

July 21: ‘Cautious optimism: On race for vaccines gather pace,’ The Hindu

 

July 20: ‘Academic labs are opening back up. Still, research isn’t exactly back to normal,’ Association of American Medical Colleges

 

July 20: ‘Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trial,’ CNBC

 

July 20: ‘Replicating RNA vaccine rebuffs COVID-19,’ DD News

 

July 20: ‘UW Medicine announces promising coronavirus vaccine prospect,’ KIRO 7 News

 

July 20: ‘Useful flexibilities for animal care and use programs to comply with the PHS policy during the COVID-19 pandemic,’ Open Mike

 

July 20: ‘Penn Vet seeking human help for canine research,’ Penn Vet

 

July 20: ‘Studies provide glimpse at efficacy of COVID-19 vaccines from Oxford-AstraZeneca and CanSino,’ STAT News

 

July 20: ‘Why vaccines are less effective in the elderly, and what it means for COVID-19,’ The Conversation

 

July 20: ‘Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial,’ The Lancet

 

July 20: ‘COVID-19 vaccine has hefty response in nonhuman primates,’ UW Medicine

 

July 20: ‘Lab-made virus mimics COVID-19 virus,’ Washington University School of Medicine in St. Louis

 

July 18: ‘COVID virus detected in S.C. dog after owner tested positive,’ The Associated Press

 

July 17: ‘From farmed mink to your pet cat, here’s what we know about coronavirus and animals,’ CNN

 

July 17: ‘The vaccine race,’ Frontline

 

July 17: ‘Inside Johnson & Johnson’s nonstop hunt for a coronavirus vaccine,’ The New York Times

 

July 17: ‘Vaxart’s soars YTD on robust coronavirus vaccine progress,’ Zacks

 

July 16: ‘J&J, on the cusp of starting coronavirus vaccine trials, sets high bar for success,’ BioPharma Dive

 

July 16: ‘A shepherd mix is the first dog in South Carolina to test positive for the coronavirus,’ The State

 

July 15: ‘Covid vaccine front-runner is months ahead of her competition,’ Bloomberg Businessweek

 

July 15: ‘COVID-19 vaccines are on the fast-track to approval. How will we know they’re safe?’ Live Science

 

July 15: ‘Potently neutralizing and protective human antibodies against SARS-CoV-2,’ Nature

 

July 14: ‘Virus vaccine candidate starts human tests,’ Australian Associated Press

 

July 14: ‘New molecule attacks COVID-19 on two fronts,’ Presse Canadienne

 

July 14: ‘Can Fluffy or Fido get COVID-19? Will they give it to me?’ Reform Austin News

 

July 14: ‘The pandemic virus is slowly mutating. But is it getting more dangerous?’ Science

 

July 14: ‘First data for Moderna COVID-19 vaccine show it spurs an immune response,’ STAT News

 

July 14: ‘Danish scientists announce “promising” COVID-19 vaccine tests,’ The Local

 

July 14: ‘Could llama antibodies be the key to a coronavirus treatment?’ The World

 

July 14: ‘KU Leuven breakthrough as modified yellow fever virus destroys COVID-19 in preclinical animal research: Clinical trials next,’ TrialSite News

 

July 13: ‘Qld COVID-19 human vaccine trials to start,’ Australian Associated Press

 

“There is no way the research team would be able to progress from animals to humans without a complete guarantee of safety and they would likely have a confidence in its effectiveness,” professor Robert Booy said.

 

July 13: ‘Vaccine ready “next year,”’ Bangkok Post

 

Vaccinated monkeys had COVID-19 antibodies.

 

July 13: ‘Second virus wave fears create growing demand for testing, treatments and vaccine candidates,’ PR Newswire

 

“At the forefront of the COVID-19 vaccine initiative is clinical-stage biotechnology company Vaxart, Inc. (NASDAQ:VXRT). The company, which is developing an oral COVID-19 vaccine, has been selected to participate in a nonhuman primate (NHP) challenge study that is being organized and funded by Operation Warp Speed, the Trump administration’s vaccine-acceleration program aimed to provide substantial quantities of a safe, effective vaccine for Americans by January 2021,” the press release said.

 

July 12: ‘Thailand to begin its COVID-19 vaccine human trials in September,’ Bloomberg

 

“We hope that the vaccine could generate neutralizing antibodies in humans seen in monkeys and mice,” Kiat Ruxrungtham, head researcher at Chulalongkorn University’s Center of Excellence in Vaccine Research and Development, said at a briefing Sunday.

 

July 11: ‘University of Minnesota leads work group on infectious dose of COVID-19,’ Star Tribune

 

“Scientists don’t yet know the infectious dose of the virus that causes COVID-19, but data from animal studies and evidence from other viruses could provide important clues, said Michael Osterholm, director of the U’s Center for Infectious Disease Research and Policy,” the article noted.

 

July 11: ‘Everything you need to know about Vaxart and its potential coronavirus vaccine,’ The Motley Fool

 

“This will be the second immunity study in animal models for the company’s COVID-19 vaccine; the first study reported favorable results in April, likely sparking the government’s interest,” the article said.

 

July 10: ‘Dog in Texas confirmed COVID-19 positive,’ Forbes

 

July 10: ‘Scientists call for pandemic investigations to focus on wildlife trade,’ Nature

 

July 10: ‘Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein,’ Nature Medicine

 

July 10: ‘New data shows Gilead’s remdesivir “potently inhibited” SARS-CoV-2 in human lung cell cultures,’ Pharmafile.com

 

Research showed positive results in mice and human lung cell cultures.

 

July 10: ‘Fujifilm’s Avigan inconclusive in COVID-19 patients in Japan trial,’ Reuters

 

“Concerns remain about the drug as it has been shown to cause birth defects in animal studies,” the report noted.

 

July 10: ‘A WHO-led mission may investigate the pandemic’s origin. Here are the key questions to ask,’ Science

 

“The two-person team from the World Health Organization (WHO) traveling to China today to address the origin of the COVID-19 pandemic is unlikely to come home with answers. Rather, the duo—an epidemiologist and an animal health expert whose names have not been released—will discuss with Chinese officials the scope of a larger international mission later, according to a WHO statement,” the article said.

 

July 9: ‘Novavax receives highest funding to develop COVID-19 vaccine,’ ABC News

 

“When asked about the effectiveness of the vaccine, [Novavax CEO Stanley] Erck said early animal studies are promising,” the article noted.

 

July 9: ‘AIM ImmunoTech signs clinical trial agreement with Roswell Park Comprehensive Cancer Center supporting Phase 1/2 clinical trial of Ampligen combined with interferon alfa-2b in COVID-19 patients with cancer,’ Accesswire

 

“In earlier SARS-CoV-1 studies in mouse models, Ampligen demonstrated a protective effect,” the press release said.

 

July 9: ‘How the world could monitor for potential pandemic viruses,’ Axios

 

“Zoonotic diseases, or those that originated in animal hosts and transferred to humans, tend to be the ones that lead to pandemics. COVID-19, MERS, Ebola, bird flu and the West Nile virus are just some that have had devastating results,” the outlet reported.

 

July 9: ‘TAHC: North Texas family’s pet dog tests positive for virus that causes COVID-19,’ CBS19

 

July 9: ‘Pigs and chickens not susceptible to SARS-CoV-2,’ News Medical

 

July 9: ‘Tarrant County dog is first in Texas to test positive for virus that causes COVID-19,’ The Dallas Morning News

 

July 9: ‘These scientists raced to find a COVID-19 drug. Then the virus found them,’ The New York Times

 

“Regeneron has built its business on what Dr. Schleifer, one of the company’s founders, calls its ‘magical mice’ — animals that have been genetically engineered to have human immune systems. The mice are infected with harmless viruses that trigger the animals to produce human antibodies,” the article said.

 

July 9: ‘New study supports remdesivir as COVID-19 treatment,’ Vanderbilt University Medical Center

 

“All of the results with remdesivir have been very encouraging, even more so than we would have hoped, but it is still investigational, so it was important to directly demonstrate its activity against SARS-CoV-2 in the lab and in an animal model of disease,” VUMC’s Andrea Pruijssers said.

 

July 9: ‘Tarrant County dog infected with virus that causes COVID-19, state animal health officials say,’ WFAA

 

July 8: ‘Safety and tolerability of anti-coronavirus drug candidates observed in an animal model further advances NanoViricides’ SARS-CoV-2 therapeutics program,’ Accesswire

 

July 8: ‘Voltron Therapeutics, Inc. initiates animal testing of self-assembling vaccine in fight against COVID-19,’ Globe Newswire

 

July 8: ‘Can boosting interferons, the body’s frontline virus fighters, beat COVID-19?’ Science

 

Different studies of interferons for treating COVID-19 patients involve ferrets and mice and show that interferons may help fight off COVID-19.

 

July 7: ‘Novavax gets another boost with $1.6B contract from Operation Warp Speed,’ BioCentury

 

“At BIO’s annual meeting in June, Novavax reported nonhuman primate data showing NVX-CoV2373 elicited SARS-CoV-2 neutralizing titers in the 10,000 range, the highest levels disclosed thus far in monkey studies (see ‘Comparing Neutralizing Titers‘),” the report said.

 

July 7: ‘Novavax wins $1.6b in “Warp Speed” funding; plans first 100m doses of COVID-19 vaccine,’ Genetic Engineering & Biotechnology News

 

“Earlier this month, Vaxart and INOVIO announced their vaccine candidates were selected for a nonhuman primate (NHP) challenge study organized and funded by Operation Warp Speed,” the article said.

 

July 7: ‘US government awards Novavax $1.6 billion for coronavirus vaccine,’ Reuters

 

“‘… I don’t think we’re behind because of our data,’ [Novavax CEO Stanley] Erck said, referring to animal data showing a strong immune response and high levels of virus-killing antibodies,” the article said.

 

July 7: ‘US signs $450 million contract with Regeneron for COVID-19 therapy,’ Reuters

 

July 6: ‘Daewoong to stage clinical trials of COVID-19 treatment using stem cells,’ Aju Business Daily

 

“Daewoong Pharmaceutical, a major bioengineering company in South Korea, will carry out the first phase of clinical trials in Indonesia for COVID-19 respiratory symptom treatment using mesenchymal stem cells after drug efficacy tests using animal models have identified anti-inflammatory and antiviral effects,” the article said.

 

July 6: ‘Coronavirus: Fear over rise in animal-to-human diseases,’ BBC News

 

July 6: ‘Report finds rising trend of viruses jumping from animal hosts to humans,’ Deutsche Presse-Agentur GmbH

 

July 6: ‘Cannabis may reduce deadly COVID-19 lung inflammation: Researchers explain why,’ Forbes

 

“In an animal study on asthma, CBD was able to reduce production of proinflammatory cytokine production, actually reducing airway inflammation. In the same study CBD also reduced pulmonary fibrosis – a condition where lung tissue becomes damaged and scarred, thickening lung tissue and making breathing more difficult,” the article said. “This is important, because COVID-19 can also leave patients with serious pulmonary fibrosis.”

 

July 6: ‘Sorrento Therapeutics – T-VIVA-19,’ Genetic Engineering & Biotechnology News

 

“Sorrento said July 1 that it published a preprint study in bioRxiv reporting initial preclinical results showing that immunization with T-VIVA-19 via injection into either the vein or the thigh muscle of a mouse induced antibodies against the SARS-CoV-2 protein in all mice within the first week of administration,” the article said.

 

July 6: ‘Double coronavirus antibody cocktail launches Phase 3 study,’ Precision Vaccinations

 

“According to the Company, Regeneron’s scientists evaluated fully-human antibodies produced by the company’s proprietary VelocImmune® mice, which have been genetically-modified to have a human immune system, as well as antibodies isolated from humans who have recovered from COVID-19,” the post said.

 

July 6: ‘Vaxart: A speculative buy for its oral COVID-19 vaccine,’ Seeking Alpha

 

Vaxart announced that “its oral COVID-19 vaccine has been selected to participate in a nonhuman primate (NHP) challenge study, organized and funded by Operation Warp Speed.”

 

July 6: ‘New UN report outlines ways to curb growing spread of animal-to-human diseases,’ UN News

 

July 5: ‘Pets, vets, vaccines and the pandemic: Animal and human health entwined more than ever in COVID times,’ Capital Current

 

July 4: ‘Covaxin safety has already been well-established from animal tests: Bharat Biotech MD,’ The Financial Express

 

July 4: ‘Researchers launch large trials of COVID-19 candidate vaccines,’ VOA Learning English

 

“Animal research suggests COVID-19 vaccines could prevent serious disease but may not completely block infection. One study showed vaccinated animals avoided being infected with pneumonia but had some virus left in their noses and throats,” the article noted.

 

July 3: ‘Testing tuberculosis vaccine combos for COVID-19,’ Home Health Choices

 

“Our on-going studies will determine how long the immune response lasts after vaccination in animal models. This is important information for future human testing of our vaccine,” Centenary Institute analysis scientist Claudio Counoupas said.

 

July 3: ‘Bharat Biotech has passed mandated protocols, animal testing and is now in clinical development of Covid vaccine, Dr Krishna Ella tells Firstpost,’ Firstpost

 

July 3: ‘Six months of coronavirus: The mysteries scientists are still racing to solve,’ Nature

 

“But there are already clues in data from animal studies and early-stage human trials, mainly testing safety. Multiple teams have conducted ‘challenge trials’ in which animals given a candidate vaccine are intentionally exposed to SARS-CoV-2 to see whether the jab can prevent infection,” the article noted.

 

July 3: ‘Inside the race to develop a safe COVID-19 vaccine,’ Popular Science

 

“A new vaccine candidate must first be tested in animals before undergoing three phases of clinical trials in people,” the article said.

 

July 3: ‘Coronavirus vaccine: India’s second COVID-19 vaccine produced by Zydus Cadila cleared for human trials,’ The Times of India

 

“The company has submitted data to DCGI based on animal trial, they conducted. Animals like- mice, rabbits, guinea pigs, rats were used and these animals developed antibodies against the virus,” mentioned a report.

 

July 3: ‘Biotech ETFs to gain as coronavirus vaccine hopes strengthen,’ Zacks

 

“Going on, Vaxart, Inc.’s (VXRT) oral COVID-19 vaccine candidate has been picked up for investigation in a nonhuman primate challenge study,” the post said.

 

July 2: ‘Horseshoe crab blood is key to making a COVID-19 vaccine—but the ecosystem may suffer,’ National Geographic

 

July 2: ‘Novavax SARS-CoV-2 vaccine candidate shows promise in animal models,’ News Medical

 

July 2: ‘HBCU scientist working on COVID-19 antiviral,’ The American South

 

“Dr. Donald Alcendor, an associate professor of microbiology and immunology at Meharry Medical College, began working on the COVID-19 antiviral in April and anticipates it is four to six weeks away from animal toxicity testing,” the report said.

 

July 2: ‘UH professor working on COVID-19 vaccine,’ The Daily Cougar

 

“We have already completed the first round of preclinical animal testing and the results were quite encouraging,” University of Houston biology and biochemistry professor Zhang said. “I think there is no doubt that more research is needed for any vaccine development.”

 

July 1: ‘How lab animals have fared in the coronavirus crisis,’ DW

 

July 1: ‘The essential role of animal studies in expediating medical research to battle the COVID-19 pandemic,’ Fox Rothschild LLP

 

July 1: ‘Anti-viral and anti-inflammatory response: GoldenBiotech’s antroquinonol receives FDA approval on COVID-19 Phase 2 trial in USA,’ PR Newswire

 

“Antroquinonol was found to reduce viral nucleic acid replication and viral protein synthesis in both cell and animal experiments,” the press release said.

 

July 1: ‘Georgia dog tests positive for virus that causes COVID-19,’ The Atlanta Journal-Constitution

 

July 1: ‘Tulane receives $1 million from alum to fight coronavirus,’ The Times-Picayune | The New Orleans Advocate

 

“The Tulane National Research Primate Center, home to several thousand monkeys and a 40,000-square foot lab, received coronavirus samples in February to study how the virus spreads and might be treated,” the article said.

 

June

 

June 30: ‘Inovio COVID-19 vaccine data highlight questions about antibody versus T cell responses,’ BioCentury

 

“Inovio … said INO-4800 provided ‘full protection’ from SARS-CoV-2 replication in the lungs of mice,” the article said.

 

June 30: ‘Fauci says “there is no guarantee” for a safe COVID-19 vaccine, but he’s “cautiously optimistic,”’ CNN

 

“It’s extremely important to have safe and effective vaccines available for everyone in this country,” Fauci said in opening remarks before a Senate committee on June 30. He emphasized that researchers have made significant headway on experimental vaccines and therapies for COVID-19 thanks to preclinical vaccine and therapy trials with animal models.

 

June 30: ‘How will COVID-19 transform veterinary practice?’ DVM 360

 

June 30: ‘INOVIO reports positive interim Phase I data for COVID-19 DNA vaccine, joins “Warp Speed” primate study,’ Genetic Engineering & Biotechnology News

 

June 30: ‘“Going to be very disturbing”: Fauci warns coronavirus cases could reach 100K a day,’ NPR

 

“But we are cautiously optimistic, looking at animal data and the early preliminary data, that we will at least know the extent of efficacy sometime in the winter and early part of next year. … Hopefully, there will be doses available by the beginning of next year,” he said.

 

June 30: ‘Coronavirus vaccine candidate found 94% effective,’ Precision Vaccinations

 

“In addition to positive interim Phase 1 data, INO-4800 has been shown to protect mice in SARS-CoV-2 viral challenge studies, where vaccination with INO-4800 prevented viral replication in the lungs of animals challenged with SARS-CoV-2,” the article said.

 

June 30: ‘INOVIO announces positive interim Phase 1 data for INO-4800 vaccine for COVID-19,’ PR Newswire

 

“In addition to positive interim Phase 1 data, INO-4800 has been shown to protect mice in SARS-CoV-2 viral challenge studies, where vaccination with INO-4800 prevented viral replication in the lungs of animals challenged with SARS-CoV-2,” the press release said.

 

June 30: ‘Health officials face questions on virus vaccine,’ The Associated Press

 

Dr. Anthony Fauci testified during a Senate committee hearing and mentioned animal data.

 

June 30: ‘Test designed to detect equine disease shows promise for COVID-19,’ The Horse

 

June 30: ‘Inovio Pharmaceuticals vaccine ‘deemed safe’ in testing,’ TheStreet

 

“In addition, Inovio said that in a preclinical animal study, INO-4800 provided full protection against coronavirus replication in the lungs in mice that were infected with the virus,” the article said.

 

June 30: ‘COVID-19 lockdowns are a unique chance to study human-wildlife interactions, researchers say,’ The World

 

June 29: ‘Auburn College of Veterinary Medicine partners with Humane Genomics Inc. on COVID-19 vaccine development,’ Auburn University College of Veterinary Medicine

 

June 29: ‘India’s first COVID-19 vaccine candidate COVAXIN gets approval for human trials,’ Business Today

 

“Those within the industry say the company seems to have achieved vaccine stabilisation and completion of animal studies in record time considering that it was only on May 9, 2020 that the ICMR announced collaboration with Bharat Biotech ‘to develop a fully indigenous vaccine for COVID-19 using the virus strain isolated at ICMR’s National Institute of Virology (NIV), Pune,'” the article said.

 

June 29: ‘Canadian-made COVID-19 vaccine ready to start human trials soon,’ CTV News

 

“In earlier animal testing of the vaccine, which is produced in tobacco plants, mice began producing a positive antibody response within 10 days of receiving a single dose, researchers said in May,” the report noted.

 

June 29: ‘Vaxart oral COVID-19 vaccine joins Trump’s “Warp Speed,” ramps up manufacturing capacity,’ Genetic Engineering & Biotechnology News

 

“On April 30, Vaxart disclosed that it obtained positive preclinical results for its COVID-19 vaccine candidates, with ‘several’ of the candidates generating immune responses in all tested animals after a single dose,” the report said.

 

June 29: ‘Researchers looking for to grasp the connection between SARS-CoV-2 and a lethal immune system malfunction,’ Home Health Choices

 

“Between the preclinical data from animal models and the retrospective data from humans, we felt there was good rationale to test this concept with COVID-19,” said Chetan Bettegowda, a professor of neurosurgery at the Johns Hopkins School of Medicine.

 

June 29: ‘A race to determine what drives COVID-19 severity,’ Nature

 

June 29: ‘Swine flu strain with human pandemic potential increasingly found in pigs in China,’ Science

 

June 29: ‘How biopharmaceutical researchers are ensuring COVID-19 vaccines will be safe and effective­,’ The Catalyst

 

“Evaluation of vaccine safety begins in the earliest phases of research, with preclinical trials involving animal and human cells or tissue systems. In this phase, scientists examine whether vaccine candidates produce the outcome they expect, as well as look for any signs of negative reactions,” the blog post said.

 

June 29: ‘Coronavirus (COVID-19) vaccine status check: Oxford vaccine most advanced, says WHO; Sanofi accelerates trials,’ The Indian Express

 

“The Chulalongkorn project employs new mRNA vaccine technology and the team expects final results from the animal-testing stage in the next two weeks,” the article said.

 

June 28: ‘Summer may decide fate of leading shots in vaccine race,’ The Associated Press

 

“Animal research suggests COVID-19 vaccines could prevent serious disease but may not completely block infection. One study that dripped the coronavirus into monkeys showed vaccinated animals avoided pneumonia but had some virus lurking in their noses and throats,” the report said.

 

June 28: ‘US company with Israeli roots to test COVID-19 vaccine on humans by August,’ The Jerusalem Post

 

The company had successful trials with mice, rats, rabbits and pigs.

 

June 27: ‘Colorado State researchers scaling up production of potential COVID-19 vaccine,’ The Denver Post

 

“A possible vaccine for the new coronavirus has shown good enough results in animals to attract federal money to take it to the next level, but the Colorado State University researchers involved caution that it has many hurdles to clear before going to the public. CSU’s labs have produced a small amount of a vaccine and tested it on hamsters, said Ray Goodrich, executive director of the university’s Infectious Disease Research Center,” the article said. “The hamsters have formed an immune defense and don’t get sick if they’re exposed to the virus, but not everything that looks promising in small animals works as well in humans.”

 

June 27: ‘What’s special about Tonix Pharma and Southern Research’s COVID-19 vaccine candidate?’ The Pharma Letter

 

“The research is part of an ongoing and broader collaboration between Tonix and Southern Research to develop and conduct animal testing of Tonix’ TNX-1800, which is a live replicating virus vaccine designed to protect against COVID-19. The data will support the interpretation of animal trial results with TNX-1800, which are expected in the fourth quarter of 2020 and subsequent human trials,” the post said.

 

June 27: ‘SDSU and UCSD developing low-cost, easy-to-make ventilators for COVID-19 patients,’ The San Diego Union-Tribune

 

SDSU Assistant Professor of Mechanical Engineering Kevin “Wood has been in touch with physicians in Tijuana and officials at COFEPRIS (Mexico’s equivalent of the FDA) about getting the device approved for use in Mexico. That will likely involve additional animal experiments, he says,” the article said.

 

June 26: ‘Local virus jab shows promise in animal tests,’ Bangkok Post

 

June 26: ‘Vaxart’s COVID-19 vaccine candidate tapped for Operation Warp Speed primate study,’ BioSpace

 

June 26: ‘U of O scientist seeking edible vaccine for COVID-19,’ CBC News

 

University of Ottawa plant biologist Allyson “MacLean’s work will be tested on mice in collaboration with John Bell of the Ottawa Health Research Institute,” the post said.

 

June 26: ‘Deadly animal diseases can jump to humans. Is vaccinating wildlife the answer?’ Discover Magazine

 

June 26: ‘Vaxart’s COVID-19 vaccine selected for the US government’s Operation Warp Speed,’ Globe Newswire

 

The company’s vaccine is in a nonhuman primate study.

 

June 26: ‘Animal research in pandemic response efforts,’ Laboratory Animal Science Professional

 

Click here to find the article on pages 18-20 and use the zoom button to enlarge the text. The article is available at this link for AALAS members.

 

June 26: ‘A little-known biotech working on a COVID-19 vaccine has surged 304% in 2 days — and it just said it was picked for the US government’s Operation Warp Speed program (VXRT),’ Markets Insider

 

“The firm said that its oral COVID-19 vaccine candidate would be involved in a nonhuman primate challenge study and that it was ‘the only oral vaccine being evaluated’ in the program,” the article said.

 

June 26: ‘COVID-19: Could gut bacteria be involved?’ Medical News Today

 

“Further to this, [researchers] explain that in mice, ‘removal of certain gut bacteria by antibiotic[s] leads to increased susceptibility to influenza virus infection in [the] lungs,’” the article said.

 

June 26: ‘Researchers continue progress on Colorado COVID-19 vaccine candidate,’ Mountain West News Bureau

 

“In those animals that did not receive the vaccine, we saw high levels of virus present in the lungs, present in the trachea, present in samples that we took from various organs within the body. In the groups that were vaccinated, there’s no evidence of adverse effects and no evidence the disease has actually been occurring,” said Ray Goodrich, director of the Infectious Disease Research Center at Colorado State University.

 

June 25: ‘Promising results mean coronavirus vaccine trial could start by August,’ HealthDay News

 

“Animal studies of a potential COVID-19 vaccine have been so encouraging that researchers plan to speed up testing of the vaccine in humans,” the article said.

 

June 25: ‘Two doses of Oxford University coronavirus vaccine tested on pig,’ Oxford Mail

 

June 25: ‘Use of statins linked to lower death rate in COVID-19 patients: Study,’ Press Trust of India

 

“According to the researchers, statins may serve such a purpose because these drugs slow the progression of lung injury in animals, improve immune cell responses, and strongly reduce inflammation, which is likely responsible for severe Covid-19 complications such as organ damage,” the article said.

 

June 25: ‘The race for a COVID-19 vaccine: What’s ahead,’ Scope

 

June 25: ‘Coronavirus: How long does it really take to get a vaccine ready? We explain to you the process,’ The Times of India

 

“Only if a certain vaccine surpasses the animal testing phase is it allowed to proceed to clinical trials on humans,” the article said.

 

June 25: ‘Coronavirus vaccines are coming, but when will they arrive?’ USC News

 

“It usually takes about two years to bring a new drug to market, even after large clinical trials are underway, although priority drugs can advance faster, she said. It’s an elaborate process, involving lab tests, animal experiments and human trials, plus ensuring that adequate production facilities, quality control and distribution chains are in place,” the article said.

 

June 24: ‘COVID-19 vaccine candidate proceeds to animal testing,’ Kazan Federal University

 

June 24: ‘Coronavirus: “Significant step” in development of vaccine for animals,’ The Independent

 

June 24: ‘Duke researchers discuss timeline for COVID-19 vaccine, clinical trials,’ WRAL

 

“One Duke researcher in Singapore who is working on a vaccine said they are in the animal testing phase right now, but hope to move to clinical trials soon,” the report said.

 

June 23: ‘Could we get a vaccine for cats before people? Two potential COVID-19 animal treatments are shown to eliminate the virus in lab tests,’ Daily Mail

 

June 23: ‘Progress in monoclonal antibodies for the treatment and prevention-of Covid-19,’ Forbes

 

“The antibodies were introduced in the mice 12 hours after the viral challenge. The experiment showed that the antibody treatment reduced the amount of virus in the animals by 32.8% for one of the antibodies and 26% for the other, when compared to a control group three days post-infection,” the article said. “The animals treated with each antibody also had fewer lung lesions than the placebo control animals.”

 

June 23: ‘Nearly 150 potential coronavirus vaccines are being developed globally,’ Newsweek

 

“The studies demonstrated that vaccination with INO-4800 generated robust binding and neutralizing antibody as well as T cell responses in mice and guinea pigs,” Inovio Pharmaceuticals said in a statement.

 

June 23: ‘ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies,’ PLOS One

 

June 23: ‘Pig trial of AstraZeneca’s COVID-19 vaccine shows promise with two shots,’ Reuters

 

June 23: ‘Hamsters protected from COVID-19 with convalescent serum; develops immunity: Study,’ Science Times

 

June 23: ‘Scientists make step forward in development of COVID-19 animal vaccines,’ University of Plymouth

 

June 22: ‘Animal antibodies for COVID-19,’ European Animal Research Association

 

June 22: ‘U of G study focusing on risk of COVID-19 to pets,’ GuelphToday

 

June 22: ‘Going back in time for an antibody to fight COVID-19,’ Nature

 

“The next steps will be to test individual antibodies and antibody cocktails in animal models, to determine whether they offer protection, and then to assess their safety and effectiveness in human clinical trials,” the article said.

 

June 22: ‘Reassuring news on the Oxford vaccine (AZD1222) against SARS-CoV-2,’ News Medical

 

“In this new study, the research group from The Pirbright Institute, the Jenner Institute of the University of Oxford, University of Surrey, Rutherford Appleton Laboratory Harwell Oxford and Public Health England decided to test the immunogenicity of either one or two doses of AZD1222 vaccine in mice and pigs in order to inform clinical development additionally,” the article said.

 

June 22: ‘Thai trials of COVID-19 vaccine reach make-or-break stage,’ Reuters

 

“Thai scientists administered a second dose of an experimental COVID-19 vaccine to monkeys on Monday, looking for another positive response to enable clinical trials in humans as early as October,” the report said.

 

June 22: ‘Monkeys, baboons to be used for COVID-19 vaccine study,’ SBG San Antonio

 

June 22: ‘Thailand’s COVID-19 vaccine trial on monkeys successful: Minister,’ Xinhua News Agency

 

June 20: ‘Corona battle: IVRI in the forefront, testing both human and animal samples,’ Hindustan Times 

 

June 20: ‘Antibodies from convalescent plasma protect against COVID-19,’ The Hindu

 

“A team of scientists led by Dennis R. Burton from the Scripps Research Institute has discovered that neutralising antibodies present in the blood of COVID-19 infected who have recovered offers powerful protection against novel coronavirus in animals,” the article said.

 

June 19: ‘In China’s vaccine race, shortage of monkeys and weekends,’ Agence France-Presse

 

June 19: ‘Cats and dogs “could spark a second wave of coronavirus cases” experts now warn,’ Daily Mirror

 

June 19: ‘Pirbright: SARS-CoV-2 has ability to enter animal cells in lab setting,’ Farm Journal’s PORK

 

June 19: ‘Wildlife trade spreads coronaviruses as animals get to market,’ The New York Times

 

June 19: ‘People probably caught coronavirus from minks. That’s a wake-up call to study infections in animals, researchers say,’ The Washington Post

 

June 18: ‘Expert advice on recovering and resuming animal research,’ Charles River Laboratories

 

June 18: ‘Could our pets trigger a second wave of COVID-19? Scientists warn that animals could become “reservoirs” of the virus even after it is eradicated in humans,’ Daily Mail

 

June 18: ‘Monoclonal antibody against COVID-19 enters clinical trial,’ Medical Xpress

 

“This is also the first clinical trial in the world of therapeutic mAb in healthy people after evaluation in a non-human primate model,” the report said.

 

June 18: ‘SARS-CoV-2 transmission to animals: Monitoring needed to mitigate risk,’ Medical Xpress

 

June 18: ‘RI state veterinarian: “Small risk” owners can infect pets with COVID-19,’ WPRI

 

June 17: ‘Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients,’ News Medical

 

“Preliminary results in animal studies have so far proven successful,” the article said.

 

June 17: ‘Cows help with COVID-19 treatment, no bull,’ NPR

 

June 17: ‘How humanity unleashed a flood of new diseases,’ The New York Times

 

“What do Covid-19, Ebola, Lyme and AIDS have in common? They jumped to humans from animals after we started destroying habitats and ruining ecosystems,” the story said.

 

June 17: ‘S. Korea to conduct tests of COVID-19 vaccine, treatment candidates on monkeys this month,’ Yonhap News Agency

 

June 16: ‘Beating back the coronavirus: Harvard researchers look for a cure,’ Boston Herald

 

“Wyss [Institute] researchers have already identified promising compounds that are currently being tested by collaborating labs in human organ chip technologies and animal models, and the team is continuing to evaluate many more drugs,” the report said.

 

June 16: ‘FDA cautions pet owners about infecting their pets in new video,’ CNN

 

June 16: ‘Human trials expected to start next month for COVID-19 treatment derived from cows’ blood,’ CNN

 

June 16: ‘New evidence that malaria drug has no antiviral effect on COVID-19,’ Knowridge

 

“In a new study, researchers examined the antiviral effect of hydroxychloroquine in macaques (a type of monkey) infected with the COVID-19 virus, used alone or in combination with drug azithromycin,” the report said.

 

June 16: ‘Researchers identify potent antibody cocktail to treat COVID-19,’ ScienceDaily

 

“The study demonstrates the rapid process of isolating, testing and mass-producing antibody therapies against any infectious disease by using both genetically engineered mice and plasma from recovered COVID-19 patients,” the press release said.

 

June 16: ‘Developing the coronavirus vaccine supply chain,’ Supply Chain Dive

 

“After lab testing, researchers move to animal testing and ultimately to humans,” the article said.

 

June 15: ‘Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model,’ Science

 

June 15: ‘Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail,’ Science

 

June 15: ‘Super-potent human antibodies protect against COVID-19 in animal tests,’ Scripps Research

 

June 15: ‘Indonesian COVID-19 vaccines to undergo strict human, animal testing,’ The Jakarta Post

 

“Eijkman Institute director Amin Soebandrio said animal testing was to ensure that the vaccine’s antigens could form antibodies in humans, which could help protect them from COVID-19. … Animal rights organizations have voiced their objections to animal testing despite researchers ensuring that they will adhere to ethical norms,” the article said.

 

June 15: ‘Search for COVID-19 vaccine includes animal tests,’ VOA Learning English

 

June 14: ‘Hydroxychloroquine ineffective in animal SARS-CoV-2 infection,’ News Medical

 

June 14: ‘Coronaviruses extremely widespread in wildlife trade: Study,’ The Sydney Morning Herald

 

June 13: ‘Future COVID-19 treatments made possible by animal testing,’ Health ThoroughFare

 

June 13: ‘The race to find a COVID-19 vaccine: The INO-4800 study participation at the University of Pennsylvania,’ TrialSite News

 

“INO-4800 evidence has been well-tolerated first in preclinical studies in mice, and then in the first cohort of 40 participants in the Phase I stage of the study,” the article said.

 

June 12: ‘As pressure for vaccine builds, regulators may face difficult decision,’ ABC News

 

“Moderna Inc., which is developing what is considered to be the lead candidate, for example, was given permission to begin testing in humans before waiting until testing in animals was complete. Animal testing is ongoing,” ABC reported.

 

June 12: ‘Latin American scientists join the coronavirus vaccine race: “No one’s coming to rescue us,”’ Nature

 

University of Sao Paulo immunologist Gustavo Cabral de Miranda’s “group is starting animal testing, and some other COVID-19 vaccine candidates in preclinical evaluation are following a similar approach,” the article said.

 

June 12: ‘Hydroxychloroquine shows no antiviral effect on SARS-Cov-2 in non-human primate models,’ News Medical

 

June 12: ‘Moderna COVID-19 vaccine appears to clear safety hurdle in mouse study,’ Reuters

 

June 12: ‘NC A&T, WSSU each receive $1 million to fight COVID-19,’ Triad Business Journal

 

“N.C. A&T said it plans to use the funding for multiple projects, from studies in both food and animal testing, affordable fever detection in K-12 schools, ways to cut down death rates among the elderly in assisted living facilities and the development of a nanoparticle that can kill the virus,” the article said.

 

June 12: ‘LSU working on “unique” COVID-19 vaccine; applying for expedited funding,’ WBRZ

 

“We believe that animal studies, including mice and monkeys, will show that the LSU patented vaccine is much more efficacious in conferring long-term responses to the virus,” Dr. Gus Kousoulas said.

 

June 11: ‘Can new drug help speed up recovery from COVID-19?’ CGTN

 

“Remdesivir is an antiviral medication developed initially by U.S. biopharmaceutical company Gilead Sciences to treat Ebola. It wasn’t effective, but during animal testing it had shown promise treating SARS and MERS, both of which are coronaviruses,” the report noted.

 

June 11: ‘COVID-19 vaccine from China’s Sinopharm clears animal tests,’ FierceBiotech

 

June 11: ‘Future COVID-19 treatments could be thanks to cows, llamas, and pangolins,’ Inverse

 

June 11: ‘Potential COVID-19 vaccine from China shows promise in animal trials,’ The Hill

 

June 11: ‘UConn researcher talks vaccine realities in an unprecedented time,’ UConn Communications

 

“This is a significant concern because despite many years of research on other human coronaviruses such as SARS‑CoV and MERS‑CoV, no vaccines of any kind have been approved. Another major concern is that some experimental vaccine studies in animal models suggest that insufficient protective immunity against coronaviruses such as SARS‑CoV may induce enhanced susceptibility to respiratory disease,” UConn vaccine researcher Paulo Verardi said. “In other words, inadequate or weak vaccines may not only lead to poor protection but also to vaccine-enhanced disease in COVID‑19 patients.”

 

June 10: ‘Ending an epidemic,’ Harvard Magazine

 

“In an experiment led by Castle professor of medicine and professor of immunology Dan Barouch, animals exposed to the virus a second time five weeks later developed no clinically observable symptoms and displayed immunologic control of the disease,” the article said.

 

June 10: ‘Veterinary labs continue to support COVID-19 testing,’ Journal of the American Veterinary Medical Association

 

June 10: ‘Vaccine makers hedge bets on which one will emerge as effective and safe,’ NPR

 

“We have a lot of confidence based on what we’ve see so far based on our animal modeling that the vaccine will work,” said Gregory Glenn, president of research and development at Novavax.

 

June 10: ‘Daewoong finds niclosamide effective against COVID-19 in animal tests,’ Pharmaceutical Technology

 

BREAKING NEWS: June 10: ‘Study: Remdesivir prevented lung damage in monkeys infected with COVID-19,’ RTTNews

 

“Gilead Sciences’ experimental COVID-19 drug, remdesivir, reduced viral load and prevented lung disease in macaques infected with the coronavirus, according to a study published in the medical journal Nature. … Remdesivir, an antiviral drug that was initially created to treat Ebola, is the first drug to show improvement in COVID-19 in human trials,” the report said.

 

June 9: ‘Novavax announces high neutralizing antibody titers in COVID-19 vaccine,’ BioCentury

 

“In a June 2 presentation, Novavax showed that NVX CoV2373 induced animals to produce neutralizing antibodies against SARS-CoV-2 and that titers increased at least eightfold following a second vaccination. The company also showed that Matrix-M enhances immunogenicity,” the article noted.

 

June 9: ‘Mini-organs push along Covid-19 and other virus research’ Knowable Magazine

 

“Organoids can do a lot — but not everything, [Josef] Penninger [a medical geneticist at the University of British Columbia in Vancouver] acknowledges: ‘This will not replace animal models,”’ the article said.

 

June 9: ‘LegoChem licenses in COVID-19 treatment candidates,’ Korea Biomedical Review

 

“When judged based on animal test results, candidates introduced through this technology transfer are likely to be developed as therapeutic agents that are effective against various viruses that have undergone mutation,” LegoChem Bioscience CEO Kim Yong-joo said.

 

June 9: ‘Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2,’ Nature

 

June 9: ‘Gilead’s remdesivir prevents lung damage in COVID-19 study on monkeys,’ Reuters

 

June 9: ‘South Korea’s Daewoong Pharmaceutical says anti-parasitic drug effective against coronavirus in animal tests,’ Reuters

 

June 9: ‘Coronavirus rips through Dutch mink farms, triggering culls to prevent human infections,’ Science

 

June 9: ‘If approved, COVID-19 vaccine patch could eliminate painful shot,’ Scripps Media

 

“Scientists at the University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center have created a fingertip-sized skin patch that is also showing promising results in animal testing,” the article said.

 

June 9: ‘Can a vaccine for COVID-19 be developed in record time?’ The New York Times

 

The Times held a virtual round table discussion with a virologist, a vaccine scientist, an immunologist and oncologist, a biotech scientist and inventor, and a former head of the Food and Drug Administration.

“An ideal animal model is one that reproduces the human disease as closely as possible — in which, for example, clinical signs resembling symptoms in humans are observed, virus replication is observed in similar organs, immune response mirrors that in humans and so on. In addition, an animal model is often used to demonstrate whether a virus can be transmitted from an infected to an uninfected animal,” said Susan Weiss, a microbiology professor at the University of Pennsylvania. “Scientists use animal models to understand how the virus causes disease.”

 

June 9: ‘With an internet of animals, scientists aim to track and save wildlife,’ The New York Times

 

June 9: ‘Update: China Focus: Chinese researchers publish inactivated COVID-19 vaccine’s effect on animals,’ Xinhua News Agency

 

June 8: ‘Niclosamide proves effective against COVID-19 in Daewoong’s animal test,’ Business Korea

 

June 8: ‘Experts optimistic in search for COVID-19 vaccine,’ HealthDay News

 

Animal research is an important part of the vaccine testing process.

 

June 8: ‘Two cats are first US pets to be sickened with COVID-19,’ HealthDay News

 

June 8: ‘Does CSF antibody testing confirm coronavirus in the brain?’ Medscape Medical News

 

“It’s not clear how the virus invades the brain, said [Dr. Karima] Benameur. Some speculate it could be through the olfactory nerve, which might explain why some patients lose their sense of taste and/or smell,”  the article said. “Benameur noted that animal research shows that when the virus is injected into nose fibers, it can travel to the brain.”

 

June 8: ‘The race for a coronavirus vaccine runs on horseshoe crab blood,’ Smithsonian Magazine

 

June 8: ‘For experts who study coronaviruses, a grim vindication,’ Undark Magazine

 

“Scientists had for years been finding viral strains in bats and other animals that were genetically similar to the virus behind the SARS epidemic. But sequence data has its limits,” the article said.

 

June 7: ‘The next pandemic is coming – and sooner than we think, thanks to changes to the environment,’ Australian Broadcasting Corporation

 

“Nearly all emerging pathogens like COVID-19 come from ‘zoonotic transfer’ — essentially, when a virus present in animals jumps to infect humans. … Zoonotic diseases are particularly complex because they overlap multiple sectors — environment, agriculture, and health — that are often siloed from one another,” the article said. “Dr. [Simon] Reid says his dream project would bring together researchers with knowledge of across multiple fields, including from human and animal medicine, ecology, sociology, microbiology and those who study the transmission of pathogens in humans, wildlife, and livestock.”

 

June 7: ‘Fujifilm says COVID-19 drug research might get extended till July,’ Republic World

 

“The trial involved the drug to be administered for a maximum of 14 days to coronavirus patients between 20 and 74 years old with mild pneumonia. The study excludes pregnant women due to side effects shown in animal testing, [a Fujifilm spokesman] added,” the report said.

 

June 7: ‘Study shows COVID-19 can spread easily between cats,’ The Asahi Shimbun

 

June 6: ‘Coronavirus: This is not the last pandemic,’ BBC News

 

“Many scientists agree that our behaviour – particularly deforestation and our encroachment on diverse wildlife habitats – is helping diseases to spread from animals into humans more frequently,” the article said.

 

June 6: ‘China begins phase 1 clinical trials of neutralizing antibody treatment for COVID-19,’ Global Times

 

“The phase I clinical trial will test the safety and dosage of the neutralizing antibody among healthy people, and this is a clinical trial for the world-first neutralizing antibody treatment against COVID-19 among healthy people after non-human primate experiments,” the article said.

 

June 5: ‘Daewoong reports progress in animal testing of tapeworm treatment medicine as COVID-19 medication,’ Aju Business Daily

 

June 5: ‘Sorrento Therapeutics stock surges after COVID-19 drug breakthrough,’ Idaho Reporter

 

“STI-4398 COVIDTRAP protein and STI-1499 neutralizing antibody have shown efficacy in an in vitro cellular infection model for SARS-CoV-2 established in our laboratory and these results justify now the progression into animal studies. We are planning to submit all preclinical data for scientific publication in the next two to three months,” said Dr. Slobodan Paessler.

 

June 5: ‘Coronavirus vaccine developers wary of errant antibodies,’ Nature

 

“I think the way forward is to take it seriously, do some animal studies, show you don’t have enhancement, monitor during the trial,” Novavax President of R&D Gregory Glenn said.

 

June 5: ‘Frozen cells and empty cages: researchers struggle to revive stalled experiments after the lockdown,’ Nature

 

The article focuses on the gradual resumption of research in animal laboratories in the U.S. as the preliminary stages of reopening get underway.

 

June 5: ‘The biggest mystery: what it will take to trace the coronavirus source,’ Nature

 

“SARS-CoV-2 came from an animal but finding which one will be tricky, as will laying to rest speculation of a lab escape,” Nature noted.

 

June 5: ‘This cow’s antibodies could be the newest weapon against COVID-19,’ Science

 

June 5: ‘Researchers study how often household pets contract COVID-19,’ The Daily Evergreen

 

June 4: ‘K-State veterinary research team receives federal grant,’ KSNT

 

“The directors also plan to expand the program by obtaining additional grants that they can use to begin coronavirus research,” the report said.

 

June 4: ‘A German shepherd is first dog in the U.S. to test positive for the coronavirus,’ National Geographic

 

BREAKING NEWS: June 4: ‘Crab blood can save your life, but not the synthetic stuff,’ Popular Mechanics

 

“Horseshoe crab blood and rFC are both used to screen injectable drugs for the presence of toxic contamination. The crabs’ unique blood chemistry leads to unmistakably clear reactions to endotoxins, which include E. coli and salmonella,” the article said.

 

BREAKING NEWS: June 4: ‘Tyson the alpaca takes heavyweight role in search for coronavirus vaccine,’ Reuters

 

Take a look at the coronavirus research Tyson the alpaca is helping with. “We know that it is the antibodies that are directed to the same very, very precise part of the virus that are important and that is what we have engineered with this antibody from Tyson,” said Gerald McInerney, head of a team at the Karolinska Institute. “In principle, all the evidence would suggest it will work very well in humans, but it is a very complex system.”

 

What’s next for Tyson? Life on his farm in Germany.

 

June 4: ‘Does Fido have coronavirus? Tufts researchers are testing hundreds of animals to find out,’ The Boston Globe

 

June 4: ‘The coronavirus pandemic claims another victim: Medical research for deadly rare diseases,’ The Washington Post

 

This article highlights the impact the COVID-19 pandemic is having on research using animal models, including research to find cures for rare diseases.

 

June 4: ‘A coronavirus vaccine could require you to get two shots. Here’s why,’ USA Today

 

“Phase 1 studies look at both dose size and, if animal studies suggest two doses might be needed, then they also look at one dose versus two doses,” said Dr. Kelly Moore, associate director of immunization education for the Immunization Action Coalition.

 

June 3: ‘The keys to speed in race for vaccine, and its perils,’ Bloomberg

 

“After testing a vaccine in animals, developers must show it’s safe and effective in humans,” the article said.

 

June 3: ‘COVID-19 drug shows 100-fold drop in viral load in animal testing, South Korea’s Celltrion says,’ Fox News

 

June 3: ‘First US dog in NY contracts COVID-19; NC pug didn’t actually have it, experts say,’ Miami Herald

 

June 3: ‘Tests for coronavirus vaccine need this ingredient: Horseshoe crabs,’ The New York Times

 

June 3: ‘Animal medicine might play a crucial role in developing the sought-after coronavirus vaccine,’ The Telegraph

 

June 3: ‘WHO resumes study of hydroxychloroquine for treating COVID-19,’ Time

 

“Studies in animals and cell cultures in the lab show it may also help suppress the aggressive immune reaction that doctors have seen in some patients’ lungs and respiratory systems. That suggests that by the time a COVID-19 patient is hospitalized, it might be too late for hydroxychloroquine to help, since the infection is already well underway,” the report said.

 

June 2: ‘Household cat in Minnesota confirmed with virus that causes COVID-19,’ KELO.com

 

June 2: ‘Does interferon therapy work in COVID-19?’ News Medical

 

“The potential for the use of interferons in coronavirus infections was examined in the earlier outbreaks of SARS and MERS. In vitro experiments showed that interferons did have antiviral activity on the SARS-CoV, especially IFN-β and IFN-γ, and for IFN- β, against MERS-CoV as well,” the article said. “Follow-up animal experiments showed that IFN-β had higher antiviral activity against MERS CoV compared to the lopinavir-ritonavir combination.”

 

June 2: ‘New gene-edited lab mice are especially good at catching COVID-19,’ OneZero

 

June 2: ‘Ibuprofen to be tested as treatment to reduce COVID-19 breathing problems,’ Press Association

 

“This is very promising. But of course it is an animal study, so we want to translate that really compelling result into humans,” King’s College London neuroimaging and psychopharmacology professor Mitul Mehta told the PA news agency.

 

June 2: ‘South Korea expects human trials of Celltrion’s potential COVID-19 treatment in Europe,’ Reuters

 

The company will move to clinical trials after testing in animals.

 

June 2: ‘Carver County cat is first animal in Minnesota diagnosed with COVID-19,’ St. Paul Pioneer Press

 

June 2: ‘Results of comprehensive SARS-CoV-2 animal model study published in Nature Microbiology,’ Texas Biomedical Research Institute

 

June 2: ‘Monkeys, ferrets offer needed clues in COVID-19 vaccine race,’ The Associated Press

 

June 2: ‘Confirmation of COVID-19 in pet dog in New York,’ USDA Animal and Plant Health Inspection Service

 

June 1: ‘Celltrion achieves initial progress in animal testing of candidates for antibody treatment,’ Aju Business Daily

 

June 1: ‘SARS-CoV-2 looks like a hybrid of viruses from two different species,’  Ars Technica

 

June 1: ‘What to know about potential COVID-19 treatment remdesivir,’ Healthline

 

“Even before COVID-19, Gilead had tested remdesivir against other coronaviruses — including those that cause SARS and MERS — in laboratory and animal studies,” the report noted.

 

June 1: ‘What’s the risk that animals will spread the coronavirus?’ Nature

 

June 1: ‘Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests,’ Pharmaceutical Technology

 

June 1: ‘Operation Warp Speed selects billionaire scientist’s COVID-19 vaccine for monkey tests,’ Science

June 1: ‘Antibody injections could fight COVID-19 infections – an infectious disease expert explains the prospects,’ The Conversation

“Why are animal models so important? Because there are many other factors that could affect antibody efficacy in a living organism that can’t be simulated in a petri dish,” the article said. “For example, how long are mAbs functional in the body and are they safe? Animal models can provide preliminary safety data. Beyond animal models, a key mAb property to consider is whether it can be efficiently manufactured in a stable, safe form for human use.”

May

 

May 31: ‘Animals at university research labs still get care during the pandemic — but scores have been euthanized to conserve “critical resources,”’ Chicago Tribune

 

May 31: ‘South Korea’s Celltrion aims to start in-human COVID-19 drug trial in July,’ Reuters

 

“South Korea’s Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it aims to start in-human clinical trials in late July,” the report said.

 

May 30: ‘The search for an animal model to study COVID-19,’ The Hindu

 

May 30: ‘Russia approves flu drug’s use against COVID-19,’ The Wall Street Journal

 

“Japan approved Avigan as a flu drug in 2014. It has only been used as a backup treatment and not given to most patients, partly because animal testing showed it could potentially cause birth defects,” WSJ reported.

 

May 29: ‘USDA says testing “unable to verify infection” in dog presumed to have COVID-19,’ ABC News

 

May 29: ‘Scientists develop COVID-19 test for dolphins, sea turtles,’ E&E News

 

May 29: ‘Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19,’ Heart Rhythm

 

“In this study we used optical mapping to demonstrate the arrhythmic effects of [hydroxychloroquine (HCQ)] on [guinea pig] and rabbit hearts perfused with the upper therapeutic serum dose of HCQ (1000 ng/mL),” the authors wrote.

 

May 29: ‘Five facts about seeking a COVID-19 vaccine,’ RealClearPolicy

 

Fact #2: “Animal research suggests COVID-19 survivors may gain immunity.”

 

May 29: ‘Rapid COVID-19 vaccine development,’ Science

 

“It will be important to demonstrate the potential for vaccine efficacy in early-phase clinical studies by measuring the induction of neutralizing antibodies and in animal models by demonstrating protection against virus replication and disease,” the article said.

 

May 29: ‘Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2,’ Science

 

May 29: ‘Evolution of pandemic coronavirus outlines path from animals to humans,’ ScienceDaily

 

May 29: ‘Can veterinarians save us from the next pandemic?’ The Hill

 

May 29: ‘COVID-19 human challenge studies: ethical issues,’ The Lancet

 

“Although vaccines are usually associated with very low risks, experimental vaccines might not protect participants and, in some cases, might even increase the severity of disease among those who are subsequently infected. These outcomes have occurred, for example, for vaccines against respiratory syncytial virus (46) and dengue virus, (47) in some cases resulting in small numbers of deaths among participants in vaccine research,” the article said. “This kind of danger might apply to coronavirus vaccines, because vaccine-enhanced disease has been observed in animal challenge studies with coronaviruses (12).”

 

May 29: ‘Research labs to become operational in coming weeks,’ The Pitt News

 

“Since each lab is different, the procedures will vary. For example, the animal research labs cannot allow researchers into the lab past a certain time or it will interfere with the circadian rhythms of the animals — making it difficult to have multiple shifts,” the report said.

 

May 28: ‘Researchers look at role of pets in COVID-19 transmission,’ Journal of the American Veterinary Medical Association

 

May 28: ‘Federal government rents monkeys from Denver business to fight COVID-19,’ LancasterOnline

 

May 28: ‘Ferritin heavy chain protein shows promise as a potential SARS-CoV-2 vaccine or antiviral,’ News Medical

 

“Research on COVID-19 patient samples has shown the presence of two antibodies that inhibit viral RBD-ACE2 binding. Animal experiments have shown that these could reduce the viral load in the lungs of infected mice,” Dr. Liji Thomas wrote.

 

May 28: ‘COVID-19 vaccine developers search for antibodies that “first do no harm,”’ Scientific American

 

Scientists “are connecting hypothetical dots based on past studies of experimental vaccines for previous outbreaks of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), in which some immunized animals developed more severe disease,” the report said.

 

May 28: ‘Novartis inks deal to make experimental coronavirus vaccine,’ The Wall Street Journal

 

“The Swiss drugmaker’s gene therapy unit AveXis is already making test batches of the vaccine and plans to start producing doses later in the summer that can be used for a clinical trial, said Dave Lennon, the unit’s president. … The Novartis unit has so far committed to manufacture doses for animal studies and a phase 1 trial, free of charge, Dr. Lennon said,” WSJ reported.

 

May 27: ‘Dogs sniff out coronavirus “far better than machines or tests,”’ Alliance for Science

 

May 27: ‘Chinese researchers find human neutralizing antibody targeting COVID-19 receptor binding site,’ Global Times

 

Researchers working with rhesus macaques published results in Nature on May 26.

 

May 27: ‘UTSA professor’s “rabbit fever” vaccine to be tested against coronavirus,’ San Antonio Express-News

 

May 27: ‘A small number of monkeys could help millions of people: Coronavirus vaccine testing,’ Speaking of Research

 

May 27: ‘US company trials coronavirus vaccine candidate in Australia,’ The Associated Press

 

Novavax started clinical trials for a coronavirus vaccine candidate, NVX-CoV2373, in Australia. Animal tests showed positive results in low doses.

 

May 27: ‘Coronavirus questions: 10 things we still urgently want to know about COVID-19 in the next 100 days,’ USA Today

 

“Oxford University in England and Maryland-based vaccine company Novavax seem ahead of the global race as their vaccine candidates have shown success in animal trials,” USA Today noted.

 

May 26: ‘Nature publishes preclinical characterization and primate efficacy data on Junshi Biosciences’ COVID-19 neutralizing antibodies,’ Globe Newswire

 

May 26: ‘A human neutralizing antibody targets the receptor binding site of SARS-CoV-2,’ Nature

 

Researchers working with rhesus macaques found the first human neutralizing monoclonal antibody for COVID-19.

 

May 26: ‘Merck, one of Big Pharma’s biggest players, reveals its COVID-19 vaccine and therapy plans,’ Science

 

Merck Research Laboratories President Roger Perlmutter reportedly said the company plans to look at EIDD-2801’s cancer-causing potential in reproductive and developmental biology animal studies.

 

May 26: ‘Coronavirus: why we’re using llamas to help fight the pandemic,’ The Conversation

 

May 26: ‘Taxpayers paid to develop remdesivir but will have no say when Gilead sets the price,’ The Washington Post

 

“In remdesivir’s case, government researchers narrowed the search from 1,000 compounds to the chemical that would become remdesivir, confirmed its potency in laboratory tests, tested it in monkeys, and finally sponsored a pivotal clinical trial in humans,” the report said.

 

May 26: ‘COVID-19 vaccine development,’ U.S. Government Accountability Office

 

“In the preclinical phase, researchers use cells and animals to assess safety and produce evidence of clinical promise, evaluated by the candidate’s ability to elicit a protective immune response,” a GAO report said.

 

May 25: ‘Thailand enters global race for vaccine with trials on monkeys,’ Agence France-Presse

 

May 25: ‘“A key milestone”: COVID-19 vaccine “highly effective” in ferrets, says VIDO-Intervac,’ Saskatoon StarPhoenix

 

May 25: ‘Canadian coronavirus vaccine candidate delivers promising results in animal tests,’ The Globe and Mail

 

May 24: ‘Who’s leading the race? A guide to coronavirus vaccines in the pipeline,’ Australian Broadcasting Corporation

 

“While it will be some months before we know whether any of the proposed vaccines are effective, initial safety trials and encouraging animal studies show promising early signs,” ABC noted.

 

May 24: ‘How animal research at UGA is adapting to COVID-19,’ The Red & Black

 

May 22: ‘VIDO-Intervac wraps up animal phase of COVID-19 vaccine testing,’ CKOM News

 

May 22: ‘SARS-CoV-2 transmission in cats,’ Outbreak News TV

 

May 22: ‘The coronavirus vaccine is on track to be the fastest ever developed,’ The New Yorker

 

“In mice, the vaccine provided full protection against viral replication in the lungs, which researchers tested by giving mice the vaccine and then deliberately infecting them with the virus,” The New Yorker reported about Moderna’s experimental vaccine. “(Scientists place a small drop of virus-laced fluid over the mouse’s nostrils. Similar trials on rhesus macaques are about to start.)”

 

May 22: ‘Coronavirus vaccine shows promising early results in China,’ The New York Times

 

The report said:

 

“‘This is promising data, but it’s early data,’ said Dr. Dan Barouch, director of vaccine research at Beth Israel Deaconess Medical Center in Boston, who was not involved in the work. ‘Over all, I would say this is good news.’

 

… And on Wednesday, Dr. Barouch and his colleagues published a study showing their prototype vaccine protected monkeys from coronavirus infection.”

 

May 21: ‘Airport dogs could sniff out coronavirus,’ CNN

 

May 20: ‘NIH supported MMRRC repository providing COVID-19 related mouse models for research,’ Mutant Mouse Resource & Research Centers

 

May 20: ‘New studies show that developing a coronavirus vaccine should be possible,’ NPR

 

“Three studies published Wednesday suggest it should be possible to come up with a coronavirus vaccine — tests performed on animals have shown the right results to prove a vaccine could be possible,” NPR reported.

 

May 20: ‘Inovio says COVID-19 vaccine produces antibodies in mice, guinea pigs,’ Reuters

 

May 20: ‘DNA vaccine protection against SARS-CoV-2 in rhesus macaques,’ Science

 

May 20: ‘Human viruses can jump into animals, too—sowing the seeds of future epidemics,’ Scientific American

 

BREAKING NEWS: May 20: ‘Two studies suggest COVID-19 antibodies provide immunity,’ The Boston Globe

 

Two studies published in Science found antibodies to SARS-CoV-2 provide some level of immunity in rhesus macaque monkeys, though it is unknown how long protection lasts.

 

May 20: ‘Wistar Institute coronavirus vaccine shows signs of eliciting immune response in animals,’ The Daily Pennsylvanian

 

May 20: ‘Vaccines can protect against COVID-19 in nonhuman primates, study says,’ The Harvard Gazette

 

May 20: ‘Two new studies suggest COVID-19 antibodies provide immunity,’ The Hill

 

“In one of the studies, nine rhesus macaque monkeys, which share 93 percent of the same DNA as humans, were injected with SARS-CoV-2, the virus that causes COVID-19. The virus quickly spread and all of the animals developed viral pneumonia, though all of them recovered within 28 days,” The Hill reported.

 

May 20: ‘Progress reported for coronavirus vaccines from Jefferson and Wistar, skepticism about Moderna,’ The Philadelphia Inquirer

 

“Our partnership with Bharat Biotech will accelerate our vaccine candidate through the next phases of development,” Jefferson Vaccine Institute Director Matthias Schnell said. “We will be able to complete animal testing and move to a phase 1 clinical trial [in humans] rapidly.”

 

May 20: ‘A new entry in the race for a coronavirus vaccine: Hope,’ The New York Times

 

“Animal studies have raised expectations, too. Researchers at Beth Israel Deaconess Medical Center on Wednesday published research showing that a prototype vaccine effectively protected monkeys from infection with the virus,” the article said. “The findings will pave the way to development of a human vaccine, said the investigators.”

 

May 20: ‘How would a drug to potentially treat the coronavirus be developed?’ Utah Public Radio

 

“Once they’ve determined an animal’s coronavirus symptoms, [Utah State University Professor Brett] Hurst said they can treat the animals with the drugs that proved to be successful in the human-cell model,” the report said.

 

May 20: ‘COVID-19 vaccine possible by early 2021, local expert says,’ WWL-TV

 

“Another thing that was similar to humans is that most of the animals [primates] didn’t get sick, visibly ill, but there were a couple that did,” said Dr. Skip Bohm, chief veterinary medical officer of the Tulane National Primate Research Center.

 

May 19: ‘Coronavirus vaccine trials have delivered their first results — but their promise is still unclear,’ Nature

 

“One way to find out whether vaccines can prevent transmission would be to study them in animals that are naturally susceptible to the virus and seem capable of spreading it, such as ferrets and hamsters, says [University of Pittsburgh Center for Vaccine Research aerobiologist Douglas] Reed,” the article said.

 

May 18: ‘As researchers at Northwestern and elsewhere scramble to find a treatment for COVID-19, they hope this time the money won’t run out before the next threat hits,’ Chicago Tribune

 

“When researchers identify the genetic sequence of a protein or enzyme that is essential to the virus’s replication, they then look for a compound that blocks it, called the inhibitor. The compounds are developed into a drug that not only lasts long enough in the body to kill the virus but is also nontoxic,” the report said. “Only then can it move to animal trials and, eventually, human trials.”

 

May 18: ‘CureVac ramps up COVID-19 mRNA vaccine effort as Moderna analysts raise questions about animal data,’ FierceBiotech 

 

“CureVac said late last week that its lead COVID-19 vaccine candidate generated ‘high levels’ of virus-neutralizing titers in animal models and that it ‘has the potential to induce a strong immunologic response to neutralize SARS-CoV-2,'” the report said.

 

May 18: ‘Lawrence Livermore scientists part of three-institution team working to develop vaccine for tularemia,’ Lawrence Livermore National Laboratory

 

Two Lawrence Livermore National Laboratory researchers will collaborate with scientists from the University of New Mexico and the Tulane National Primate Research Center.

“Lab researchers see the [nanolipoprotein particles] NLPs platform as a flexible tool that can broadly be applied to developing vaccines for different pathogens,” the press release said.

 

May 18: ‘Moderna’s coronavirus vaccine shows promise in early results,’ Live Science 

 

The article said:

“‘These interim phase 1 data, while early, demonstrate that vaccination with mRNA-1273 elicits an immune response of the magnitude caused by natural infection starting with a dose as low as 25 µg,’ Dr. Tal Zaks, the chief medical officer at Moderna, said in the statement. When combined with data from the mouse study, these results ‘substantiate our belief that mRNA-1273 has the potential to prevent COVID-19 disease and advance our ability to select a dose for pivotal trials.’”

 

May 18: ‘Early data show Moderna COVID-19 vaccine generates immune response,’ STAT News

 

“The neutralizing antibody and safety results from the Phase 1 clinical study are promising for the Moderna mRNA vaccine candidate and supportive to proceed forward with the planned Phase 2 studies,” RenovaCare Chief Scientific Officer Robin Robinson told STAT.

The health-oriented news website reported: “Vaccination with the candidate vaccine, provisionally labeled mRNA-1273, also prevented viral replication in the lungs of mice in preclinical testing, the [Moderna’s] statement said.”

 

May 18: “Why Rhesus monkeys are used for most vaccine trials,” The Times of India

 

May 18: ‘Tulane scientists discuss ongoing coronavirus research including plans to vaccinate animals,’ WVUE

 

May 18: ‘Chinese researchers identify highly potent neutralizing antibodies against COVID-19,’ Xinhua News Agency

 

“Chinese researchers have successfully identified multiple highly potent neutralizing antibodies against SARS-CoV-2, the virus that causes COVID-19, from convalescent plasma by high-throughput single-cell sequencing, according to a new study published in Cell on Sunday. … New results from animal studies showed that neutralizing antibodies provide a potential cure for COVID-19 as well as a means for short-term prevention, which marks a major milestone in the fight against the pandemic,” the report said.

 

May 15: ‘Coronavirus vaccine: Macaque monkey trial offers hope,’ BBC News

 

BREAKING NEWS: May 15: ‘Researchers use cows to develop antibody treatment,’ CNN

 

“Scientists at SAb Biotherapeutics are planning to start studies this summer on coronavirus treatments created by using antibodies derived from cows with genetically engineered human immune systems,” CNN reported. Watch the video segment.

 

May 15: ‘Coronavirus research: The known “risk” scientists are taking in race for COVID-19 vaccine,’ Nine News Sydney

 

“It costs quite a bit of money to run phase one and two studies, and you might be halfway through that when you show your animal has no protection,” Director of the Peter Doherty Institute for Infection and Immunity Sharon Lewin said.

 

May 15: ‘Testing of COVID-19 skin patch vaccine begun by Verndari Inc. in collaboration with UC Davis,’ The California Aggie

 

“Before you move [the vaccine] into the human, […] you need to work in multiple animal models, which takes time, to show that not only were you able to show that it’s safe, but that in the event that that individual got infected, it stopped the infection from causing a clinical disease or at least reduced the clinical symptoms,” said Kristin Grimsrud, the associate director of vivaria and veterinary care at UC Davis’ Mouse Biology Program.

 

May 15: ‘UK researchers hope dogs can be trained to detect coronavirus,’ The Guardian 

 

Research has shown that diseases such as malaria have a distinctive odor and also that respiratory disease can change the body’s odor. Scientists are working to determine if medical detection dogs can detect COVID-19 in humans.

 

May 14: ‘Pathogenesis and transmission of SARS-CoV-2 in golden hamsters,’ Nature

 

May 14: ‘From hamsters to baboons: The animals helping scientists understand the coronavirus,’ Scientific American

 

May 14: ‘SARS lessons for COVID-19 vaccine design,’ ScienceDaily

 

“The ‘spike’ proteins of both SARS-CoV and SARS-CoV-2 are related and they attach to the same molecule called ACE 2 on human cells to infect people. We now also know through animal experiments with SARS-CoV-2 that neutralising antibodies protect from reinfection,” University of Melbourne professor Kanta Subbarao wrote in an article.

 

May 14: ‘WSU researchers look to head off COVID-19’s deadly pneumonia,’ WSU Insider

 

This Washington State University press release announced the development of an antibody that successfully neutralizes protein A9, a protein that triggers inflammation, including severe pneumonia in COVID-19 patients. University researchers discovered the specific role of this A9 protein by doing research with mice and studying the A9 protein in mice. Then they were able to develop an antibody.

 

May 13: ‘GC Wellbeing finds placenta injection relieves COVID-19 symptoms through animal testing,’ Aju Business Daily

 

A Korean placenta injection showed positive results in a ferret model.

 

May 13: ‘UW studying coronavirus’s impact on pets,’ Patch

 

May 13: ‘Infection of bat and human intestinal organoids by SARS-CoV-2,’ Nature

 

May 13: ‘Cats with no symptoms spread virus to other cats in lab test,’ The Associated Press

 

May 12: ‘Respiratory disease in rhesus macaques inoculated with SARS-CoV-2,’ Nature

 

May 12: ‘Research underway to understand how COVID-19 affects different animal species,’ Scripps Media

 

BREAKING NEWS: May 12: ‘Unveiling “Warp Speed,” the White House’s America-first push for a coronavirus vaccine,’ Science

 

The White House will soon announce its “Operation Warp Speed” to speed up the development of a COVID-19 vaccine. “The project, vaguely described to date but likely to be formally announced by the White House in the coming days, will pick a diverse set of vaccine candidates and pour essentially limitless resources into unprecedented comparative studies in animals, fast-tracked human trials, and manufacturing,” the article said.

 

May 12: ‘Pigs exempted: Study uncovers 48 animal species most likely to get coronavirus,’ Science Times

 

May 11: ‘Researchers develop promising MERS vaccine, with potential for COVID-19,’ Drug Target Review

 

“A Korean research team has developed a new vaccine platform using RNA-based adjuvants for the Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), which showed promise in nonhuman primates,” the publication reported.

 

May 11: ‘New HIV vaccine combination strategy provides better and more durable protection,’ Emory University

 

“Researchers from the Emory Consortium for Innovative AIDS Research in Nonhuman Primates and their colleagues across North America have shown a new HIV vaccine is better at preventing infection and lasts longer, continuing to protect one year after vaccination. The findings, which are published online today in Nature Medicine, provide important insights for preventing HIV, and the timeliness of the results could also help shape the scientific community’s approach to developing vaccines for COVID-19,” a press release said.

 

May 9: ‘Animals and COVID-19,’ The Scranton Times-Tribune

 

“Recent research shows that ferrets, cats and golden Syrian hamsters can be experimentally infected with the virus and can spread the infection to other animals of the same species in laboratory settings,” the Q&A article said.

 

May 8: ‘From proposals to funded research in 48 hours: Tulane scientists receive Fast Grants,’ Tulane

 

“Mairi Noverr of Tulane University School of Medicine along with Monica Vaccari and Tracy Fischer of Tulane National Primate Research Center all received Fast Grants for COVID-19 research,” according to the university.

 

May 7: ‘Vanderbilt University Medical Center and IDBiologics ally in race to develop breakthrough medicines for COVID-19,’ Business Wire

 

May 7: ‘The latest on the COVID-19 vaccine,’ Extra TV

 

On May 7, Extra TV’s Billy Bush sat down with Dr. Armand Dorian to discuss the latest headlines surrounding COVID-19. They discussed the University of Oxford’s successful COVID-19 vaccine trials with rhesus macaques. This allowed Oxford University to move into human trials in late April. Watch the Extra TV segment to learn more! Video credit: Extra TV

 

May 7: ‘Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins,’ Nature

 

May 7: ‘The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice,’ Nature

 

May 6: ‘Pitt collaborating with other researchers on nasal spray that could prevent coronavirus infection,’ CBS Pittsburgh

 

“In animal studies, Q-griffithsin worked against Ebola, hepatitis, MERS, SARS and other viruses,” the report said.

 

May 6: ‘Rapid development of an inactivated vaccine candidate for SARS-CoV-2,’ Science 

 

May 6: ‘Hoping llamas will become coronavirus heroes,’ The New York Times

 

May 5: ‘Antibodies from llamas are a promising avenue in fight against COVID-19,’ Laboratory Equipment

 

BREAKING NEWS: May 5: ‘Belgian, U.S. scientists look to llama in search for COVID-19 treatment,’ Reuters

 

“A llama called Winter could prove useful in the hunt for a treatment for COVID-19, according to U.S. and Belgian scientists who have identified a tiny particle that appears to block the new coronavirus,” the article said.

 

May 4: ‘Fauci: No scientific evidence the coronavirus was made in a Chinese lab,’ National Geographic

 

“Fauci has said that he thinks a final vaccine could be available for general use as early as January, which would break records for the speed at which previous vaccines were developed,” National Geographic reported. “One reason for his confidence is the ‘impressive’ results being seen now in animals tested with a vaccine candidate made by Cambridge, Massachusetts-based Moderna Therapeutics, which brought it into human trials in a record 42 days.”

 

May 4: ‘How coronavirus is affecting the world’s endangered animals,’ Reader’s Digest

May 4: ‘San Antonio researchers land $200,000 to develop possible COVID-19 vaccine,’ San Antonio Current

 

May 4: ‘A coronavirus vaccine project takes a page from gene therapy,’ The New York Times

 

Researchers at two Harvard-affiliated hospitals have studied their vaccine candidates in mice. The team expects to test for safety in monkeys in about a month.

 

May 1: ‘COVID-19 antibody testing: Tougher than true/false,’ Knowable Magazine

 

“Animal research does suggest that SARS-CoV-2 antibodies may appear and confer some immunity,” the article said.

 

May 1: ‘Impression Healthcare to commence animal testing of CBD drug for COVID-19 related respiratory conditions,’ Small Caps

 

April

 

April 30: ‘Animal health laboratories aid testing for COVID-19 in people,’ Journal of the American Veterinary Medical Association

 

April 30: ‘Napa company begins testing a potential COVID-19 vaccine,’ Napa Valley Register

 

“Verndari, Inc. is also in discussions with the California National Primate Research Center at UC Davis to conduct further testing in nonhuman primates,” the article said.

 

April 30: ‘Verndari begins preclinical testing of COVID-19 vaccine candidate,’ Pharma News Daily

 

April 30: ‘We found and tested 47 old drugs that might treat the coronavirus: Results show promising leads and a whole new way to fight COVID-19,’ The Conversation

 

April 30: ‘Old drugs may find a new purpose: Fighting the coronavirus,’ The New York Times 

 

April 30: ‘San Antonio Partnership for Precision Therapeutics awards $200,000 toward COVID-19 vaccine project,’ The University of Texas at San Antonio

 

“Vaccine development takes a long time. There has to be rigorous testing in different animal models, and then small-scale studies in humans,” said microbiologist Karl Klose, director of the South Texas Center for Emerging Infectious Diseases and professor of microbiology at UTSA. “The process is designed to ensure the safety of the people who take the vaccine. We will learn a lot from this process, including how to use a live vaccine platform to protect against an emerging disease. Hopefully in the future, we can respond quicker with a vaccine against the next pandemic.”

 

April 29: ‘UC Davis researchers to begin testing coronavirus vaccine patch this week,’ CBS Sacramento

 

“Verndari, Inc., a biopharmaceutical company based in Napa, will begin preclinical testing of a possible coronavirus vaccine on mice this week in partnership with UC Davis’ mouse biology program,” the report said.

 

April 29: ‘Research delayed, rodent populations reduced during pandemic,’ Journal of the American Veterinary Medical Association

 

BREAKING NEWS: April 29: ‘Maine research facility working with mice to develop more COVID-19 testing,’ WGME

 

“This is gonna be a critical piece. It’s like you can’t fight a war without tanks,” said Dr. Ed Liu, president and CEO of The Jackson Laboratory. “You can’t fight a war, this war, the pandemic, without a model system to test whether the drugs or the vaccines work.”

 

April 29: ‘Gilead’s remdesivir improves recovery time of coronavirus patients in NIH trial,’ The Washington Post

 

April 28: ‘Flow Pharma reports Ebola vaccine success and how that directed FlowVax COVID-19 vaccine design,’ Accesswire

 

“Our article published today shows that a single injection of our Ebola vaccine provided 100% protection for mice exposed to Ebola virus” said Flow Pharma Chief Science Officer Charles Herst, the first author on the article. “By relying on killer T-cells rather than antibodies, FlowVax Ebola is able to attack the nucleocapsid protein located at the center of the virus where antibodies cannot reach. We are taking the same approach with FlowVax COVID-19.”

 

April 27: ‘In race for a coronavirus vaccine, an Oxford group leaps ahead,’ The New York Times

 

“Scientists at the National Institutes of Health’s Rocky Mountain Laboratory in Montana last month inoculated six rhesus macaque monkeys with single doses of the Oxford vaccine. The animals were then exposed to heavy quantities of the virus that is causing the pandemic — exposure that had consistently sickened other monkeys in the lab,” the report said. “But more than 28 days later all six were healthy, said Vincent Munster, the researcher who conducted the test.

 

‘The rhesus macaque is pretty much the closest thing we have to humans,’ Dr. Munster said, noting that scientists were still analyzing the result.”

 

April 26: ‘KBP begins testing COVID-19 vaccine candidate on animals,’ Owensboro Times

 

April 25: ‘Coronavirus: In a race against time, vaccine testing expands,’ Mercury News

 

April 24: ‘New COVID-19 vaccine shows promise in monkeys. Next step: humans,’ Live Science

 

April 24: ‘Celebrating #WorldImmunizationWeek 2020: #VaccinesWorkforAll,’ Speaking of Research

 

April 23: ‘A look back at medical advances in 2019 and the role played by animal research,’ European Animal Research Association

 

BREAKING NEWS: April 23: ‘COVID-19 vaccine protects monkeys from new coronavirus, Chinese biotech reports,’ Science

 

Beijing-based Sinovac Biotech’s COVID-19 vaccine-in-development showed promise in rhesus macaques, scientists reported.

 

April 23: ‘Three ways to make coronavirus drugs in a hurry,’ Scientific American

 

April 22: ‘Statement in support of the global research community’s efforts to end the COVID-19 crisis,’ Speaking of Research

 

This joint statement is the result of a collaboration between several research advocacy organizations along with individual biomedical researchers, animal care experts and university communicators.

 

April 20: ‘COVID-19: New animal data back up Gilead’s remdesivir as other treatment candidates emerge,’ FierceBiotech

 

April 20: ‘Why the new coronavirus affects some animals, but not others,’ Smithsonian Magazine

 

April 19: ‘PAK1-blockers: Potential therapeutics against COVID-19,’ Medicine in Drug Discovery

 

“Ciclesonide is used to treat inflammatory disesaes such as asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma etc. It was patented in 1990 and approved for adults and children 12 and over by the FDA in 2006,” the article said. “Regarding the molecular mechanism underlying its anti-inflammatory effect, it is most likely that this hormone blocks PAK1, mainly for following reasons: (i) first of all, inflammation in general requires PAK1 [3], and in PAK1-null mutant of mice no inflammation takes place [15], (ii) ciclesonide (10 mg/kg/day) almost completely suppresses the PAK1-dependent growth of lung cancer (A541 cell line) xenografts in immune-deficient mice as well [16], and (iii) this hormone was recently shown to block both PAK1-dependent replication and pathogenesis (fibrosis = lung inflammation) blocks COVID-19 pathogenesis clinically [2]: https://writening.net/page?FC3QPm.”

 

April 18: ‘Rocky Mountain Labs make advancements in race to combat COVID,’ NBC Montana 

 

“Investigators at Rocky Mountain Labs tested [remdesivir] in a non-human primate model, a SARS-Coronavirus Type 2 or Covid-19,” said RML’s associate director for scientific management, Dr. Marshall Bloom. “They found that this drug had significant affect in ameliorating the course and severity of COVID-19 infections in non-human primates, if given early enough during the course of the disease.”

 

April 17: ‘Coronavirus: Animal testing may be best tool to defeat COVID-19| Bailey,’ Asbury Park Press

 

April 17: ‘Investigational chimp adenovirus MERS-CoV vaccine protects monkeys,’ National Institutes of Health

 

April 17: ‘Remdesivir eases COVID-19 symptoms in monkeys in 12 hours, small preliminary study shows,’ Newsweek

 

April 16: ‘Scientists at Tulane National Primate Research Center studying vaccines, treatments for COVID-19,’ The Lens

 

April 14: ‘San Antonio researchers lead the race to create a coronavirus vaccine,’ KENS 5

 

“We have seven scientists and a staff of over 30 people working overtime on establishing [nonhuman primate] animal models,” Texas Biomed President and CEO Larry Schlesinger said.

 

April 14: ‘News feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine,’ Proceedings of the National Academy of Sciences of the United States of America

 

April 14: ‘Why will it take so long to develop a COVID-19 vaccine?’ The Globe and Mail

 

April 13: ‘Saskatoon based lab’s COVID-19 vaccine in animal testing stage,’ DiscoverMooseJaw.com

 

April 13: ‘Clinical trials for promising COVID-19 drug underway in north Texas,’ KERA News

 

“Remdesivir is one of the unique compounds that actually gets stuck and makes the replication complex stop in its tracks,” Dr. Robert Gottlieb told KERA. “It has been used against SARS in vitro, and actually that’s why it became such a good lead compound with the current epidemic. … We’ve studied [SARS-CoV-1] and some similar viruses like [MERS] … both in small animals as well as in larger animals, and this remdesivir seems to work just fine in those cases.”

 

April 13: ‘Could a 100-year-old vaccine protect against COVID-19?’ Live Science

 

April 13: ‘UC Davis researchers work toward developing potential vaccine for COVID-19,’ The Aggie

 

“We learned from [previous research] about basically how to grow this virus, what things might inhibit it, what are some vaccine strategies that could be tried and then we start to think about the biology of this new agent and whether these strategies are applicable,” said Denis Hartigan-O’Connor, an associate professor in the department of medical microbiology and immunology and a core scientist at the California National Primate Research Center.
 
 
 
 
 
 
“Veterinary diagnostic labs across the country are developing their own tests for Covid-19, and many use the same basic processes that human tests do,” the article said.
 
 
 
 
 
 
 
 
 
“In order to assess vaccine efficacy, COVID-19 specific animal models are being developed, including ACE2-transgenic mice, hamsters, ferrets and non-human primates. Biosafety-level 3 containment measures are needed for animal studies involving live-virus challenges, and the demand for these capabilities is likely to require international coordination to ensure that sufficient laboratory capacity is available,” the article said.
 
 
 
 
 
 
“Flow Pharma, Inc., a San Francisco Bay Area biotechnology company developing the FlowVax(TM) peptide vaccine platform technology, today announced that researchers at the University of Texas Medical Branch at Galveston (UTMB) will begin testing
Flow Pharma’s FlowVax COVID-19 vaccine candidate by challenging nonhuman primates with SARS-CoV-2, the virus that causes COVID-19 in humans, after the animals are vaccinated this month with FlowVax COVID-19,” a press release said.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“When you talk about developing a vaccine for millions of people, safety is an enormous priority,” said Dr. Mark Poznansky, director of the Vaccine and Immunotherapy Center at Massachusetts General Hospital.
 
 
 
 
 
 
Scientists from Emory University in Atlanta; the University of North Carolina at Chapel Hill; and Vanderbilt University Medical Center in Nashville, Tennessee, reported promising results after testing the drug EIDD-2801 on mice infected with coronaviruses similar to the one that causes COVID-19.
 
 
 
 
 
 
 
 
 
 
 
 
“In animal tests against SARS and MERS, diseases caused by similar coronaviruses, the drug helped prevent infection and reduced the severity of symptoms when given early enough in the course of illness,” the AP reported.
 
 
 
 
 
 
 
 
 
The Tulane National Primate Research Center in Louisiana will study COVID-19 in three species of nonhuman primates and evaluate potential COVID-19 vaccines and treatments in the nonhuman primate species that most closely mimics the progression of the disease in a human.
 
 
 
 
 
 
The World Health Organization cleared potential coronavirus vaccines for animal testing. Researchers in Australia have inserted vaccine samples into ferrets. “Australia’s Commonwealth Scientific and Industrial Research Organization (CSIRO) says its tests will be the first comprehensive pre-clinical trials of the vaccines to use an animal model,” the article said.